View Inc. - Ordinary Shares (VIEW) 10-Q 15 Jun 22 2021 Q2 Quarterly report Financial data

Cover Page

Cover Page - shares	6 Months Ended
	Jun. 30, 2021	Jun. 10, 2022
Entity Listings [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2021
Document Transition Report	false
Entity File Number	001-39470
Entity Registrant Name	VIEW, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	84-3235065
Entity Address, Address Line One	195 South Milpitas Blvd
Entity Address, City or Town	Milpitas
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95035
City Area Code	408
Local Phone Number	263-9200
Entity Current Reporting Status	No
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		219,222,346
Amendment Flag	false
Entity Central Index Key	0001811856
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q2
Class A common stock, par value, $0.0001 per share
Entity Listings [Line Items]
Title of 12(b) Security	Class A common stock, par value, $0.0001 per share
Trading Symbol	VIEW
Security Exchange Name	NASDAQ
Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
Entity Listings [Line Items]
Title of 12(b) Security	Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
Trading Symbol	VIEWW
Security Exchange Name	NASDAQ

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 451,359	$ 63,232
Accounts receivable, net of allowances of $224 as of June 30, 2021 and December 31, 2020, respectively	12,914	12,252
Inventories	8,295	6,483
Prepaid expenses and other current assets	8,633	6,213
Total current assets	481,201	88,180
Property and equipment, net	273,765	282,560
Restricted cash	8,468	10,461
Deposits with supplier	588	1,084
Other assets	5,926	7,862
Total assets	769,948	390,147
Current liabilities:
Accounts payable	9,847	14,562
Accrued expenses and other current liabilities	40,743	42,150
Accrued compensation	11,473	10,827
Deferred revenue	5,137	2,649
Debt, current	735	247,248
Total current liabilities	67,935	317,436
Debt, non-current	14,695	15,430
Redeemable convertible preferred stock warrant liability	0	12,323
Sponsor earn-out liability	26,101	0
Other liabilities	56,690	56,844
Total liabilities	165,421	402,033
Commitments and contingencies (Note 6)
Redeemable convertible preferred stock, $0.0001 par value; none authorized, issued and outstanding as of June 30, 2021; 224,409,612 shares authorized, 121,431,310 shares issued and outstanding as of December 31, 2020; no aggregate liquidation preference as of June 30, 2021 and $1,749,201 as of December 31, 2020		1,812,678
Stockholders’ equity (deficit):
Preferred stock, $0.0001 par value; 1,000,000 shares authorized, none issued and outstanding as of June 30, 2021; none authorized, issued and outstanding as of December 31, 2020	0	0
Common stock, $0.0001 par value; 600,000,000 and 262,797,235 shares authorized as of June 30, 2021 and December 31, 2020; 217,115,573 and 1,708,476 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively	22
Additional paid-in capital	2,688,613	89,789
Accumulated deficit	(2,084,108)	(1,914,353)
Total stockholders’ equity (deficit)	604,527	(1,824,564)
Total liabilities, redeemable convertible preferred stock, and stockholders’ equity (deficit)	$ 769,948	$ 390,147

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (unaudited) (Parentheticals) - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 224,000	$ 224,000
Redeemable convertible preferred stock par or stated value per share ( in dollars per share)	$ 0.0001	$ 0.0001
Redeemable convertible preferred stock authorized (in shares)	0	224,409,612
Redeemable convertible preferred stock shares issued (in shares)	0	121,431,310
Redeemable convertible preferred stock shares outstanding (in shares)	0	121,431,310
Redeemable convertible preferred stock liquidation preference	$ 0	$ 1,749,201,000
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	1,000,000	0
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	600,000,000	262,797,235
Common stock, shares issued (in shares)	217,115,573	1,708,476
Common stock, share outstanding (in shares)	217,115,573	1,708,476

Condensed Consolidated Statemen

Condensed Consolidated Statements of Comprehensive Loss (unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Income Statement [Abstract]
Revenue	$ 16,926	$ 5,647	$ 26,695	$ 14,679
Costs and expenses:
Cost of revenue	49,610	35,834	85,789	72,297
Research and development	21,040	13,361	37,610	36,449
Selling, general, and administrative	34,633	16,596	56,333	37,960
Total costs and expenses	105,283	65,791	179,732	146,706
Loss from operations	(88,357)	(60,144)	(153,037)	(132,027)
Interest and other income (expense), net
Interest income	15	41	20	486
Interest expense	(331)	(6,146)	(5,639)	(11,431)
Other expense, net	(4,978)	(80)	(6,420)	(105)
Gain (loss) on fair value change, net	(2,065)	(3,068)	5,348	1,360
Loss on extinguishment of debt	0	0	(10,018)	0
Interest and other income (expense), net	(7,359)	(9,253)	(16,709)	(9,690)
Loss before benefit (provision) of income taxes	(95,716)	(69,397)	(169,746)	(141,717)
Benefit (provision) for income taxes	(4)	(98)	(9)	(103)
Net and comprehensive loss	(95,720)	(69,495)	(169,755)	(141,820)
Net and comprehensive loss	$ (95,720)	$ (69,495)	$ (169,755)	$ (141,820)
Net loss per share, basic (in dollars per share)	$ (0.45)	$ (41.30)	$ (1.26)	$ (84.94)
Net loss per share, diluted (in dollars per share)	$ (0.45)	$ (41.30)	$ (1.26)	$ (84.94)
Weighted-average shares used in calculation of net loss per share, basic (in shares)	212,116,112	1,682,704	134,240,831	1,669,739
Weighted-average shares used in calculation of net loss per share, diluted (in shares)	212,116,112	1,682,704	134,240,831	1,669,739

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (unaudited) - USD ($) $ in Thousands	Total	As Previously Reported	Retroactive application of reverse recapitalization	Common Stock	Common StockAs Previously Reported	Common StockRetroactive application of reverse recapitalization	Additional Paid-In Capital	Additional Paid-In CapitalAs Previously Reported	Additional Paid-In CapitalRetroactive application of reverse recapitalization	Accumulated Deficit	Accumulated DeficitAs Previously Reported
Beginning balance (in shares) at Dec. 31, 2019	121,436,000	5,223,032,000	(5,101,596,000)
Beginning balance at Dec. 31, 2019	$ 1,812,724	$ 1,812,724
Increase (Decrease) in Temporary Equity [Roll Forward]
Cancellation of Series A, Series B, and Series E redeemable convertible preferred stock (in shares)	(5,000)
Cancellation of Series A, Series B, and Series E redeemable convertible preferred stock	$ (46)
Ending balance (in shares) at Mar. 31, 2020	121,431,000
Ending balance at Mar. 31, 2020	$ 1,812,678
Beginning balance (in shares) at Dec. 31, 2019				1,651,000	71,000,000	(69,349,000)
Beginning balance at Dec. 31, 2019	(1,604,271)	$ (1,604,271)			$ 7	$ (7)	$ 60,356	$ 60,349	$ 7	$ (1,664,627)	$ (1,664,627)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cancellation of Series A, Series B, and Series E redeemable convertible preferred stock	46						46
Issuance of common stock upon exercise of stock options (in shares)				28,000
Issuance of common stock upon exercise of stock options	149						149
Stock-based compensation	9,218						9,218
Net loss	(72,325)									(72,325)
Ending balance (in shares) at Mar. 31, 2020				1,679,000
Ending balance at Mar. 31, 2020	$ (1,667,183)			$ 0			69,769			(1,736,952)
Beginning balance (in shares) at Dec. 31, 2019	121,436,000	5,223,032,000	(5,101,596,000)
Beginning balance at Dec. 31, 2019	$ 1,812,724	$ 1,812,724
Ending balance (in shares) at Jun. 30, 2020	121,431,000
Ending balance at Jun. 30, 2020	$ 1,812,678
Beginning balance (in shares) at Dec. 31, 2019				1,651,000	71,000,000	(69,349,000)
Beginning balance at Dec. 31, 2019	(1,604,271)	(1,604,271)			$ 7	$ (7)	60,356	60,349	7	(1,664,627)	(1,664,627)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(141,820)	$ (140,164)
Ending balance (in shares) at Jun. 30, 2020				1,684,000
Ending balance at Jun. 30, 2020	$ (1,729,829)			$ 0			76,618			(1,806,447)
Beginning balance (in shares) at Dec. 31, 2019	121,436,000	5,223,032,000	(5,101,596,000)
Beginning balance at Dec. 31, 2019	$ 1,812,724	$ 1,812,724
Ending balance (in shares) at Dec. 31, 2020	121,431,310	5,222,852,000	(5,101,421,000)
Ending balance at Dec. 31, 2020	$ 1,812,678	$ 1,812,678
Beginning balance (in shares) at Dec. 31, 2019				1,651,000	71,000,000	(69,349,000)
Beginning balance at Dec. 31, 2019	(1,604,271)	(1,604,271)			$ 7	$ (7)	60,356	60,349	7	(1,664,627)	(1,664,627)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(141,800)
Ending balance (in shares) at Dec. 31, 2020				1,709,000	73,483,000	(71,774,000)
Ending balance at Dec. 31, 2020	$ (1,824,564)	(1,824,564)			$ 7	$ (7)	89,789	89,782	7	(1,914,353)	(1,914,353)
Beginning balance (in shares) at Mar. 31, 2020	121,431,000
Beginning balance at Mar. 31, 2020	$ 1,812,678
Ending balance (in shares) at Jun. 30, 2020	121,431,000
Ending balance at Jun. 30, 2020	$ 1,812,678
Beginning balance (in shares) at Mar. 31, 2020				1,679,000
Beginning balance at Mar. 31, 2020	(1,667,183)			$ 0			69,769			(1,736,952)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				5,000
Issuance of common stock upon exercise of stock options	47						47
Stock-based compensation	6,802						6,802
Net loss	(69,495)	$ (69,224)								(69,495)
Ending balance (in shares) at Jun. 30, 2020				1,684,000
Ending balance at Jun. 30, 2020	$ (1,729,829)			$ 0			76,618			(1,806,447)
Beginning balance (in shares) at Dec. 31, 2020	121,431,310	5,222,852,000	(5,101,421,000)
Beginning balance at Dec. 31, 2020	$ 1,812,678	$ 1,812,678
Increase (Decrease) in Temporary Equity [Roll Forward]
Conversion of redeemable convertible preferred stock to common stock in connection with reverse recapitalization (in shares)	(121,431,000)
Conversion of redeemable convertible preferred stock to common stock in connection with reverse recapitalization	$ (1,812,678)
Ending balance (in shares) at Mar. 31, 2021	0
Ending balance at Mar. 31, 2021	$ 0
Beginning balance (in shares) at Dec. 31, 2020				1,709,000	73,483,000	(71,774,000)
Beginning balance at Dec. 31, 2020	(1,824,564)	$ (1,824,564)			$ 7	$ (7)	89,789	89,782	7	(1,914,353)	(1,914,353)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of redeemable convertible preferred stock to common stock in connection with reverse recapitalization (in shares)				121,431,000
Conversion of redeemable convertible preferred stock to common stock in connection with reverse recapitalization	1,812,678			$ 12			1,812,666
Reverse recapitalization transaction, net of fees (in shares)				93,865,000
Reverse recapitalization transaction, net of fees	745,751			$ 10			745,741
Conversion of redeemable convertible preferred stock warrants to common stock warrants in connection with reverse recapitalization	7,267						7,267
Issuance of common stock upon exercise of stock options (in shares)				72,000
Issuance of common stock upon exercise of stock options	382						382
Stock-based compensation	10,463						10,463
Net loss	(74,035)									(74,035)
Ending balance (in shares) at Mar. 31, 2021				217,077,000
Ending balance at Mar. 31, 2021	$ 677,942			$ 22			2,666,308			(1,988,388)
Beginning balance (in shares) at Dec. 31, 2020	121,431,310	5,222,852,000	(5,101,421,000)
Beginning balance at Dec. 31, 2020	$ 1,812,678	$ 1,812,678
Ending balance (in shares) at Jun. 30, 2021	0
Beginning balance (in shares) at Dec. 31, 2020				1,709,000	73,483,000	(71,774,000)
Beginning balance at Dec. 31, 2020	$ (1,824,564)	$ (1,824,564)			$ 7	$ (7)	89,789	$ 89,782	$ 7	(1,914,353)	$ (1,914,353)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	190,000
Net loss	$ (169,755)
Ending balance (in shares) at Jun. 30, 2021				217,116,000
Ending balance at Jun. 30, 2021	$ 604,527			$ 22			2,688,613			(2,084,108)
Beginning balance (in shares) at Mar. 31, 2021	0
Beginning balance at Mar. 31, 2021	$ 0
Ending balance (in shares) at Jun. 30, 2021	0
Beginning balance (in shares) at Mar. 31, 2021				217,077,000
Beginning balance at Mar. 31, 2021	$ 677,942			$ 22			2,666,308			(1,988,388)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				4,000
Issuance of common stock upon exercise of stock options	31						31
Vesting of restricted stock units (in shares)				35,000
Stock-based compensation	22,274						22,274
Net loss	(95,720)									(95,720)
Ending balance (in shares) at Jun. 30, 2021				217,116,000
Ending balance at Jun. 30, 2021	$ 604,527			$ 22			$ 2,688,613			$ (2,084,108)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Cash flows from operating activities:
Net loss	$ (169,755)	$ (141,820)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	14,021	12,900
Loss on extinguishment of debt	10,018	0
Gain on fair value change, net	(5,348)	(1,360)
Stock-based compensation	32,737	16,020
Other	917	1,179
Changes in operating assets and liabilities:
Accounts receivable	(662)	6,595
Inventories	(1,812)	525
Prepaid expenses and other current assets	(3,421)	22,640
Other assets	(2,521)	(289)
Accounts payable	(3,378)	(613)
Deferred revenue	2,487	(435)
Accrued compensation	646	790
Accrued expenses and other liabilities	903	1,309
Net cash used in operating activities	(125,168)	(82,559)
Cash flows from investing activities:
Purchases of property and equipment	(5,820)	(27,571)
Maturities of short-term investments	0	32,866
Net cash provided by (used in) investing activities	(5,820)	5,295
Cash flows from financing activities:
Proceeds from draws related to revolving debt facility	0	172,115
Repayment of revolving debt facility	(257,454)	(75,000)
Repayment of other debt obligations	0	(1,714)
Payments of obligations under capital leases	(356)	(734)
Proceeds from issuance of common stock upon exercise of stock options	403	197
Proceeds from reverse recapitalization and PIPE financing	815,184	0
Payment of transaction costs related to reverse recapitalization	(41,655)	0
Net cash provided by financing activities	516,122	94,864
Net increase in cash, cash equivalents, and restricted cash	385,134	17,600
Cash, cash equivalents, and restricted cash, beginning of period	74,693	148,674
Cash, cash equivalents, and restricted cash, end of period	459,827	166,274
Supplemental disclosure of cash flow information:
Cash paid for interest	19,349	4,131
Cash paid for income taxes	28	24
Non-cash investing and financing activities:
Change in accounts payable balance and other liabilities related to purchase of property and equipment	(1,115)	(3,781)
Conversion of redeemable convertible preferred stock to common stock	1,812,678	0
Conversion of redeemable convertible preferred stock warrants to common stock warrants	7,267	0
Common stock issued in exchange for services associated with the reverse recapitalization	$ 7,500	$ 0

Organization and Summary of Sig

Organization and Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Summary of Significant Accounting Policies	Organization and Summary of Significant Accounting Policies Organization View, Inc. (f/k/a CF Finance Acquisition Corp. II) and its wholly-owned subsidiaries (collectively “View” or the “Company”) headquartered in Milpitas, California, is a technology company that manufactures smart building products intended to help improve people’s health, productivity and experience, while simultaneously reducing energy consumption. View’s primary product is a proprietary electrochromic or “smart” glass panel that when combined with View’s proprietary network infrastructure and software, intelligently adjusts in response to the sun by tinting from clear to dark states, and vice versa thereby reducing heat and glare. The Company is devoting substantially all of its efforts towards the manufacturing, sale and further development of its product platforms, and marketing of both custom and standardized product solutions. The Company has also devoted significant resources to enable its new View Smart Building Platform, a new offering beginning in 2021. On March 8, 2021 (the “Closing Date” or “Closing”), CF Finance Acquisition Corp. II (“CF II”), a Delaware corporation, consummated the previously announced merger pursuant to an Agreement and Plan of Merger, dated November 30, 2020 (the “Merger Agreement”), by and among CF II, PVMS Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of CF II (“Merger Sub”), and View, Inc. (hereinafter referred to as “Legacy View”). Pursuant to the Merger Agreement, a business combination between CF II and Legacy View was effected through the merger of Merger Sub with and into Legacy View, with Legacy View (the “Business Combination”) surviving as the surviving company and as a wholly-owned subsidiary of CF II (the “Merger” and collectively with the other transactions described in the Merger Agreement, the “Transactions”). On the Closing Date, CF II changed its name from CF Finance Acquisition Corp. II to View, Inc. and Legacy View changed its name to View Operating Corporation. On March 8, 2021, the Company completed the Transactions and raised net proceeds of $771.3 million, net of transaction costs of $43.9 million. In conjunction with the Transactions, the Company repaid in full the revolving debt facility of $276.8 million, including accrued interest and future interest through maturity of the notes of $26.8 million. See Note 3 for additional information regarding the reverse recapitalization. Basis of Presentation The condensed consolidated financial statements and accompanying notes have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and regulations of the U.S. Securities and Exchange Commission (“SEC”) for interim financial reporting and are unaudited. The Company’s condensed consolidated financial statements include the accounts of View, Inc. and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. The Company’s fiscal year ends on December 31. Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2020, included in View’s 2021 Annual Report on Form 10-K filed with the SEC on June 15, 2022 (the "2021 Form 10-K"). The information as of December 31, 2020 included in the condensed consolidated balance sheets was derived from those audited consolidated financial statements as restated for the items described within this report. See Note 2 for further information. As a result of the Transactions completed on March 8, 2021, prior period share and per share amounts presented in the accompanying condensed consolidated financial statements and these related notes have been retroactively converted in an amount determined by application of the exchange ratio of 0.02325 (“Exchange Ratio”), which was based on Legacy View’s implied price per share prior to the Merger. The condensed consolidated financial statements were prepared on the same basis as the audited consolidated financial statements and included herein reflect all adjustments, including normal recurring adjustments, which are, in the opinion of management, necessary for a fair statement of the Company’s financial position as of June 30, 2021, the results of operations for the three and six months ended June 30, 2021 and the cash flows for the six months ended June 30, 2021. The results of operations for the three and six months ended June 30, 2021 are not necessarily indicative of the results that may be expected for the full year or any other future interim or annual periods. All amounts are presented in U.S. dollars ($). Liquidity and Going Concern The accompanying condensed consolidated financial statements have been prepared on the basis that the Company will continue as a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern. Since inception, the Company has not achieved profitable operations or positive cash flows from operations. The Company’s accumulated deficit totaled $2,084.1 million as of June 30, 2021. For the six months ended June 30, 2021, we had a net loss of approximately $169.8 million and negative cash flows from operations of approximately $125.2 million. In addition, for the six months ended June 30, 2020, we had a net loss of approximately $141.8 million and negative cash flows from operations of approximately $82.6 million. Cash and cash equivalents as of June 30, 2021 was $451.4 million. The Company has historically financed its operations through the issuance and sale of redeemable convertible preferred stock, the issuance of debt financing, the gross proceeds associated with the Merger and revenue generation from product sales. The Company’s continued existence is dependent upon its ability to obtain additional financing, enter into profitable sales contracts and generate sufficient cash flow to meet its obligations on a timely basis. The Company’s business will require significant amounts of capital to sustain operations and the Company will need to make the investments it needs to execute its long-term business plans. The Company has determined that there is substantial doubt about its ability to continue as a going concern, as the Company does not currently have adequate financial resources to fund its forecasted operating costs and meet its obligations for at least twelve months from the filing of this Quarterly Report on Form 10-Q. While the Company will seek to raise additional capital, there can be no assurance the necessary financing will be available on terms acceptable to the Company, or at all. If the Company raises funds by issuing equity securities, dilution to stockholders may result. Any equity securities issued may also provide for rights, preferences or privileges senior to those of holders of common stock. If we raise funds by issuing debt securities, these debt securities would have rights, preferences and privileges senior to those of preferred and common stockholders. The terms of debt securities or borrowings could impose significant restrictions on our operations. The capital markets have in the past, and may in the future, experience periods of upheaval that could impact the availability and cost of equity and debt financing. In addition, recent and anticipated future increases in federal fund rates set by the Federal Reserve, which serve as a benchmark for rates on borrowing, will impact the cost of debt financing. If we are unable to obtain adequate capital resources to fund operations, we would not be able to continue to operate our business pursuant to our current business plan, which would require us to modify our operations to reduce spending to a sustainable level by, among other things, delaying, scaling back or eliminating some or all of our ongoing or planned investments in corporate infrastructure, business development, sales and marketing, research and development and other activities, which would have a material impact on our operations and our ability to increase revenues, or we may be forced to discontinue our operations entirely. View’s Pandemic Response The COVID-19 pandemic has impacted health and economic conditions throughout the U.S., including the construction industry. The COVID-19 pandemic continues to be dynamic and evolving, and the extent to which COVID-19 impacts the Company’s operations will depend on future developments that cannot be predicted with certainty, including the duration of the pandemic, resurgences of COVID-19 infections and the emergence of new variants, the availability and efficacy of vaccines, new information that may emerge concerning the severity of COVID-19 and the governmental measures to contain or treat its impact, among others. COVID-19’s disruptions to the construction industry may reduce or delay new construction projects or result in cancellations or delays of existing planned construction. Supply of certain materials used by the Company in the manufacturing of its products that are sourced from a limited number of suppliers may also be disrupted. For example, we utilize semiconductor chips in certain products that we manufacture, and semiconductor chips have been subject to an ongoing global shortage. This shortage may cause delays in our production and increase the cost to obtain semiconductor chips and components that use semiconductor chips. In addition, long-term effects of COVID-19 on employer work-from-home policies and therefore demand for office space cannot be predicted. Any one or a combination of such events could have a material adverse effect on the Company’s financial results. To address these conditions, the Company established protocols to continue business operations as an essential industry, helped insulate its supply chain from delays and disruptions, and assessed its business operations and financial plans as a result of COVID-19. The Company optimized its financial plan by focusing on sales growth and by reducing and delaying incremental spending on operating and capital expenditures compared with the pre-COVID business plan. In particular, in the second quarter of 2020, the Company began reducing operating costs through headcount reductions and reduction of operating expenditures for third-party contractors. During 2021, these cost reduction efforts were relaxed and headcount increased in order to respond to increased demand for our product and services. Summary of Significant Accounting Policies Other than policies noted below, there have been no significant changes to the significant accounting policies disclosed in Note 1 of the audited consolidated financial statements as of and for the year ended December 31, 2021 included in View’s 2021 Form 10-K. Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts and disclosures in the condensed consolidated financial statements and the accompanying notes. Significant estimates include the warranty accrual, the fair value of common stock prior to reverse recapitalization and other assumptions used to measure stock-based compensation, the fair value of the redeemable convertible preferred stock, warrants, sponsor earn-out liability, and the estimation of costs to complete the performance obligations under contracts for revenue recognition. Other estimates include the fair value of acquired intangible assets and their respective useful lives, the determination of standalone selling price of various performance obligations, the valuation of deferred tax assets and uncertain income tax positions, and the recoverability of long-lived assets. The Company bases its estimates on historical experience, the current economic environment, and on assumptions that it believes are reasonable under the circumstances. The Company is subject to uncertainties such as the impact of future events, economic and political factors, and changes in the Company’s business environment; therefore, actual results could differ from these estimates. The Company adjusts such estimates and assumptions when facts and circumstances dictate which may require significant judgment. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods. Actual results could differ significantly from these estimates. Concentration of Credit Risk and Other Risks and Uncertainties Financial instruments which potentially subject the Company to concentration of credit risk consist primarily of cash and cash equivalents, restricted cash, and accounts receivable. Cash and cash equivalents are held by domestic financial institutions with high credit standings. Such deposits may, at times, exceed federally insured limits. As of June 30, 2021, the Company has not experienced any losses on its deposits of cash and cash equivalents. For the six months ended June 30, 2021, three customers represented greater than 10.0% of total revenue, each accounting for 16.5%, 11.8% and 10.1% of total revenue. For the six months ended June 30, 2020, three customers represented greater than 10.0% of total revenue, each accounting for 17.3%, 16.7% and 11.6% of total revenue. Three customers accounted for 53.7% of accounts receivable, net as of June 30, 2021, including 24.1%, 15.5%, and 14.1%, respectively. One customer accounted for 23.6% of accounts receivable, net as of December 31, 2020. Accounts receivable are stated at the amount the Company expects to collect. The Company generally does not require collateral or other security in support of accounts receivable. To reduce credit risk, management performs ongoing credit evaluations of its customers’ financial condition. Certain materials used by the Company in the manufacturing of its products are purchased from a limited number of suppliers. Shortages could occur in these materials due to an interruption of supply or increased demand in the industry. For the six months ended June 30, 2021, one supplier accounted for 34.5% of total purchases. For the six months ended June 30, 2020, two suppliers accounted for 42.9% and 10.7% of total purchases, respectively. Cash, Cash Equivalents and Restricted Cash The Company considers all highly liquid investments with original maturities from the date of purchase of three months or less to be cash equivalents. Cash equivalents are invested in demand deposits, U.S. Treasury bills and money market mutual funds. The Company considers investments with original maturities greater than three months and remaining maturities less than one year to be short-term investments. Demand deposits and U.S Treasury bills are carried at cost, which approximates fair value and money market funds are reported at fair value based upon quoted market prices. The Company is required by its bank to collateralize letters of credit issued to the Company’s lessors, suppliers, customers, utility providers, and for the Company’s purchasing card program. All amounts in restricted cash as of June 30, 2021 and December 31, 2020 represent funds held in certificates of deposit and are stated at cost, which approximates fair value. Restricted cash is classified as current or non-current on the consolidated balance sheets based on the remaining term of the restriction. Cash, cash equivalents, and restricted cash reported within the accompanying condensed consolidated balance sheets that sum to the total of the same such amounts presented in the accompanying condensed consolidated statements of cash flows consisted of the following (in thousands): June 30, December 31, 2020 Cash $ 43,902 $ 24,657 Cash equivalents $ 407,457 $ 38,575 Cash and cash equivalents $ 451,359 $ 63,232 Restricted cash included in prepaid expenses and other current assets $ — $ 1,000 Restricted cash $ 8,468 $ 10,461 Total cash, cash equivalents, and restricted cash presented in the statements of cash flows $ 459,827 $ 74,693 Fair Value Measurement of Financial Assets and Liabilities Fair value is defined as an exchange price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be either recorded or disclosed at fair value, the Company considers the principal or most advantageous market in which it would transact, and it also considers assumptions that market participants would use when pricing the asset or liability. The Company maximizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value. U.S. GAAP establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is as follows: Level 1 Observable inputs such as quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. Level 2 Inputs other than the quoted prices in active markets that are observable either directly or indirectly. Level 3 Unobservable inputs in which there are little or no market data and which require the Company to develop its own assumptions. Cash equivalents relating to demand deposits and U.S. Treasury bills, accounts receivable, and accounts payable are carried at cost, which approximates fair value due to the short maturity of these instruments. Short-term and long-term debt are carried at amortized cost, which approximates its fair value. See Note 5 for further information. Contract Assets and Liabilities Billing practices for certain contracts with customers are governed by the contract terms of each project based on (i) progress toward completion approved by the owner, (ii) achievement of milestones or (iii) pre-agreed schedules. Billings do not necessarily correlate with revenues recognized under the cost-to-cost input method. The Company records contract assets and contract liabilities to account for these differences in timing. Certain contracts under which we perform work contain retainage provisions. Retainage refers to amounts that we have billed to the customer, but such amounts are being held for payment by the customer pending satisfactory completion of the project. Retainage on active contracts is classified as a current asset regardless of the term of the contract and is generally collected within one year of the completion of a contract. At June 30, 2021 and December 31, 2020, contract assets included $0.2 million and nil, respectively, of retainage, which was being contractually withheld by customers until completion of the associated contracts. Other contract assets arise when the Company recognizes revenues for performance under its contracts, but the Company is not yet entitled to bill the customer under the terms of the contract. At June 30, 2021 and December 31, 2020, these other contract assets totaled $3.2 million and $1.2 million, respectively, for revenue that has been recognized for performance, but the customer has not yet been billed. Once amounts are billed to customers, the asset is classified within Accounts Receivable, Net of Allowances. Contract liabilities represent the Company’s obligation to provide goods or services to a customer for which the Company has been paid by the customer or for which the Company has billed the customer under the terms of the contract. Revenue for future services reflected in this account are recognized, and the liability is reduced, as the Company subsequently satisfies the performance obligation under the contract. Contract liabilities are presented as deferred revenue on the consolidated balance sheets. Inventories Inventories consist of finished goods which are stated at the lower of cost or net realizable value. Costs are measured on a first-in, first out basis using standard cost, which approximates actual cost. Net realizable value is the estimated selling price of the Company’s products in the ordinary course of business less reasonably predictable costs of completion, disposal, and transportation. Inventories are written down to their net realizable value if they have become obsolete, have a cost basis in excess of expected net realizable value, or are in excess of expected demand. Once inventory is written down, its new value is maintained until it is sold, scrapped, or written down for further valuation losses. The valuation of inventories requires the Company to make judgments based on currently available information about the likely method of disposition and current and future product demand relative to the remaining product life. The Company recorded inventory impairments of $6.1 million as of June 30, 2021. Impairment of Long-Lived Assets The Company evaluates long-lived assets for impairment whenever events indicate that a potential impairment may have occurred. If such events arise, the Company will compare the carrying amount of the asset group comprising the long-lived assets to the estimated future undiscounted cash flows expected to be generated by the asset group. If the estimated aggregate undiscounted cash flows are less than the carrying amount of the asset group, an impairment charge is recorded as the amount by which the carrying amount of the asset group exceeds the fair value of the assets, as based on the expected discounted future cash flows attributable to those assets. Long-lived assets to be disposed of are reported at the lower of carrying amount or fair value less costs to sell. The Company regularly reviews its long-lived assets for triggering events or other circumstances that could indicate impairment. As of June 30, 2021, no triggering events or other circumstances were identified. There were no impairments of long-lived assets during the three and six months ended June 30, 2021 and 2020. Product Warranties The Company provides a standard assurance type warranty that its insulating glass units (“IGUs”) will be free from defects in materials and workmanship for generally 10 years from the date of delivery to customers. IGUs with sloped or laminated glass generally have a warranty of 5 or 10 years. Control systems associated with the sale of Controls, Software and Services (“CSS”) typically have a 5-year warranty. As part of the Company’s Smart Building Platform contracts, the Company generally warrants that the workmanship of the sub-assemblies and installation of the Smart Building Platform are free from defects and in conformance with the contract documents for one year from completion. In resolving warranty claims, the Company’s standard warranty terms provide that the Company generally has the option of repairing, replacing or refunding the selling price of the covered product. The Company has not been requested to and has not provided any refunds, which would be treated as a reduction to revenue, to date as of June 30, 2021. The Company accrues for estimated claims of defective products at the time revenue is recognized based on historical warranty claims rates. The Company’s estimated costs for standard warranty claims are based on future estimated costs the Company expects to incur to replace the IGUs or control systems multiplied by the estimated IGU or control system warranty claims, respectively, based on warranty contractual terms and business practices. The total warranty liability included $5.3 million and $5.5 million as of June 30, 2021 and December 31, 2020, respectively, related to this standard assurance warranty. In 2019, the Company identified a quality issue with certain material purchased from one of its suppliers utilized in the manufacturing of certain IGUs. The Company stopped using the affected materials upon identification of the quality issue in 2019. The Company has replaced and expects to continue to replace the affected IGUs for the remainder of the period covered by the warranty. The Company developed a statistical model to analyze the risk of failure of the affected IGUs related to this quality issue and predict the potential number of future failures that may occur during the remaining warranty period, as well as the timing of the expected failures. Management judgment is necessary to determine the distribution fit and covariates utilized in the statistical model, as well as the relative tolerance to declare convergence. The statistical model considered the volume of units sold, the volume of unit failures, data patterns, and other characteristics associated with the failed IGUs as well as the IGUs that had not yet failed as of each financial reporting period. These characteristics include, but are not limited to, time to failure, manufacture date, location of installation, and environmental factors. Based on this analysis, the Company has recorded a specific warranty liability using the estimated number of affected IGUs expected to fail in the remaining warranty period and applying estimated costs the Company expects to incur to replace the IGUs based on warranty contractual terms and business practices. The total warranty liability included $40.4 million and $42.1 million as of June 30, 2021, and December 31, 2020, respectively, related to these IGUs. The Company monitors warranty obligations and may make adjustments to its warranty liabilities if actual costs of product repair and replacement are significantly higher or lower than estimated. Accruals for anticipated future warranty costs are recorded to cost of revenue in the condensed consolidated statements of comprehensive loss and included in other current liabilities and other liabilities on the condensed consolidated balance sheet. Warranty liabilities are based on estimates of failure rates and future costs to settle warranty claims that are updated periodically, taking into consideration inputs such as changes in the volume of claims compared with the Company’s historical experience, and changes in the cost of servicing warranty claims. The estimated cost includes the Company’s expectations regarding future total cost of replacement, as well as fixed cost absorption as production increases. The Company accounts for the effect of changes in estimates prospectively. Changes in warranty liabilities are presented below (in thousands). See Note 2 for discussion of the material misstatement of the previously reported warranty liability balances as of December 31, 2020. June 30, December 31, 2020 Beginning balance $ 47,678 $ 53,296 Accruals for warranties issued 816 $ 1,304 Changes to estimates of volume and costs — $ (1,002) Settlements made (2,761) $ (5,920) Ending balance $ 45,733 $ 47,678 Warranty liability, current, beginning balance $ 8,864 $ 8,038 Warranty liability, noncurrent, beginning balance $ 38,814 $ 45,258 Warranty liability, current, ending balance $ 8,923 $ 8,864 Warranty liability, noncurrent, ending balance $ 36,810 $ 38,814 During the three months ended June 30, 2021 and 2020, the Company recorded a charge to Cost of revenues of $0.4 million and $0.3 million, respectively, related to adjustments to the warranty liability. During the six months ended June 30, 2021 and 2020, the Company recorded a charge to Cost of revenues of $0.8 million and $0.6 million, respectively, related to adjustments to the warranty liability. Considering the uncertainty inherent in the failure analysis, including the actual timing of the failures and the number of defective IGUs, as well as uncertainty regarding future supply chain costs and production volumes that may impact the projected costs to replace defective IGUs in future years, it is reasonably possible that the amount of costs to be incurred to replace the defective IGUs could ultimately be materially different from the estimate. Unforeseen component failures or exceptional component performance can also result in changes to warranty costs. If actual warranty costs differ substantially from the Company’s estimates, revisions to the estimated warranty liability would be required, which could have a material adverse effect on the Company’s business, financial condition and results of operations. In addition to the warranty liabilities presented above, the Company has $4.4 million and $0.8 million included within Accrued expenses and other current liabilities in its Condensed Consolidated Balance Sheets as of June 30, 2021 and December 31, 2020, respectively, for incremental performance obligations promised to customers in connection with IGU failures associated with the quality issue described above. The costs associated with these obligations are included within Cost of revenue in the Condensed Consolidated Statement of Comprehensive Loss, and was nil and $1.7 million for the three months ended June 30, 2021 and 2020, respectively, and $5.1 million and $2.7 million for the six months ended June 30, 2021 and 2020, respectively. Revenue Recognition The Company has historically generated revenue from (i) the manufacturing and sale of View Smart Glass IGUs, that are coated on the inside with a proprietary technology and are designed and built to customer specifications that include sizes for specific windows, skylights, and doors in specified or designated areas of a building and (ii) selling the View Smart Glass CSS, which includes electrical connections schema, sky sensors, window controllers and control panels with embedded software, cables and connectors that when combined with the IGUs enable the IGUs to tint. Also included in CSS is a system design, in which a design document is provided to lay out the IGUs, as well as a commissioning service, in which the installed IGUs and CSS components are tested and tinting configurations are set by the Company. For this Smart Glass products offering, View serves as a materials provider to its Smart Glass customers, which are typically glaziers for IGUs and low-voltage electricians (“LVE”) or General Contractors (“GC”) for CSS. Under View’s Smart Glass product offering, when the owner, tenant or developer of the building approves of the use of View products, a non-binding letter of understanding with the owner, tenant or developer is signed. The Company subsequently enters into the legally enforceable supplier contracts with its Smart Glass customers (i.e., glaziers for IGUs and LVEs or GCs for CSS), to deliver the Smart Glass products and services. For Smart Glass projects, the Company does not have a role in the assembly nor the installation of the framed IGUs. The design of the integrated platform, as well as assembly and installation of the IGUs and the electrical components included in the CSS is performed by the Smart Glass customers. The Company performs a commissioning service under the CSS contract after its customers have completed installation of the IGUs and CSS electrical components. Additionally, in limited circumstances, the Company contracts to provide extended or enhanced warranties of its products in addition to its standard assurance warranty, which are recognized as revenue over the respective term of the warranty period. During 2021, the Company entered into and commenced work on the first contract under its new product offering, View’s Smart Building Platform. In these types of arrangements, the Company contracts with the Smart Building Platform customers, which are typically the owners, tenants or developers of buildings, or the general contractor acting on behalf of the Company’s customers. With View's Smart Building Platform, the smart building network serves as the backbone of the offering and is integrated by View into the building envelope system along with the View Smart Glass IGUs, which serve as individual nodes on the building network. This platform also enables the Company's Smart Building Technologies product offerings, as more fully described further below, to also be integrated as additional nodes on View’s smart building network and tailored to the cust

Restatement of Previously Issue

Restatement of Previously Issued Financial Statements	6 Months Ended
	Jun. 30, 2021
Accounting Changes and Error Corrections [Abstract]
Restatement of Previously Issued Financial Statements	Restatement of Previously Issued Financial Statements Background of the Restatement As previously disclosed in August 2021, the Audit Committee of the Company’s Board of Directors (the “Audit Committee”) initiated an independent investigation concerning the adequacy of the Company’s previously presented warranty-related obligations (the “Investigation”), which has since been completed. As a result of the Investigation, the Audit Committee concluded that (i) the Company’s previously reported liabilities associated with warranty-related obligations and the cost of revenue associated with the recognition of those liabilities were materially misstated, (ii) the Company’s former Chief Financial Officer and certain former accounting staff negligently failed to properly record the liabilities for warranty-related obligations and cost of revenue, and (iii) the Company’s former Chief Financial Officer and certain former accounting staff intentionally failed to disclose certain information to the Company's Board of Directors and the independent auditors, regarding the applicable costs incurred and expected to be incurred in connection with the warranty-related obligations when replacing the IGUs. Specifically, the Company had inappropriately excluded from the warranty obligation the installation labor and freight costs that it had incurred, and expected to continue to incur, when replacing the IGUs. It was also determined that partially offsetting the misstatement which understated the warranty obligation was another misstatement resulting in an overestimate in the estimated failure rates of the impacted IGUs. As a result of these material misstatements, the Company’s warranty liabilities were understated by $25.0 million as of December 31, 2020 and the Company’s Cost of Revenue and Net Loss were understated by $1.1 million and overstated $2.4 million for the three and six months ended June 30, 2020, respectively, as well as understated by $25.0 million for periods prior to 2020, which has been corrected for as an adjustment to Accumulated Deficit as of December 31, 2019. As a result of the Investigation, the Company has not previously filed its Q2 2021 Quarterly Report on Form 10-Q. However, the unaudited quarterly financial statements as of June 30, 2020 and for the three and six months then ended have been previously presented as part of (i) the unaudited quarterly financial statements as of September 30, 2020 and for the nine months then ended within the Company's Form S-4 filed with the SEC on December 23, 2020 and (ii) the audited financial statements as of December 31, 2020 and the year then ended within the Company's Form 8-K filed with the SEC on March 12, 2021. Accordingly, the Company is restating the accompanying financial statements as of December 31, 2020 and for the three and six months ended June 30, 2020. The Company has also restated its audited annual financial statements for the years ended December 31, 2020 and 2019 in connection with the filing of its 2021 Form 10-K filed with the SEC on June 15, 2022 , its unaudited quarterly financial statements as of March 31, 2021 and 2020 and for the three months then ended in connection with the filing of its Q1 2021 Form 10-Q/A filed with the SEC on June 15, 2022 and its unaudited quarterly financial statements as of September 30, 2020 and for three and nine months then ended in connection with the filing of its Q3 2021 Form 10-Q filed with the SEC on June 15, 2022. In addition to restating for the warranty-related misstatements, the Company is also correcting for other immaterial misstatements in the accompanying financial statements, included within the Other Adjustments column of the tables below. Such adjustments include a $1.8 million understatement of Net Loss which originated in periods prior to 2020, as well as the following: (a) the misstatement of depreciation expense for certain fixed assets; (b) timing of the recognition of commissions expense due to contractual service requirements necessary to earn such commission; (c) timing differences resulting from performance obligations associated with certain revenue contracts that were not initially identified and deferred over the period earned; (d) the misstatement of liabilities associated with performance obligations promised to customers in connection with IGU failures; and (e) certain income statement and balance sheet misclassifications, as well as other immaterial misstatements. Effect of the Restatement The effects of the prior-period misstatements on our Condensed Consolidated Balance Sheet, Statements of Comprehensive Income and Cash Flows are reflected in the tables below (in thousands, except per share data). The As Previously Reported column within the Condensed Consolidated Balance Sheets below include the retroactive application of the reverse capitalization as further discussed in Note 3 and as disclosed in previous filings. As it relates to the Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Deficit, the impact of the restatement was to increase net loss and comprehensive loss as shown below, which had a corresponding impact on Accumulated Deficit. We have also restated impacted amounts within the accompanying notes to the condensed consolidated financial statements, as applicable. Condensed Consolidated Balance Sheet December 31, 2020 As Previously Reported Investigation Adjustments Other Adjustments As Restated Assets Current assets Cash and cash equivalents $ 63,232 $ — $ — $ 63,232 Accounts receivable, net of allowances 12,252 — — 12,252 Inventories 6,483 — — 6,483 Prepaid expenses and other current assets 6,881 — (668) (b), (e) 6,213 Total current assets 88,848 — (668) 88,180 Property and equipment, net 282,560 — — 282,560 Restricted cash 10,461 — — 10,461 Deposits with supplier 1,084 — — 1,084 Other assets 7,862 — — 7,862 Total assets $ 390,815 $ — $ (668) $ 390,147 Liabilities, Redeemable Convertible Preferred Stock, and Stockholders’ Equity (Deficit) Current liabilities Accounts payable $ 14,562 $ — $ — $ 14,562 Accrued expenses and other current liabilities 36,480 4,849 821 (d) 42,150 Accrued compensation 14,665 — (3,838) (b) 10,827 Deferred revenue 2,111 — 538 (c) 2,649 Debt, current 247,248 — — 247,248 Total current liabilities 315,066 4,849 (2,479) 317,436 Debt, non-current 15,430 — — 15,430 Redeemable convertible preferred stock warrant liability 12,323 — — 12,323 Other liabilities 36,731 20,113 — 56,844 Total liabilities 379,550 24,962 (2,479) 402,033 Redeemable convertible preferred stock 1,812,678 — — 1,812,678 Stockholders' equity (deficit): Additional paid-in-capital 89,789 — — 89,789 Accumulated deficit (1,891,202) (24,962) 1,811 (1,914,353) Total stockholders' equity (deficit) (1,801,413) (24,962) 1,811 (1,824,564) Total liabilities, redeemable convertible preferred stock, and stockholders’ equity (deficit) $ 390,815 $ — $ (668) $ 390,147 Condensed Consolidated Statements of Comprehensive Loss Three Months Ended June 30, 2020 As Previously Reported Investigation Adjustments Other Adjustments As Restated Revenue $ 6,664 $ — $ (1,017) (c), (e) 5,647 Costs and expenses: Cost of revenue 33,800 (1,063) 3,097 (a), (d), (e) 35,834 Research and development 13,536 — (175) (a), (e) 13,361 Selling, general, and administrative 19,201 — (2,605) (a), (b), (e) 16,596 Total costs and expenses 66,537 (1,063) 317 65,791 Loss from operations (59,873) 1,063 (1,334) (60,144) Interest and other income (expense), net Interest income 41 — — 41 Interest expense (6,146) — — (6,146) Other expense, net (80) — — (80) Gain (loss) on fair value change, net (3,068) — — (3,068) Interest and other income (expense), net (9,253) — — (9,253) Loss before benefit (provision) of income taxes (69,126) 1,063 (1,334) (69,397) Benefit (provision) for income taxes (98) — — (98) Net and comprehensive loss $ (69,224) $ 1,063 $ (1,334) $ (69,495) Net loss per share, basic and diluted $ (41.14) $ 0.63 $ (0.79) $ (41.30) Weighted-average shares used in calculation of net loss per share, basic and diluted 1,682,704 — — 1,682,704 Six Months Ended June 30, 2020 As Previously Reported Investigation Adjustments Other Adjustments As Restated Revenue $ 15,831 $ — $ (1,152) (c), (e) 14,679 Costs and expenses: Cost of revenue 69,372 (2,444) 5,369 (a), (d), (e) 72,297 Research and development 34,794 — 1,655 (a), (e) 36,449 Selling, general, and administrative 42,036 — (4,076) (a), (b), (e) 37,960 Total costs and expenses 146,202 (2,444) 2,948 146,706 Loss from operations (130,371) 2,444 (4,100) (132,027) Interest and other income (expense), net Interest income 486 — — 486 Interest expense (11,431) — — (11,431) Other expense, net (105) — — (105) Gain (loss) on fair value change, net 1,360 — — 1,360 Interest and other income (expense), net (9,690) — — (9,690) Loss before benefit (provision) of income taxes (140,061) 2,444 (4,100) (141,717) Benefit (provision) for income taxes (103) — — (103) Net and comprehensive loss $ (140,164) $ 2,444 $ (4,100) $ (141,820) Net loss per share, basic and diluted $ (83.94) $ 1.46 $ (2.46) $ (84.94) Weighted-average shares used in calculation of net loss per share, basic and diluted 1,669,739 — — 1,669,739 Condensed Consolidated Statement of Cash Flows Six Months Ended June 30, 2020 As Previously Reported Investigation Adjustments Other Adjustments As Restated Cash flows from operating activities: Net loss $ (140,164) $ 2,444 $ (4,100) (a), (b), (c), (d), (e) $ (141,820) Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization 12,040 — 860 (a) 12,900 Gain on fair value change, net (1,360) — — (1,360) Stock-based compensation 16,020 — — 16,020 Other 1,179 — — 1,179 Changes in operating assets and liabilities: Accounts receivable 5,504 — 1,091 (e) 6,595 Inventories 525 — — 525 Prepaid expenses and other current assets 23,294 — (654) (b), (e) 22,640 Other assets 26 — (315) (e) (289) Accounts payable (613) — — (613) Deferred revenue (822) — 387 (c) (435) Accrued compensation 1,313 — (523) (b) 790 Accrued expenses and other liabilities 499 (2,444) 3,254 (d), (e) 1,309 Net cash used in operating activities $ (82,559) $ — $ — $ (82,559) Non-cash investing and financing activities: Change in accounts payable balance and other liabilities related to purchase of property and equipment $ (2,742) $ — $ (1,039) (e) $ (3,781)

Reverse Recapitalization

Reverse Recapitalization	6 Months Ended
	Jun. 30, 2021
Reverse Recapitalization [Abstract]
Reverse Recapitalization	Reverse Recapitalization In connection with the Merger, the Company raised $815.2 million of gross proceeds including the contribution of $374.1 million of cash held in CF II’s trust account from its initial public offering, net of redemptions of CF II Class A Common Stock held by CF II’s public stockholders of $125.9 million, $260.8 million of private investment in public equity (“PIPE”) at $10.00 per share of CF II’s Class A Common Stock, and $180.3 million of additional PIPE at $11.25 per share of CF II’s Class A Common Stock. Immediately before the Merger, all of Legacy View’s outstanding warrants were net exercised for shares of Legacy View Class A common stock. Upon consummation of the Merger, all holders of Legacy View Class A common stock and redeemable convertible preferred stock received shares of the Company’s Class A common stock at a deemed value of $10.00 per share after giving effect to the Exchange Ratio based on the completion of the following transactions contemplated by the Merger Agreement: • the cancellation of each issued and outstanding share of Legacy View Capital Stock and the conversion into the right to receive a number of shares of View Inc. Class A Common Stock equal to the Exchange Ratio; • the conversion of all outstanding Legacy View Warrants into warrants exercisable for shares of View Inc. Class A Common Stock with the same terms except for the number of shares exercisable and the exercise price, each of which was adjusted using the Exchange Ratio; and • the conversion of all outstanding vested and unvested Legacy View Options into options exercisable for shares of View Inc. Class A Common Stock with the same terms except for the number of shares exercisable and the exercise price, each of which was adjusted using the Exchange Ratio. In connection with the Merger, the Company incurred $43.9 million of Transaction costs, consisting of underwriting, legal, and other professional fees, of which $42.4 million was recorded to additional paid-in capital as a reduction of proceeds and the remaining $1.5 million was expensed immediately. The number of shares of Class A common stock issued immediately following the consummation of the Merger at March 8, 2021 was: Number of Shares Common stock of CF II outstanding prior to the Merger (1) 62,500,000 Less redemption of CF II shares (12,587,893) CF II Sponsor Earnout Shares outstanding prior to the Merger 1,100,000 Common stock of CF II 51,012,107 Shares issued in PIPE financing 42,103,156 Shares issued for in kind banker fee payment 750,000 Merger and PIPE financing shares 42,853,156 Legacy View shares converted (2) 123,211,449 Total 217,076,712 1. Includes CF II Class A shareholders of 50,000,000 and CF II Class B shareholders of 12,500,000. 2. The number of Legacy View shares was determined from the 76,565,107 shares of Legacy View common stock and 5,222,852,052 shares of Legacy View redeemable convertible preferred stock outstanding, which were converted to an equal number of shares of Legacy View common stock upon the closing of the Merger, and then converted at the Exchange Rate to Class A common stock of the Company. All fractional shares were rounded down to the nearest whole share. The Merger was accounted for as a reverse recapitalization because Legacy View was determined to be the accounting acquirer. Under this method of accounting, CF II was treated as the “acquired” company for financial reporting purposes. Accordingly, for accounting purposes, the financial statements of the Company will represent a continuation of the financial statements of Legacy View with the Merger treated as the equivalent of Legacy View issuing stock for the net assets of CF II, accompanied by a recapitalization. The net assets of CF II will be stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the Merger are those of Legacy View. Legacy View was determined to be the accounting acquirer based on the following facts and circumstances: • Legacy View stockholders comprised a relative majority of voting power of View; • Legacy View had the ability to nominate a majority of the members of the board of directors of View; • Legacy View’s operations prior to the acquisition comprising the only ongoing operations of View; • Legacy View’s senior management comprising a majority of the senior management of View; and • View substantially assuming the Legacy View name.

Revenue

Revenue	6 Months Ended
	Jun. 30, 2021
Revenue from Contract with Customer [Abstract]
Revenue	Revenue Disaggregation of Revenue The Company disaggregates revenue between products and services, as well as by major product offering and by geographic market that depict the nature, amount, and timing of revenue and cash flows. The following table summarizes the Company’s revenue by products and services (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Revenue: Products $ 16,814 $ 4,945 $ 26,525 $ 13,889 Services 112 702 170 790 Total $ 16,926 $ 5,647 $ 26,695 $ 14,679 View’s Smart Glass contracts to provide CSS include the sale of both products and services. These services primarily relate to CSS installation and commissioning, and are presented in the table above as Services. Also included within Services in the table above are revenues associated with extended or enhanced warranties. View Smart Glass contracts to provide IGUs, View Smart Building Platform contracts and View Smart Building Technologies contracts relate to the sale of products. The following table summarizes the Company’s revenue by major product offering (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Revenue: Smart Glass $ 11,580 $ 5,647 $ 19,795 $ 14,679 Smart Building Platform 5,136 — 5,136 — Smart Building Technologies $ 210 $ — $ 1,764 $ — Total $ 16,926 $ 5,647 $ 26,695 $ 14,679 Smart Glass Under View’s Smart Glass product offering, the Company is a provider of building materials in the form of IGUs and CSS. The Company recognizes revenue over time as each IGU is manufactured. The Company generally recognizes revenue at a point in time for CSS products. Revenue is recognized for CSS system design, installation and commissioning upon customer acceptance and revenue is recognized for the CSS control panels upon shipment. In limited circumstances, the Company contracts to provide extended or enhanced warranties of our products outside of the terms of its standard assurance warranty, which are recognized as revenue over the respective term of the respective extended or enhanced warranty period. Smart Building Platform During 2021, the Company entered into and commenced work on the first contract under our new offering, View Smart Building Platform, a complete interrelated and integrated platform that combines our smart glass IGUs, the fabrication, unitization and installation of the framing of those IGUs, any combination of View Smart Building Technologies, and installation of the completed smart glass windows and CSS components into a fully installed Smart Building Platform. As the Company performs a significant service of integrating the promised goods and services into a combined output, these contracts constitute a single, combined performance obligation. Revenue from these contracts is recognized over time using a cost-to-cost input method. Changes in estimated costs to complete View Smart Building Platform projects and the related effect on revenue are recognized using a cumulative catch-up adjustment which recognizes in the current period the cumulative effect of the changes on current and prior periods based on a contract’s progress towards fulfillment of the performance obligation. The cumulative catch-up adjustments have not been material for the six months ended June 30, 2021. Smart Building Technologies The Company's Smart Building Technologies includes a suite of products that can be either integrated into the View Smart Building Platform, added-on to View Smart Glass contracts or sold separately. Revenue is generally recognized over time. Revenue generated from these products has not been material to date. The following table summarizes the Company’s revenue by geographic area, which is based on the shipping address of the customers (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Revenue: United States $ 12,053 $ 5,322 $ 21,718 $ 14,009 Canada 4,403 299 4,507 620 Other 470 26 470 50 Total $ 16,926 $ 5,647 $ 26,695 $ 14,679 Remaining Performance Obligations The Company’s IGU contracts are short-term in nature and the practical expedient has been applied. The Company’s performance obligations in CSS contracts are generally short-term in nature, for which the practical expedient has been applied, with the exception of commissioning services, which are provided at the end of a construction project. Revenue for commissioning services performance obligations is not material. The Company’s performance obligations in Smart Building Platform contracts are longer-term in nature, however many of these contracts provide the customer with a right to cancel or terminate for convenience with no substantial penalty. The transaction price allocated to remaining performance obligations for non-cancelable Smart Building Platform contracts as of June 30, 2021 was $4.9 million that the Company expects to recognize as it satisfies the performance obligations over the next 12 to 24 months which are, among other things, dependent on the construction schedule of the site for which the Company's products and services are provided. The Company’s performance obligations in Smart Building Technologies contracts are generally short-term in nature, for which the practical expedient has been applied. Contract Assets and Liabilities Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing, where payment is conditional, as well as retainage for amounts that we have billed to the customer but are being held for payment by the customer pending satisfactory completion of the project. Current contract assets as of June 30, 2021 and December 31, 2020 were $2.7 million and $1.2 million, respectively, and were included in other current assets. The increase in 2021 primarily relates to contract assets associated with View’s Smart Building Platform contracts, which commenced in 2021. The progress billing schedules for these contracts result in timing differences as compared to the Company’s satisfaction of its performance obligation. Non-current contract assets as of June 30, 2021 and December 31, 2020 were $0.7 million and nil, respectively, and were included in other assets. Contract liabilities relate to amounts invoiced or consideration received from customers, typically for the Company’s CSS contracts, in advance of the Company’s satisfaction of the associated performance obligation. Such contract liabilities are recognized as revenue when the performance obligation is satisfied. Contract liabilities are presented as deferred revenue on the condensed consolidated balance sheets.

Fair Value

Fair Value	6 Months Ended
	Jun. 30, 2021
Fair Value Disclosures [Abstract]
Fair Value	Fair Value The following table presents information about the Company’s financial assets and liabilities measured at fair value on a recurring basis (in thousands): June 30, 2021 Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 407,458 $ — $ — $ 407,458 Total cash equivalents 407,458 — — 407,458 Restricted cash: Certificates of deposit 8,468 — 8,468 Total assets measured at fair value $ 407,458 $ 8,468 $ — $ 415,926 Private warrants liability $ — $ — $ 639 $ 639 Sponsor earn-out liability — — 26,101 26,101 Total liabilities measured at fair value $ — $ — $ 26,740 $ 26,740 December 31, 2020 Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 38,574 $ — $ — $ 38,574 Total cash equivalents 38,574 — — 38,574 Restricted cash: Certificates of deposit — 11,461 — 11,461 Total assets measured at fair value $ 38,574 $ 11,461 $ — $ 50,035 Redeemable convertible preferred stock warrants $ — $ — $ 12,323 $ 12,323 Total liabilities measured at fair value $ — $ — $ 12,323 $ 12,323 The following table provides a reconciliation of the beginning and ending balances for the level 3 financial liabilities measured at fair value using significant unobservable inputs (in thousands): Private Sponsor Redeemable Balance as of December 31, 2020 $ — $ — $ 12,323 Additions during the period 589 26,443 — Change in fair value 50 (342) (5,056) Reclass to additional paid-in-capital upon Closing — — (7,267) Balance as of June 30, 2021 $ 639 $ 26,101 $ — Sponsor Earn-out Shares, Private Warrants and redeemable convertible preferred stock warrants are subject to remeasurement to fair value at each balance sheet date. Changes in fair value as a result of the remeasurement are recognized in gain (loss) on fair value change, net in the condensed consolidated statements of operations. The following table summarizes the gain (loss) on fair value change, net (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Private Warrants $ 53 $ — $ (50) $ — Sponsor Earn-out Liability (2,118) — 342 — Redeemable Convertible Preferred Stock Warrants — (3,068) 5,056 1,360 Gain (loss) on fair value change, net $ (2,065) $ (3,068) $ 5,348 $ 1,360 Valuation of redeemable convertible preferred stock warrants The Company used the Black-Scholes option-pricing model, which incorporates assumptions and estimates, to value the redeemable convertible preferred stock warrants. The Company determined the fair value per share of the underlying redeemable convertible preferred stock by taking into consideration the most recent sales of its redeemable convertible preferred stock, results obtained from third-party valuations and additional factors that are deemed relevant. As the Company operated as a private company until March 2021, specific historical and implied volatility information of its stock is not available. Therefore, the Company estimated the expected stock volatility based on the historical volatility of publicly traded peer companies for a term equal to the expected term of the redeemable convertible preferred stock warrant. The risk-free interest rate was determined by reference to the U.S. Treasury yield curve for time periods approximately equal to the expected term of the redeemable convertible preferred stock warrant. The Company estimated a 0% expected dividend yield based on the fact that the Company had never paid or declared dividends through the Closing Date at which time these redeemable convertible preferred stock warrants were converted to common stock warrants and classified as a component of stockholders’ equity. See Note 3 for additional information regarding the reverse recapitalization. The market-based assumptions used in the valuations include the following: March 8, 2021 (Closing Date) December 31, 2020 Expected volatility 52%-75% 70% Expected term (in years) 0.08-7.71 2.0 Expected dividends 0% 0% Risk-free rate 0.04%-1.28% 0.1% Discount for lack of marketability 5.0%-33.0% 11%-55% Valuation of Sponsor Earn-Out liability The estimated fair value of the Sponsor Earn-Out Shares was determined using a Monte Carlo simulation valuation model using the following assumptions: June 30, 2021 March 8, 2021 (Closing Date) Stock price $8.48 $9.19 Expected volatility 37.30% 29.20% Risk free rate 0.77% 0.86% Expected term (in years) 4.7 5.0 Expected dividends 0% 0% Current stock price: The stock price was based on the closing price as of the valuation date. Expected volatility: The volatility rate was determined using a Monte Carlo simulation to estimate the implied volatility of the warrants as such warrants are publicly traded. Risk-free interest rate: The risk-free interest rate is based on the U.S. Treasury yield curve for zero-coupon U.S. Treasury notes with maturities corresponding to the remaining expected term of the earnout period. Expected term: The expected term is the remaining contractual term of the earnout period. Expected dividend yield: The expected dividend rate is zero as the Company currently has no history or expectation of declaring dividends in the foreseeable future. Valuation of Private Warrants The estimated fair value of the Private Warrants was determined using the Black-Scholes option-pricing model using the following assumptions: June 30, 2021 March 8, 2021 (Closing Date) Stock price $8.48 $9.19 Expected volatility 37.30% 29.20% Risk free rate 0.67% 0.73% Expected term (in years) 4.2 4.5 Expected dividends 0% 0% Other

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Operating Leases The Company has an operating lease of approximately 77,200 square feet of office space in Milpitas, California. The lease will expire on September 30, 2028. The lease requires a letter of credit in the amount of $1.0 million. The letter of credit was issued by the Company’s primary commercial bank and is fully secured by a certificate of deposit. The Company has classified this certificate of deposit as restricted cash on the condensed consolidated balance sheets. In July 2010, the Company entered into an operating lease with Industrial Developments International for approximately 300,000 square feet of manufacturing space in Olive Branch, Mississippi, which is effective through March 2026. The lease requires, in addition to the minimum payments noted below, a letter of credit in the amount of $0.4 million in lieu of a deposit. The letter of credit was issued by the Company’s primary commercial bank and is fully secured by a certificate of deposit. The Company has classified this certificate of deposit as restricted cash on the condensed consolidated balance sheets. In September 2015, the Company amended the lease for an additional 267,300 square feet effective from March 2016. In March 2018, the Company entered into a second amendment for an additional 236,804 square feet, which lease expires on March 31, 2028. In January 2019, the Company entered into an industrial facility operating lease with IDIG Crossroads I, LLC for manufacturing space of 510,350 square feet in Olive Branch, Mississippi with expiration on February 28, 2029. The lease required a security deposit in the amount of $1.1 million as of December 31, 2020, which was recorded as other assets on the condensed consolidated balance sheet. In April 2021, the Company terminated this operating lease that had total future minimum rental payments of $19.5 million, which were excluded from the table below. There was no security deposit as of June 30, 2021 related to this lease. As of June 30, 2021, the future minimum rental payments under all operating leases are as follows (in thousands): Year Ending December 31, Operating Leases 2021 (remaining six months) $ 2,756 2022 5,618 2023 5,750 2024 5,887 2025 6,026 Thereafter 15,230 Total minimum lease payments $ 41,267 Indemnifications From time to time, the Company enters into certain types of contracts that contingently require the Company to indemnify the Company's officers, directors, and employees for liabilities arising out of their employment relationship. Generally, a maximum obligation under these contracts is not explicitly stated. Because the maximum amounts associated with these agreements are not explicitly stated, the overall maximum amount of the obligation cannot be reasonably estimated. The Company has not been required to make payments under these obligations, and no liabilities have been recorded for these obligations on the Company's condensed consolidated balance sheets. Standby Letter of Credit During the course of business, the Company’s bank issues standby letters of credit on behalf of the Company to certain vendors and other third parties of the Company. As of June 30, 2021 and December 31, 2020, the total value of the letters of credit issued by the bank are $8.5 million and $11.5 million, respectively. No amounts have been drawn under the standby letter of credit. Commitments In June 2021, the Company entered into a promissory note with one of its customers pursuant to which the customer may draw amounts in a maximum aggregate principal amount of $10.0 million. The amount of the draws are limited to amounts incurred by subcontractors contracted by View in relation to the project. The note is not a revolving facility, which means that outstanding amounts under the note that are repaid cannot be re-borrowed. The promissory note has a maturity date set at the fourth anniversary of the date of the first advance to the customer. The promissory note bears no interest during the period between the first advance to the customer and the maturity date, with interest increasing to an annual rate of 3.5% thereafter. As of June 30, 2021, the customer has made zero advances on the promissory note. Litigation Settlement In December 2014, the Company finalized the terms of a litigation settlement with a third party where the Company agreed to pay the other party a total of $32.0 million periodically over the next ten years. The Company recorded the present value of future payments as a liability and records interest expense, included in interest and other, net in the condensed consolidated statements of comprehensive loss, as it accretes the liability. The balance of the litigation settlement liability is reflected on our condensed consolidated balance sheets as follows (in thousands): June 30, December 31, 2020 Litigation settlement liability - current $ 3,000 $ 3,000 Litigation settlement liability - non-current 7,239 9,658 Total litigation settlement liability $ 10,239 $ 12,658 Litigation From time to time, the Company is subject to claims, litigation, internal or governmental investigations, including those related to labor and employment, contracts, intellectual property, environmental, regulatory compliance, commercial matters and other related matters, some of which allege substantial monetary damages and claims. Some of these actions may be brought as class actions on behalf of a class or purported class of employees. The Company is also defendants in judicial and administrative proceedings involving matters incidental to our business. Legal expenses are expensed as incurred. The Company accrues a charge when management determines that it is probable that a liability has been incurred and the amount of loss can be reasonably estimated. When a loss is probable, the Company records an accrual based on the reasonably estimable loss or range of loss. When no point of loss is more likely than another, the Company records the lowest amount in the estimated range of loss and discloses the estimated range. The Company does not record liabilities for reasonably possible loss contingencies, but does disclose a range of reasonably possible losses if they are material and the Company is able to estimate such a range. If the Company cannot provide a range of reasonably possible losses, the Company explains the factors that prevent it from determining such a range. The Company regularly evaluates current information available to it to determine whether an accrual should be established or adjusted. The ultimate outcome of legal proceedings involves judgments, estimates, and inherent uncertainties and cannot be predicted with certainty. Should the ultimate outcome of any legal matter be unfavorable, the Company's business, financial condition, results of operations, or cash flows could be materially and adversely affected. The Company may also incur substantial legal fees, which are expensed as incurred, in defending against legal claims. Securities Litigation On August 18, 2021, plaintiff Asif Mehedi filed a putative securities class action in the United States District Court for the Northern District of California ( Mehedi v. View, Inc. f/k/a CF Finance Acquisition Corp. II et al. (No. 5:21CV06374, N.D. Cal.)) alleging violations of the federal securities laws by the Company, Rao Mulpuri, and Vidul Prakash. The complaint alleges that defendants violated Section 10(b) of the Securities Exchange Act of 1934 (and SEC Rule 10b-5 promulgated thereunder) and that Mulpuri and Prakash violated Section 20(a) of the Exchange Act. The complaint asserts claims on behalf of a putative class of persons who acquired the Company’s stock between November 30, 2020 and August 16, 2021. The complaint alleges that defendants failed to disclose to investors that the Company had not properly accrued warranty costs related to its product; that there was a material weakness in the Company’s internal control over financial reporting related to warranty accrual; that the Company’s financial results for prior periods were misstated as a result; and that defendants’ positive statements about the Company’s business were materially misleading. The complaint alleges that the foregoing statements caused the price of the Company’s stock to be inflated and that class members were damaged when the price of the Company’s stock declined on August 16, 2021, when the Company announced an independent investigation concerning the adequacy of the Company’s previously disclosed warranty accrual. Plaintiff seeks unspecified compensatory damages and costs, including attorneys’ and expert fees. On February 8, 2022, the Court appointed Stadium Capital LLC lead plaintiff and denied the competing motion of Sweta Sonthalia. On March 14, 2022, Ms. Sonthalia filed a Petition for a Writ of Mandamus, asking the Ninth Circuit Court of Appeals to vacate the lead plaintiff order. On April 11, 2022, the district court denied Ms. Sonthalia’s motion to stay proceedings in the district court pending disposition of the writ petition. The writ petition is now fully briefed in the Ninth Circuit and is being considered for oral argument in August, September, or October 2022. Pursuant to a stipulated schedule, Stadium Capital will file an amended complaint no later than 30 days after View files its Restatement with the SEC; defendants will file an answer or motion(s) to dismiss within 60 days of the filing of the amended complaint; Stadium Capital will file its opposition(s) to the motion(s) within 30 days of the filing of the motion(s) to dismiss; and defendants will file any reply in support of the motion(s) to dismiss within 30 days of the filing of the opposition brief. Given the early stage of this matter, we cannot reasonably estimate the possible loss (or range of loss), if any, at this time; therefore, a liability has not been recorded as of June 30, 2021. Derivative Litigation On December 6, 2021, a purported Company shareholder filed a verified stockholder derivative complaint (nominally on behalf of the Company) against Rao Mulpuri, Nigel Gormly, Harold Hughes, Tom Leppert, Toby Cosgrove, Lisa Picard, Julie Larson-Green, and Vidul Prakash ( Jacobson v. Mulpuri, et al. (No. 1:21CV01719, D. Del.)). The complaint alleges that Mulpuri and Prakash violated Sections 10(b) and 21D of the Exchange Act, and asserts claims against the director defendants for breach of fiduciary duty and waste of corporate assets. The complaint alleges that defendants Mulpuri, Gormly, Hughes, Leppert, Cosgrove, Picard, and Larson-Green failed to prevent the Company from making false statements regarding the Company’s business results and prospects and that the Company has been harmed by incurring legal fees and potential liability in investigations and lawsuits. The complaint seeks unspecified damages and costs, a judgment directing the Company to reform its corporate governance and internal procedures, and unspecified restitution from defendants to the Company. On February 14, 2022, the Court entered the parties’ stipulation staying the litigation until fifteen days after the earliest of: (a) dismissal with prejudice of the Mehedi v. View securities class action and exhaustion of all appeals, or dismissal by settlement; (b) the motion(s) to dismiss Mehedi v. View are denied; or (c) either party gives notice that it no longer consents to the stay. On May 24, 2022, a different purported Company shareholder filed another verified stockholder derivative complaint (nominally on behalf of the Company) against Mulpuri, Gormly, Hughes, Leppert, Cosgrove, Picard, Larson-Green, and Prakash ( Damidi v. Mulpuri et al. (No. 1:22CV00675, D. Del.)). The complaint asserts claims for violation of Sections 10(b) and 21D of the Exchange Act, breach of fiduciary duty, aiding and abetting breach of fiduciary duty, unjust enrichment, and waste of corporate assets. The complaint alleges that defendants Mulpuri, Gormly, Hughes, Leppert, Cosgrove, Picard, and Larson-Green failed to prevent the Company from making false statements regarding the Company’s business results and prospects and that the Company has been harmed by incurring legal fees and potential liability in investigations and lawsuits. The complaint seeks unspecified damages and costs, punitive damages, and unspecified restitution from defendants to the Company. The Damidi action has been docketed as related to the Jacobson action. Given the early stage of this matter, we cannot reasonably estimate the possible loss (or range of loss), if any, at this time; therefore, a liability has not been recorded as of June 30, 2021. Government Investigation On November 9, 2021, we announced that we had voluntarily reported to the SEC that the Audit Committee of the Company’s Board of Directors was conducting an independent, internal investigation into the adequacy of the Company’s previously reported warranty accrual. In January 2022, we were informed that the SEC is conducting a formal investigation of this matter. We have cooperated with the SEC’s investigation and intend to continue doing so. Given the early stage of this matter, we cannot reasonably estimate the possible loss (or range of loss), if any, at this time; therefore, a liability has not been recorded as of June 30, 2021. Northern District of Mississippi Environmental Matter In September and August of 2021, the Mississippi Commission on Environmental Quality (“MCEQ”), Desoto County Regional Utility Authority (“DCRUA”) and the City of Olive Branch, Mississippi (“Olive Branch”), each issued notices and orders to the Company with respect to its discharges of water from its Olive Branch facility into the publicly owned treatment works (“POTW”) of DCRUA and Olive Branch without first obtaining a pretreatment permit. In August 2021, a Subpoena to Testify Before a Grand Jury was issued out of the United States District Court for the Northern District of Mississippi (“Subpoena”) to the Company requiring it to produce to the Environmental Protection Agency (“EPA”) various documents relating to environmental matters at its Olive Branch facility, including but not limited to hazardous waste records, air emissions records, storm water discharges records and wastewater disposal records. The Company has cooperated fully with each such notice, order and Subpoena. On April 13, 2022, the Company and the United States Attorney’s Office for the United States District Court for the Northern District of Mississippi agreed in principle to the terms of a global settlement resolving the prospect of claims and charges against the Company relating to all prior discharges of water into the POTW of DCRUA and Olive Branch without first obtaining a pretreatment permit. The principal terms of the settlement are: 1. the Company pleading guilty to a single misdemeanor count for negligently discharging wastewater to a POTW without first obtaining a pretreatment permit in violation of 33 U.S.C. § 1319(c)(1)(A); 2. the Company paying a fine of $3.0 million over a three-year period in equal installments of $1.0 million to the federal government; 3. the Company paying a special assessment of $125 to the federal government pursuant to 18 U.S.C. § 3013(a)(1)(B); 4. the Company entering a separate civil Agreed Order with the MCEQ that requires the payment of a separate civil penalty of $1.5 million; 5. the Company making a separate community service payment in the amount of $0.5 million to DCRUA, to be used for the sole purpose of expanding wastewater treatment capacity in DeSoto County, Mississippi, within 30 days of entering the Plea Agreement; 6. the Company implementing an environmental management system that conforms to ISO 14001:2015 standards or a similar environmental management system approved by the United States Environmental Protection Agency, which is expected to result in $0.3 million in consulting and personnel costs; 7. the Company implementing agreed upon wastewater reduction plans, which is expected to result in approximately $2.0 million in capital expenditures to install a wastewater treatment and recycling system; 8. the Company obtaining a pretreatment permit from MDEQ, or entering an Agreed Order with MCEQ and operating in compliance with that Agreed Order until a permit can be obtained; 9. the Company obtaining wastewater discharge permits from DCRUA and Olive Branch, or entering into Consent/Compliance Order(s) or Agreement(s) with DCRUA and Olive Branch that are consistent with any Agreed Order entered with MCEQ and operating in compliance with such Consent/Compliance Order(s) or Agreement(s) until permits can be obtained; and 10. the Company agreeing to probation for three years. The terms of the Plea Agreement are subject to the approval of the United States District Court for the Northern District of Mississippi. View is in the process of coordinating with MDEQ and the local authorities with respect to the civil orders and/or agreements contemplated by the settlement terms, including obtaining a pretreatment permit from MCEQ, which has not been granted as of the date of this Report. The Plea Agreement will be presented to the Court for approval following these efforts. The date for presentation of the Plea Agreement to the Court has not yet been determined. The Company has recognized the $5.0 million of penalties incurred in conjunction with this settlement within Other expense, net, for the three and six months ended June 30, 2021, which is included within Accrued expenses and other current liabilities as of June 30, 2021.

Debt

Debt	6 Months Ended
	Jun. 30, 2021
Debt Disclosure [Abstract]
Debt	Debt Debt outstanding consisted of the following (in thousands): Interest Rate June 30, December 31, 2020 Term loan, due June 30, 2032 0% $ 15,430 $ 15,430 Revolving debt facility, repaid on March 8, 2021 LIBOR+9.05% — 250,000 Debt discount — (2,752) Total debt 15,430 262,678 Debt, current 735 247,248 Debt, non-current $ 14,695 $ 15,430 Principal payments on all debt outstanding as of June 30, 2021 are estimated as follows (in thousands): Year Ending December 31, Total 2021 (remaining six months) $ — 2022 1,470 2023 1,470 2024 1,470 2025 1,470 Thereafter 9,550 Total $ 15,430 Term Loan On November 22, 2010, the Company entered into a debt arrangement with a lender, in an amount of $40.0 million ("Term Loan"), for the purpose of financing equipment and tenant improvements at its manufacturing facility in Olive Branch, Mississippi. Pursuant to the original terms, the loan provides for interest-free debt to be repaid in semi-annual payments due on June 30 and December 31 each year. The loan was originally being paid over 24 semi-annual installments through June 30, 2024. On October 22, 2020, the Company entered into an amended and restated debt arrangement with the lender. The amended and restated debt arrangement temporarily suspended the payments. Starting June 30, 2022, the Company is required to make semi-annual payments of $0.7 million through June 30, 2032. The term loan agreement required the Company to invest certain amounts in land, building and equipment and create a certain number of jobs. The term loan agreement, as amended, also includes a covenant for audited consolidated financial statements to be delivered to the lender within 210 days of the Company’s fiscal year end. As of June 30, 2021, the Company was in compliance with these covenants. Revolving Debt Facility In October 2019, the Company entered into a secured revolving debt facility pursuant to which the Company may draw amounts in a maximum aggregate principal amount of $200.0 million until January 3, 2020 and $250.0 million after such date, for the purpose of paying payables and other corporate obligations. In October 2019, the Company drew a principal amount of $150.0 million under the facility with weekly maturity dates ranging from 8 days to 364 days. In May 2020, the Company drew the remaining principal amount of $100.0 million available under the facility, which was repayable on May 1, 2021. The facility's original expiration was October 22, 2023, at which time all drawn amounts were to be repaid in full. The interest rate applicable to amounts outstanding under the facility was LIBOR, plus 9.05%. As security for the payment and performance of all obligations under the facility, the Company granted the finance provider a security interest in substantially all of the Company’s assets. Under the original agreement, repaid principal amounts became immediately available to be redrawn under the facility with maturity dates of one year through October 23, 2022. As of December 31, 2020, the Company’s available borrowing capacity was nil. As of December 31, 2020, the Company classified the outstanding balance of $250.0 million as a current liability because the Company was in violation of the stockholders’ equity covenant as of such date and the limited waiver from the finance provider waived such violation only through March 31, 2021. In December 2020, the Company entered into an amendment to replace thirteen weekly draws of approximately $2.9 million each, aggregating to $37.5 million in principal amount, with four notes of approximately $9.4 million each, aggregating to $37.5 million in principal amount. On March 8, 2021, upon Closing, the facility was repaid in full in the amount of $276.8 million, including accrued interest and future interest through maturity of the notes of $26.8 million prior to the expiration of the limited waiver from the finance provider. Upon repayment of its obligation, the Company recorded a debt extinguishment loss of $10.0 million, and the facility was terminated.

Stockholders' Equity

Stockholders' Equity	6 Months Ended
	Jun. 30, 2021
Stockholders' Equity Note [Abstract]
Stockholders' Equity	Stockholders’ Equity Legacy View Redeemable Convertible Preferred Stock Prior to the Merger, Legacy View had outstanding shares of Series A, Series B, Series C, Series D, Series E-2, Series F, Series G, and Series H redeemable convertible preferred stock. Immediately prior to the Merger, each outstanding share of Legacy View redeemable convertible preferred stock converted to Legacy View common stock on a 1:1 conversion ratio. Upon Closing, each issued and outstanding share of Legacy View common stock was cancelled and the holders thereof in exchange received shares of the Company’s common stock in an amount determined by application of the Exchange Ratio. As such, as of June 30, 2021, the Company has no redeemable convertible preferred stock outstanding. See Note 3 for additional information regarding the reverse recapitalization. As of December 31, 2020, the redeemable convertible preferred stock consisted of the following (in thousands, except for share amounts): Shares Authorized December 31, 2020 Shares Outstanding December 31, 2020 Carry Value December 31, 2020 Liquidation Preference Common Stock Issuable Upon Conversion Series A 23,250 18,441 $ 166 $ 238 18,441 B 1,571,798 1,217,066 19,210 18,845 1,217,066 C 2,274,766 608,118 11,495 11,417 608,118 D 2,673,700 612,994 13,263 13,235 612,994 E 7,440,000 4,606,784 100,225 119,361 4,606,784 E-1 131,584 — — — — E-2 115,787 — — — — F 10,462,500 4,861,658 175,182 188,193 4,861,658 G 62,775,000 47,881,788 330,466 231,686 47,881,788 G-1 930,000 — — — — H 75,177,482 10,613,198 197,488 200,852 10,613,198 H-1 60,833,745 51,011,263 965,183 965,374 51,011,263 224,409,612 121,431,310 $ 1,812,678 $ 1,749,201 121,431,310 Common Stock On March 9, 2021, the Company’s common stock and warrants began trading on the Nasdaq Global Select Market under the ticker symbols “VIEW” and “VIEWW,” respectively. Pursuant to the Company’s certificate of incorporation, the Company is authorized to issue 600,000,000 shares of common stock with a par value of $0.0001 per share. As of June 30, 2021, the Company had 217,115,573 shares of common stock issued and outstanding. Preferred Stock Pursuant to the Company’s certificate of incorporation, the Company is authorized to issue 1,000,000 shares of preferred stock having a par value of $0.0001 per share (“View Inc. Preferred Stock”). The Company’s board of directors has the authority to issue View, Inc. Preferred Stock and to determine the rights, preferences, privileges, and restrictions, including voting rights, of those shares. As of June 30, 2021, no shares of View, Inc. Preferred Stock were issued and outstanding. Dividend Common stock is entitled to dividends when and if declared by the Company’s board of directors, subject to the rights of all classes of stock outstanding having priority rights to dividends. The Company has not paid any cash dividends on common stock to date. The Company may retain future earnings, if any, for the further development and expansion of its business and has no current plans to pay cash dividends for the foreseeable future. Any future determination to pay dividends will be made at the discretion of the Company’s board of directors and will depend on, among other things, the Company’s financial condition, results of operations, capital requirements, restrictions contained in future agreements and financing instruments, business prospects and such other factors as the Company’s board of directors may deem relevant.

Stock Warrants

Stock Warrants	6 Months Ended
	Jun. 30, 2021
Equity [Abstract]
Stock Warrants	Stock Warrants Public and Private Warrants Prior to the Merger, CF II issued 366,666 Private Warrants and 16,666,637 Public Warrants. Each whole warrant entitles the holder to purchase one share of the Company’s common stock at a price of $11.50 per share, subject to adjustments. The Warrants become exercisable on August 26, 2021. The Public Warrants and Private Warrants will expire five years after the Closing and five years after August 26, 2020, respectively. Once the Public Warrants become exercisable, the Company may redeem the outstanding warrants, in whole and not in part, upon a minimum of 30 days’ prior written notice of redemption (“Redemption Period”). For purposes of the redemption, “Reference Value” shall mean the last reported sales price of the Company’s common stock for any twenty thirty The Company may redeem the outstanding Public Warrants for cash at a price of $0.01 per warrant if the Reference Value equals or exceeds $18.00 per share. The warrant holders have the right to exercise their outstanding warrants prior to the scheduled redemption date during the Redemption Period at $11.50 per share. If the Company calls the Public Warrants for redemption, the Company will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis”, as described in the warrant agreement. The Private Warrants are identical to the Public Warrants except that the Private Warrants were not transferable, assignable or salable until April 7, 2021. Additionally, the Private Warrants are exercisable on a cashless basis and are non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Warrants are held by someone other than the initial purchasers or their permitted transferees then such warrants will be redeemable by the Company and exercisable by the warrant holders on the same basis as the Public Warrants. As of June 30, 2021, there were 366,666 Private Warrants and 16,666,637 Public Warrants outstanding, and no Warrants had been exercised. Other Warrants Legacy View also issued redeemable convertible preferred stock and common stock warrants, to various service providers, lenders, investors, at various points in time, which were subsequently converted to the common stock warrants of the Company. Upon consummation of the Merger, each Legacy View warrant that was outstanding was assumed by CF II and converted into a common stock warrant exercisable for common stock equal to the product (rounded down to the nearest whole number) of (a) the number of shares of Legacy View capital stock subject to the Legacy View warrant immediately prior to the Merger multiplied by (b) the Exchange Ratio. Such warrants have a per share exercise price equal to the quotient (rounded up to the nearest whole cent) obtained by dividing (i) the exercise price per share of Legacy View capital stock subject to the Legacy View warrant immediately prior to the Merger by (ii) the Exchange Ratio, and, except as specifically provided in the Merger Agreement, each warrant continues to be governed by the same terms and conditions (including vesting and exercisability terms) as were applicable to the corresponding former Legacy View warrant immediately prior to the Merger. Prior to the merger, the redeemable convertible preferred stock warrants were classified as liabilities on the condensed consolidated balance sheets. See Note 5 for a reconciliation of the beginning and ending balances for the level 3 financial liabilities measured at fair value. The following table summarizes the outstanding common stock warrants: Warrant issue date Types of shares Number of Warrants Number of Warrants December 31, 2020 (As converted) Exercise Expiry Date August 2010 - June 2011 Common stock (previously Series B redeemable convertible preferred stock) 46,498 46,498 $ 15.49 March 2023 August 2011 - January 2012 Common stock (previously Series C redeemable convertible preferred stock) 53,256 53,256 18.78 March 2023 August 2012 Common stock (previously Series D redeemable convertible preferred stock) 45,388 45,388 21.60 March 2023 December 2013 Common stock (previously Series E redeemable convertible preferred stock) 63,296 63,296 25.91 March 2023 April 2015 - April 2016 Common stock (previously Series F redeemable convertible preferred stock) 45,207 161,457 38.71 Through December 2022 April 2016 - November 2018 Common stock (previously Series H redeemable convertible preferred stock) 1,135,391 1,135,391 18.93 Through November 2028 March 2017 Common stock (previously Series H redeemable convertible preferred stock) 1,849,431 1,849,431 12.91 March 2027 March 2014 Common stock 2,324 2,324 9.47 August 2023 August 2015 Common stock 12,916 12,916 11.62 December 2022 December 2018 Common stock 24,910 24,910 9.04 December 2028 August 2020 Common stock (Private Warrants) 366,666 — 11.50 Through March 2026 August 2020 Common stock (Public Warrants) 16,666,637 — 11.50 Through March 2026 Total stock warrants 20,311,920 3,394,867

Stock-Based Compensation

Stock-Based Compensation	6 Months Ended
	Jun. 30, 2021
Share-based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock-Based Compensation 2018 Plan Legacy View’s 2018 Amended and Restated Equity Incentive Plan (formerly the 2009 Equity Incentive Plan), effective November 21, 2018 (the “2018 Plan”), allowed Legacy View to grant incentive stock options, nonstatutory stock options, stock appreciation rights, restricted stock awards and restricted stock units to eligible employees, directors, and consultants of Legacy View and any parent or subsidiary of Legacy View. In connection with the Closing of the Merger, the 2018 Plan was terminated, the remaining unallocated share reserve under the 2018 Plan was cancelled and no new awards will be granted under the 2018 Plan. 24,657,302 options (as converted, due to retroactive application of reverse recapitalization) outstanding under the 2018 Plan at Closing were assumed by the Company under the 2021 Plan (defined below). The options assumed under the 2021 Plan (defined below) generally vest 20% upon completion of one year of service and 1/60 per month thereafter or vest 25% upon completion of one year of service and 1/48 per month thereafter and generally expire 10 years from the date of grant. 2021 Plan In connection with the Closing of the Merger, the Company adopted the 2021 Equity Incentive Plan (the “2021 Plan”) under which 58,631,907 shares of common stock were initially reserved for issuance. The 2021 Plan permits the grant of incentive stock options (“Options”), nonstatutory stock options, stock appreciation rights, restricted stock, restricted stock units (“RSUs)”, and stock bonus awards. As of June 30, 2021, the Company had 15,590,157 shares of common stock reserved for future issuance of equity awards to employees, officers, directors, or consultants under the 2021 Plan. Pursuant to the terms of the Agreement and Plan of Merger, at the Closing of the Merger on March 8, 2021, the Company granted 12,500,000 Officer RSUs for shares of Class A Common Stock of the Company and 5,000,000 options to purchase Class A Common Stock of the Company (“Officer Options”) to View’s executive officers. The Officer RSUs are subject to both time and market-based vesting conditions. The Officer RSUs time vest over a four-year period with 25% to vest on the twelve-month anniversary of the Closing and the remaining 75% to vest on a monthly basis over the following thirty-six months subject to the following market-based vesting. 50% of the Officer RSUs granted to each executive officer will only vest if the share price hurdle of $15.00 is achieved and the remaining 50% of such Officer RSUs will vest if the share price hurdle of $20.00 is achieved. The Officer Options time vest over a four-year period with 25% to vest on the twelve-month anniversary of the Closing and the remaining 75% will vest on a monthly basis over the following thirty-six months. CEO Incentive Plan In connection with the Closing of the Merger, the Company adopted the 2021 Chief Executive Officer Incentive Plan (the “CEO Incentive Plan”) effective March 8, 2021. Pursuant to the CEO Incentive Plan and the terms of the Agreement and Plan of Merger, on March 8, 2021, the Company granted the CEO an option award to purchase Class A common stock of the Company at an exercise price of $10.00 per share, which vests and becomes exercisable upon satisfaction of the performance conditions set forth in the table below, contingent upon the CEO’s continued employment with the Company on each such vesting date. Tranche Option Shares (#) Average 60-day 1 2,500,000 20.00 2 2,500,000 30.00 3 2,500,000 40.00 4 2,500,000 50.00 5 2,500,000 60.00 6 2,500,000 70.00 7 2,500,000 80.00 8 2,500,000 90.00 9 2,500,000 100.00 10 2,500,000 110.00 The following table summarizes the activity under the 2021 Plan (in thousands, except per share data and contractual term) for time vested options: Options Outstanding Number of Weighted- Weighted-Average Aggregate Intrinsic Value 1 Outstanding as of December 31, 2020 1,071,605 $ 0.22 7.6 $ 20,564 Retroactive application of reverse recapitalization (1,046,690) Balance as of December 31, 2020, as converted 24,915 $ 9.32 7.6 $ 20,564 Options granted 5,000 $ 10.00 — — Exercised (190) $ 9.04 — — Canceled/forfeited (138) $ 9.29 — — Outstanding as of June 30, 2021 29,587 $ 9.44 7.6 $ 186 Options vested and expected to vest as of June 30, 2021 28,584 $ 9.46 7.6 $ 164 Exercisable as of June 30, 2021 16,281 $ 9.48 7.0 $ 55 ______________________ 1 The aggregate intrinsic value is calculated as the difference between the market value of the Company's common shares as of the relevant period end and the respective exercise prices of the options. The market value as of June 30, 2021 was $8.48 per share, which is the closing sale price of View's common shares on that day as reported by the Nasdaq Global Market. The market value as of December 31, 2020 was $9.89 per share, which is the fair value of View's common stock as historically determined in accordance with the guidelines outlined in the American Institute of Certified Public Accountants Practice Aid, Valuation of Privately-Held-Company Equity Securities Issued as Compensation. The weighted-average grant date fair value per share of stock options granted was $4.38 for the six months ended June 30, 2021. The total grant date fair value of stock options vested was $12.8 million during the six months ended June 30, 2021. The total intrinsic value of options exercised during the six months ended June 30, 2021 was $0.4 million. As of June 30, 2021, total unrecognized compensation cost related to unvested stock options, net of estimated forfeitures, was $52.0 million and is expected to be recognized over a weighted-average remaining service period of 2.4 years. In addition to the time vested options above, as of June 30, 2021, total outstanding stock options under the CEO Incentive Plan was 25,000,000 shares which were issued during the six months ended June 30, 2021 with a grant date exercise price per share of $10.00 and remaining contractual term of 9.7 years. As of June 30, 2021, the CEO Option Award had no intrinsic value. There were no options issued under this plan in 2020. The weighted-average grant date fair value per share of stock options granted under the CEO Incentive Plan was $3.54 for the six months ended June 30, 2021. As of June 30, 2021, total unrecognized compensation cost related to options under the CEO Incentive plan, net of estimated forfeitures, was $82.5 million and is expected to be recognized over a weighted-average remaining service period of 4.9 years. The following table summarizes the activities for our outstanding RSUs under the Company’s 2021 Plan (in thousands, except per share data) during the six months ended June 30, 2021: Number of Weighted Outstanding as of December 31, 2020 — $ — Granted 12,758 $ 6.15 Vested (35) $ 7.23 Outstanding as of June 30, 2021 12,723 $ 6.15 The total grant date fair value of RSUs vested was $0.2 million during the six months ended June 30, 2021. As of June 30, 2021, total unrecognized compensation cost related to RSUs, net of estimated forfeitures, was $66.0 million and is expected to be recognized over a weighted-average remaining service period of 2.0 years. To the extent that the actual forfeiture rate is different than what the Company has anticipated, stock-based compensation related to these awards will be different from expectations. Valuation The estimated grant date fair values of the Company’s time vested stock options granted to employees were calculated using the Black-Scholes option-pricing models based on the following assumptions: Six Months Ended June 30, 2021 2020 Expected volatility 53.0% 70% Expected terms (in years) 6.0 5.4-6.7 Expected dividends 0% 0% Risk-free rate 1.07% 0.4%-1.5% Prior to the Merger, due to the absence of a public market, the Company’s common stock required the Company’s board of directors to estimate the fair value of its common stock for purposes of granting options and for determining stock-based compensation expense by considering several objective and subjective factors, including contemporaneous third-party valuations, actual and forecasted operating and financial results, market conditions and performance of comparable publicly traded companies, developments and milestones in the Company, the rights and preferences of redeemable convertible preferred stock and common, and transactions involving the Company’s stock. The fair value of the Company’s common stock was determined in accordance with applicable elements of the American Institute of Certified Public Accountants guide, Valuation of Privately Held Company Equity Securities Issued as Compensation. The estimated grant date fair value for each tranche of CEO Option Award and Officer RSUs is determined by using the Monte Carlo Simulation valuation model and the assumptions below. The estimated grant date fair value of the Officer Options is determined using the Black-Scholes option-pricing model. The valuation models incorporated the following key assumptions: CEO Option Officer RSUs Officer Options Expected stock price $9.19 $9.19 $9.19 Expected volatility 54.0% 56.0% 53.0% Risk-free rate 1.59% 0.60% 1.07% Expected terms (in years) 10.0 4.0 6.0 Expected dividends 0% 0% 0% Discount for lack of marketability 20% n/a n/a Stock-based Compensation Expense The Company’s stock-based compensation included in its condensed consolidated statements of comprehensive loss was as follows (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Cost of revenue $ 1,297 $ 570 $ 2,175 $ 1,116 Research and development 2,628 559 3,543 3,467 Selling, general, and administrative 18,349 5,673 27,019 11,437 Total $ 22,274 $ 6,802 $ 32,737 $ 16,020

Income Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2021
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company calculates the provision for income taxes during interim reporting periods by applying an estimate of the annual effective tax rate for the full fiscal year to ordinary income or loss for the interim reporting period. When applicable, the year-to-date tax provision reflects adjustments from discrete tax items. For the three and six months ended June 30, 2021 and June 30, 2020, the Company’s income tax expense was immaterial. As our U.S. operations are projecting to be in a taxable loss in the year and based on all available objectively verifiable evidence during the six months ended June 30, 2021, the Company believes it is more likely than not that the tax benefits of the U.S. losses incurred will not be realized. Accordingly, the Company will continue to maintain a full valuation allowance on the U.S. deferred tax assets. The Company’s income tax expense for the three and six months ended June 30, 2021 is due primarily to income taxes in Canada. The Company accounts for the uncertainty in income taxes by utilizing a comprehensive model for the recognition, measurement, presentation and disclosure in financial statements of any uncertain tax positions that have been taken or are expected to be taken on an income tax return. During the six months ended June 30, 2021, there have been no changes in the estimated uncertain tax benefits.

Net Loss Per Share

Net Loss Per Share	6 Months Ended
	Jun. 30, 2021
Earnings Per Share [Abstract]
Net Loss Per Share	Net Loss Per Share The following table sets forth the computation of basic and diluted net loss per share (in thousands, except share and per share data): Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Net loss $ (95,720) $ (69,495) $ (169,755) $ (141,820) Weighted-average shares outstanding, basic and diluted 212,116,112 1,682,704 134,240,831 1,669,739 Net loss per share, basic and diluted $ (0.45) $ (41.30) $ (1.26) $ (84.94) As a result of the Merger, the weighted-average number of shares of common stock used in the calculation of net loss per share have also been retroactively converted by applying the Exchange Ratio. For the three and six months ended June 30, 2021, common stock equivalents consisted of stock options, restricted stock units and warrants. For the three and six months ended June 30, 2020, common stock equivalents consisted of stock options, warrants, redeemable convertible preferred stock and related warrants. None of the common stock equivalents were included in the calculation of diluted net loss per share for all periods presented as the Company recorded a net loss. The following outstanding shares of common stock equivalents were excluded from the computation of diluted net loss per share for the periods presented because including them would have had an anti-dilutive effect: June 30, 2021 2020 Stock options to purchase common stock 29,587,210 25,063,655 Unvested restricted stock units 257,625 — Warrants to purchase common stock 20,311,920 40,150 Redeemable convertible preferred stock (on an if-converted basis) — 121,431,310 Warrants to purchase redeemable convertible preferred stock (on an if-converted basis) — 3,354,717 Total 50,156,755 149,889,832 The 4,970,000 Sponsor Earn-Out Shares are excluded from basic and diluted net loss per share as such shares are contingently recallable until the share price of the Company exceeds specified thresholds that have not been achieved as of June 30, 2021. The 25,000,000 shares and the 12,500,000 shares of common stock equivalents subject to the CEO Option Award and the Officer RSUs, respectively, are excluded from the anti-dilutive table as the underlying shares are contingently issuable until the share price of the Company exceeds the specified thresholds that have not been achieved.

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2021
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events The Company has evaluated subsequent events from the balance sheet date through the date the financial statements were issued and has determined that no additional material subsequent events exist other than the Securities Litigation, Derivative Litigation, Government Investigation and Northern District of Mississippi Environmental Matter disclosed in Note 6 .

Organization and Summary of S_2

Organization and Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization	Organization View, Inc. (f/k/a CF Finance Acquisition Corp. II) and its wholly-owned subsidiaries (collectively “View” or the “Company”) headquartered in Milpitas, California, is a technology company that manufactures smart building products intended to help improve people’s health, productivity and experience, while simultaneously reducing energy consumption. View’s primary product is a proprietary electrochromic or “smart” glass panel that when combined with View’s proprietary network infrastructure and software, intelligently adjusts in response to the sun by tinting from clear to dark states, and vice versa thereby reducing heat and glare. The Company is devoting substantially all of its efforts towards the manufacturing, sale and further development of its product platforms, and marketing of both custom and standardized product solutions. The Company has also devoted significant resources to enable its new View Smart Building Platform, a new offering beginning in 2021.
Basis of Presentation	Basis of Presentation The condensed consolidated financial statements and accompanying notes have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and regulations of the U.S. Securities and Exchange Commission (“SEC”) for interim financial reporting and are unaudited. The Company’s condensed consolidated financial statements include the accounts of View, Inc. and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. The Company’s fiscal year ends on December 31. Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2020, included in View’s 2021 Annual Report on Form 10-K filed with the SEC on June 15, 2022 (the "2021 Form 10-K"). The information as of December 31, 2020 included in the condensed consolidated balance sheets was derived from those audited consolidated financial statements as restated for the items described within this report. See Note 2 for further information. As a result of the Transactions completed on March 8, 2021, prior period share and per share amounts presented in the accompanying condensed consolidated financial statements and these related notes have been retroactively converted in an amount determined by application of the exchange ratio of 0.02325 (“Exchange Ratio”), which was based on Legacy View’s implied price per share prior to the Merger. The condensed consolidated financial statements were prepared on the same basis as the audited consolidated financial statements and included herein reflect all adjustments, including normal recurring adjustments, which are, in the opinion of management, necessary for a fair statement of the Company’s financial position as of June 30, 2021, the results of operations for the three and six months ended June 30, 2021 and the cash flows for the six months ended June 30, 2021. The results of operations for the three and six months ended June 30, 2021 are not necessarily indicative of the results that may be expected for the full year or any other future interim or annual periods. All amounts are presented in U.S. dollars ($).
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts and disclosures in the condensed consolidated financial statements and the accompanying notes. Significant estimates include the warranty accrual, the fair value of common stock prior to reverse recapitalization and other assumptions used to measure stock-based compensation, the fair value of the redeemable convertible preferred stock, warrants, sponsor earn-out liability, and the estimation of costs to complete the performance obligations under contracts for revenue recognition. Other estimates include the fair value of acquired intangible assets and their respective useful lives, the determination of standalone selling price of various performance obligations, the valuation of deferred tax assets and uncertain income tax positions, and the recoverability of long-lived assets. The Company bases its estimates on historical experience, the current economic environment, and on assumptions that it believes are reasonable under the circumstances. The Company is subject to uncertainties such as the impact of future events, economic and political factors, and changes in the Company’s business environment; therefore, actual results could differ from these estimates. The Company adjusts such estimates and assumptions when facts and circumstances dictate which may require significant judgment. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods. Actual results could differ significantly from these estimates.
Concentration of Credit Risk and Other Risks and Uncertainties	Concentration of Credit Risk and Other Risks and Uncertainties Financial instruments which potentially subject the Company to concentration of credit risk consist primarily of cash and cash equivalents, restricted cash, and accounts receivable. Cash and cash equivalents are held by domestic financial institutions with high credit standings. Such deposits may, at times, exceed federally insured limits. As of June 30, 2021, the Company has not experienced any losses on its deposits of cash and cash equivalents. For the six months ended June 30, 2021, three customers represented greater than 10.0% of total revenue, each accounting for 16.5%, 11.8% and 10.1% of total revenue. For the six months ended June 30, 2020, three customers represented greater than 10.0% of total revenue, each accounting for 17.3%, 16.7% and 11.6% of total revenue. Three customers accounted for 53.7% of accounts receivable, net as of June 30, 2021, including 24.1%, 15.5%, and 14.1%, respectively. One customer accounted for 23.6% of accounts receivable, net as of December 31, 2020. Accounts receivable are stated at the amount the Company expects to collect. The Company generally does not require collateral or other security in support of accounts receivable. To reduce credit risk, management performs ongoing credit evaluations of its customers’ financial condition. Certain materials used by the Company in the manufacturing of its products are purchased from a limited number of suppliers. Shortages could occur in these materials due to an interruption of supply or increased demand in the industry. For the six months ended June 30, 2021, one supplier accounted for 34.5% of total purchases. For the six months ended June 30, 2020, two suppliers accounted for 42.9% and 10.7% of total purchases, respectively.
Cash, Cash Equivalents and Restricted Cash	Cash, Cash Equivalents and Restricted Cash The Company considers all highly liquid investments with original maturities from the date of purchase of three months or less to be cash equivalents. Cash equivalents are invested in demand deposits, U.S. Treasury bills and money market mutual funds. The Company considers investments with original maturities greater than three months and remaining maturities less than one year to be short-term investments. Demand deposits and U.S Treasury bills are carried at cost, which approximates fair value and money market funds are reported at fair value based upon quoted market prices. The Company is required by its bank to collateralize letters of credit issued to the Company’s lessors, suppliers, customers, utility providers, and for the Company’s purchasing card program. All amounts in restricted cash as of June 30, 2021 and December 31, 2020 represent funds held in certificates of deposit and are stated at cost, which approximates fair value. Restricted cash is classified as current or non-current on the consolidated balance sheets based on the remaining term of the restriction.
Cash, Cash Equivalents and Restricted Cash	Cash, Cash Equivalents and Restricted Cash The Company considers all highly liquid investments with original maturities from the date of purchase of three months or less to be cash equivalents. Cash equivalents are invested in demand deposits, U.S. Treasury bills and money market mutual funds. The Company considers investments with original maturities greater than three months and remaining maturities less than one year to be short-term investments. Demand deposits and U.S Treasury bills are carried at cost, which approximates fair value and money market funds are reported at fair value based upon quoted market prices. The Company is required by its bank to collateralize letters of credit issued to the Company’s lessors, suppliers, customers, utility providers, and for the Company’s purchasing card program. All amounts in restricted cash as of June 30, 2021 and December 31, 2020 represent funds held in certificates of deposit and are stated at cost, which approximates fair value. Restricted cash is classified as current or non-current on the consolidated balance sheets based on the remaining term of the restriction.
Fair Value Measurement of Financial Assets and Liabilities	Fair Value Measurement of Financial Assets and Liabilities Fair value is defined as an exchange price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be either recorded or disclosed at fair value, the Company considers the principal or most advantageous market in which it would transact, and it also considers assumptions that market participants would use when pricing the asset or liability. The Company maximizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value. U.S. GAAP establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is as follows: Level 1 Observable inputs such as quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. Level 2 Inputs other than the quoted prices in active markets that are observable either directly or indirectly. Level 3 Unobservable inputs in which there are little or no market data and which require the Company to develop its own assumptions. Cash equivalents relating to demand deposits and U.S. Treasury bills, accounts receivable, and accounts payable are carried at cost, which approximates fair value due to the short maturity of these instruments. Short-term and long-term debt are carried at amortized cost, which approximates its fair value. See Note 5 for further information.
Inventories	InventoriesInventories consist of finished goods which are stated at the lower of cost or net realizable value. Costs are measured on a first-in, first out basis using standard cost, which approximates actual cost. Net realizable value is the estimated selling price of the Company’s products in the ordinary course of business less reasonably predictable costs of completion, disposal, and transportation. Inventories are written down to their net realizable value if they have become obsolete, have a cost basis in excess of expected net realizable value, or are in excess of expected demand. Once inventory is written down, its new value is maintained until it is sold, scrapped, or written down for further valuation losses. The valuation of inventories requires the Company to make judgments based on currently available information about the likely method of disposition and current and future product demand relative to the remaining product life. The Company recorded inventory impairments of
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets The Company evaluates long-lived assets for impairment whenever events indicate that a potential impairment may have occurred. If such events arise, the Company will compare the carrying amount of the asset group comprising the long-lived assets to the estimated future undiscounted cash flows expected to be generated by the asset group. If the estimated aggregate undiscounted cash flows are less than the carrying amount of the asset group, an impairment charge is recorded as the amount by which the carrying amount of the asset group exceeds the fair value of the assets, as based on the expected discounted future cash flows attributable to those assets. Long-lived assets to be disposed of are reported at the lower of carrying amount or fair value less costs to sell.
Product Warranties	Product Warranties The Company provides a standard assurance type warranty that its insulating glass units (“IGUs”) will be free from defects in materials and workmanship for generally 10 years from the date of delivery to customers. IGUs with sloped or laminated glass generally have a warranty of 5 or 10 years. Control systems associated with the sale of Controls, Software and Services (“CSS”) typically have a 5-year warranty. As part of the Company’s Smart Building Platform contracts, the Company generally warrants that the workmanship of the sub-assemblies and installation of the Smart Building Platform are free from defects and in conformance with the contract documents for one year from completion. In resolving warranty claims, the Company’s standard warranty terms provide that the Company generally has the option of repairing, replacing or refunding the selling price of the covered product. The Company has not been requested to and has not provided any refunds, which would be treated as a reduction to revenue, to date as of June 30, 2021. The Company accrues for estimated claims of defective products at the time revenue is recognized based on historical warranty claims rates. The Company’s estimated costs for standard warranty claims are based on future estimated costs the Company expects to incur to replace the IGUs or control systems multiplied by the estimated IGU or control system warranty claims, respectively, based on warranty contractual terms and business practices. The total warranty liability included $5.3 million and $5.5 million as of June 30, 2021 and December 31, 2020, respectively, related to this standard assurance warranty. In 2019, the Company identified a quality issue with certain material purchased from one of its suppliers utilized in the manufacturing of certain IGUs. The Company stopped using the affected materials upon identification of the quality issue in 2019. The Company has replaced and expects to continue to replace the affected IGUs for the remainder of the period covered by the warranty. The Company developed a statistical model to analyze the risk of failure of the affected IGUs related to this quality issue and predict the potential number of future failures that may occur during the remaining warranty period, as well as the timing of the expected failures. Management judgment is necessary to determine the distribution fit and covariates utilized in the statistical model, as well as the relative tolerance to declare convergence. The statistical model considered the volume of units sold, the volume of unit failures, data patterns, and other characteristics associated with the failed IGUs as well as the IGUs that had not yet failed as of each financial reporting period. These characteristics include, but are not limited to, time to failure, manufacture date, location of installation, and environmental factors. Based on this analysis, the Company has recorded a specific warranty liability using the estimated number of affected IGUs expected to fail in the remaining warranty period and applying estimated costs the Company expects to incur to replace the IGUs based on warranty contractual terms and business practices. The total warranty liability included $40.4 million and $42.1 million as of June 30, 2021, and December 31, 2020, respectively, related to these IGUs. The Company monitors warranty obligations and may make adjustments to its warranty liabilities if actual costs of product repair and replacement are significantly higher or lower than estimated. Accruals for anticipated future warranty costs are recorded to cost of revenue in the condensed consolidated statements of comprehensive loss and included in other current liabilities and other liabilities on the condensed consolidated balance sheet. Warranty liabilities are based on estimates of failure rates and future costs to settle warranty claims that are updated periodically, taking into consideration inputs such as changes in the volume of claims compared with the Company’s historical experience, and changes in the cost of servicing warranty claims. The estimated cost includes the Company’s expectations regarding future total cost of replacement, as well as fixed cost absorption as production increases. The Company accounts for the effect of changes in estimates prospectively.
Revenue Recognition	Contract Assets and Liabilities Billing practices for certain contracts with customers are governed by the contract terms of each project based on (i) progress toward completion approved by the owner, (ii) achievement of milestones or (iii) pre-agreed schedules. Billings do not necessarily correlate with revenues recognized under the cost-to-cost input method. The Company records contract assets and contract liabilities to account for these differences in timing. Certain contracts under which we perform work contain retainage provisions. Retainage refers to amounts that we have billed to the customer, but such amounts are being held for payment by the customer pending satisfactory completion of the project. Retainage on active contracts is classified as a current asset regardless of the term of the contract and is generally collected within one year of the completion of a contract. At June 30, 2021 and December 31, 2020, contract assets included $0.2 million and nil, respectively, of retainage, which was being contractually withheld by customers until completion of the associated contracts. Other contract assets arise when the Company recognizes revenues for performance under its contracts, but the Company is not yet entitled to bill the customer under the terms of the contract. At June 30, 2021 and December 31, 2020, these other contract assets totaled $3.2 million and $1.2 million, respectively, for revenue that has been recognized for performance, but the customer has not yet been billed. Once amounts are billed to customers, the asset is classified within Accounts Receivable, Net of Allowances. Contract liabilities represent the Company’s obligation to provide goods or services to a customer for which the Company has been paid by the customer or for which the Company has billed the customer under the terms of the contract. Revenue for future services reflected in this account are recognized, and the liability is reduced, as the Company subsequently satisfies the performance obligation under the contract. Contract liabilities are presented as deferred revenue on the consolidated balance sheets. Revenue Recognition The Company has historically generated revenue from (i) the manufacturing and sale of View Smart Glass IGUs, that are coated on the inside with a proprietary technology and are designed and built to customer specifications that include sizes for specific windows, skylights, and doors in specified or designated areas of a building and (ii) selling the View Smart Glass CSS, which includes electrical connections schema, sky sensors, window controllers and control panels with embedded software, cables and connectors that when combined with the IGUs enable the IGUs to tint. Also included in CSS is a system design, in which a design document is provided to lay out the IGUs, as well as a commissioning service, in which the installed IGUs and CSS components are tested and tinting configurations are set by the Company. For this Smart Glass products offering, View serves as a materials provider to its Smart Glass customers, which are typically glaziers for IGUs and low-voltage electricians (“LVE”) or General Contractors (“GC”) for CSS. Under View’s Smart Glass product offering, when the owner, tenant or developer of the building approves of the use of View products, a non-binding letter of understanding with the owner, tenant or developer is signed. The Company subsequently enters into the legally enforceable supplier contracts with its Smart Glass customers (i.e., glaziers for IGUs and LVEs or GCs for CSS), to deliver the Smart Glass products and services. For Smart Glass projects, the Company does not have a role in the assembly nor the installation of the framed IGUs. The design of the integrated platform, as well as assembly and installation of the IGUs and the electrical components included in the CSS is performed by the Smart Glass customers. The Company performs a commissioning service under the CSS contract after its customers have completed installation of the IGUs and CSS electrical components. Additionally, in limited circumstances, the Company contracts to provide extended or enhanced warranties of its products in addition to its standard assurance warranty, which are recognized as revenue over the respective term of the warranty period. During 2021, the Company entered into and commenced work on the first contract under its new product offering, View’s Smart Building Platform. In these types of arrangements, the Company contracts with the Smart Building Platform customers, which are typically the owners, tenants or developers of buildings, or the general contractor acting on behalf of the Company’s customers. With View's Smart Building Platform, the smart building network serves as the backbone of the offering and is integrated by View into the building envelope system along with the View Smart Glass IGUs, which serve as individual nodes on the building network. This platform also enables the Company's Smart Building Technologies product offerings, as more fully described further below, to also be integrated as additional nodes on View’s smart building network and tailored to the customer's specific needs depending upon their desired smart building functionality. In these arrangements View takes responsibility for all activities needed to fulfill its single performance obligation of transferring control to the customer of a fully operational Smart Building Platform deliverable; from design, fabrication, installation, integration, commissioning, and testing. Underlying these activities is View’s responsibility for performing an essential and significant service of integrating each of the inputs of its completed solution. These inputs include View’s smart network infrastructure and IGUs, both of which are integrated into the window glazing system, which is fabricated by an unrelated subcontractor contracted by View to work on its behalf, as well as designing how the entire Smart Building Platform will be integrated and installed into the customer’s architectural specifications for the building that is being constructed or retrofitted. View’s integration services also include the activities of installing, commissioning and testing to enable the transfer of a complete and operational system. The Company also uses subcontractors it selects and hires for portions of the installation labor. Given that View is responsible for providing the service of integrating each of the inputs into a single combined output, View controls that output before it is transferred to the customer and accordingly, View is the principal in the arrangement and will recognize the entire arrangement fee as its revenue, with any fees that View pays to its subcontractors recognized in its cost of revenue. Other factors present in these arrangements which supports the assertion that View controls the deliverable before it is transferred to the customer include: the customer considers View to be primarily responsible for fulfilling the promise to provide a fully integrated Smart Building Platform, View has significant inventory risk, and it has complete discretion in the price negotiated with all parties engaged by View, including the customer, subcontractors, and third-party suppliers. Lastly, View determines how it will fulfill these arrangements and has complete discretion over the contracting of subcontractors to work on its behalf as well as the pricing discretion over these subcontractor arrangements. The pricing discretion that View exercises, both with respect to the customer as well as with View’s subcontractors, can often result in View having all of the risk of loss on the contract, as the performance obligation promised to the customer included within these contracts is generally in exchange for fixed fees while payments made to the subcontractors are based on cost plus margin or fixed fee arrangements. The Company's Smart Building Technologies includes a suite of products that are either integrated into the View Smart Building Platform, added-on to View Smart Glass contracts or sold separately, and (i) transform View smart windows into transparent, digital, interactive surfaces to enable immersive experiences, (ii) provide the ability to measure and optimize certain environmental variables, (iii) provide the customer the ability to self-monitor for intrusions, (iv) provide a platform to aggregate building and tenant data into a consolidated dashboard to optimize every aspect of building operations and workplace experience or (v) provide a hosted platform to facilitate smart and secure management of global networked assets. These offerings have been internally developed by the Company, such as View Immersive Experiences, and View Sense. When these products are integrated into the View Smart Building Platform, such offerings are included as part of the full contract with the customer. When these products are added-on to Smart Glass contracts or sold separately, the Company contracts separately with the customer to provide such items. Revenue generated from these products has not been material to date. View recognizes revenue as or when a customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. View determines revenue recognition through the following five steps: Step 1: Identify the contract(s) with a customer; Step 2: Identify the performance obligations in the contract; Step 3: Determine the transaction price; Step 4: Allocate the transaction price to the performance obligations in the contract; and Step 5: Recognize revenue as or when the entity satisfies a performance obligation. Contracts for View’s Smart Building Platform When a customer elects to purchase the Smart Building Platform, View signs legally enforceable contracts directly with the building owner/developers or their GC, acting on their behalf, for delivery of the Smart Building Platform. The Company enters into legally binding trade contracts with the customer that outlines the rights and obligations of the Company, including specifications of the integrated platform to be provided. The promises to the customer included within these contracts, as described above, are integrated and highly interdependent, and they must work seamlessly together to deliver a fully functional Smart Building Platform. As the Company performs a significant service of integrating the promised goods and services into a combined output, these contracts constitute a single, combined performance obligation. The contracting for these Smart Building Platform arrangements with building owners, real estate developers, or their agents, is subject to significant negotiations. Accordingly, each of these contracts must be evaluated on the terms and conditions of the underlying agreement based on their individual facts and circumstances. The Company determines the transaction price based on the consideration expected to be received, which is the contract price. When the contract contains payment terms that are extended beyond one year or other financing arrangements in conjunction with the contract, a significant financing component may exist. In such cases, the Company adjusts the contract price at an amount that reflects the cash selling price. Payment terms may vary but are generally net 30 days from request for payment. As the View Smart Building Platform is typically a single performance obligation, the entire transaction price is allocated to this performance obligation. The Company recognizes revenue over time using a cost-to-cost input method where progress on the performance obligation is measured by the proportion of actual costs incurred to the total costs expected to complete the contract. Recognizing revenue using a cost-to-cost input method provides an objective measure of progress and thereby best depicts the extent of transfer of control to the customer. Management judgment is required to estimate the progress towards completion. Significant changes in this estimate could affect the profitability of our contracts. Changes to estimated profit on contracts are recognized using a cumulative catch-up adjustment which recognizes in the current period the cumulative effect of the changes on current and prior periods based on a contract’s progress towards fulfillment of the performance obligation. When the total estimated costs for a contract exceed contracted revenue, an accrual for the loss on the contract is recognized as cost of revenue at the time of contract execution. As actual costs are incurred that are in excess of revenue recognized, they are recorded against the loss accrual, which is therefore reduced. During the six months ended June 30, 2021, the Company recognized a total of $14.3 million, respectively, for initial contract loss accruals, of which the balance of estimated contract losses for work that had not yet been completed totaled $11.5 million as of June 30, 2021. There were no Smart Building Platform contracts during the six months ending June 30, 2020 and therefore the contract loss accrual at June 30, 2020 was nil. Change orders are modifications of an original contract that effectively change the existing provisions of the contract without adding new provisions or terms. Change orders may include changes in specifications or designs, manner of performance, materials and period of completion of the work. Either the Company or our customers may initiate change orders. The Company has had an immaterial amount of change orders to date, and has recognized these as a contract modification when the change order is approved. Contracts for View Smart Glass Under View’s Smart Glass product offering, the Company is a provider of building materials in the form of IGUs and CSS. These materials are designed and fabricated by the Company in order to meet the building-site specifications of the end user, which is typically the owner, tenant or developer of buildings. When the end user approves of the use of View products, a non-binding letter of understanding with the owner, tenant or developer is signed. The Company subsequently enters into the legally enforceable supplier contracts with its Smart Glass customers (i.e., glaziers for IGUs and LVEs or GCs for CSS), to deliver the Smart Glass products and services. The glaziers and LVEs are subcontracted by the end user and are responsible for the installation of the Smart Glass products at the building-site. The Company enters into separate legally binding agreements with both the glazier and the LVE or GC to deliver IGUs and CSS, respectively, who are unrelated parties and therefore such contracts cannot be combined and accounted for as a single contract. Contracts with glaziers for IGUs include the promise to provide multiple customized IGUs. Each IGU represents a distinct and separate single performance obligation as the customer can benefit from each unit on its own. Each unit is separately identifiable, and does not modify or customize other units. The Company determines the transaction price based on the consideration expected to be received, which is generally the contractual selling price. Since the IGUs are customized to meet the building-site specifications of the ultimate end customer and have no alternative use to the Company and the Company has contractually enforceable rights to proportionate payment of the transaction price for performance completed to date, the Company recognizes revenue over time as each IGU is manufactured using a cost-to-cost input method. Recognizing revenue using a cost-to-cost input method best depicts the Company’s performance in transferring control of the IGUs to the customer. The amount of work in process at the end of any financial reporting period has historically been insignificant. The Company’s contracts to deliver CSS to the customer, typically LVEs or GCs, contain multiple performance obligations for each promise in the CSS arrangement. Each of the identified promises, including electrical connections schema, sky sensors, window controllers and control panels with embedded software, cables and connectors, and professional services to provide a system design and commission the installed products are capable of being distinct and each promise is separately identifiable in the context of the contract. This assessment requires management to make judgments about the individual promised good and service and whether each good and service is separable from the other goods and services in the contract. The Company determines the transaction price based on the consideration expected to be received, which is generally the contractual selling price. The Company allocates the transaction price to each performance obligation based on the relative standalone selling price. Management judgment is required in determining SSP for contracts that contain products and services for which revenue is recognized both over time and at a point in time, and where such revenue recognition transcends multiple financial reporting periods due to the timing of delivery of such products and services. SSP is estimated based on the price at which the performance obligation is sold separately. The Company recognizes revenue allocated to each performance obligation at the time the related performance obligation is satisfied by transferring control of the promised good or service to a customer. For the control panels and electrical components, transfer of control generally occurs at a point in time upon shipment or delivery of the product and revenue is recognized upon shipment. For the system design, transfer of control generally occurs upon customer acceptance and revenue is recognized upon customer acceptance. For the commissioning services, which has a relatively short period of time over which the services are provided, transfer of control generally occurs upon acceptance of the installed products by the end user and revenue is recognized upon customer acceptance. The allocation of transaction price for CSS contracts with performance obligations that cross multiple periods has not historically risen to a level that could have a material impact to reported revenues. In limited circumstances, the Company contracts to provide extended or enhanced warranties of our products outside of the terms of its standard assurance warranty, which are recognized as revenue over the respective term of the respective extended or enhanced warranty period. When the contract contains payment terms that are extended beyond one year or the Company enters into loan or financing arrangement in conjunction with the contract, a significant financing component may exist. In such cases, the Company adjusts the contract price at an amount that reflects the cash selling price. The Company uses a discount rate representing a borrowing rate had a separate financing transaction been entered between the two parties based on the customer’s creditworthiness. Contracts for View Smart Building Technologies The Company's Smart Building Technologies includes a suite of products that can be either integrated into the View Smart Building Platform, added-on to View Smart Glass contracts or sold separately. Our customers are typically the owners or tenants of buildings. Revenue generated from these products has not been material to date. Shipping and Handling Costs The Company considers shipping and handling activities as costs to fulfill the sales of products. Freight charged to customers is included in revenue when control of the product is transferred to the customer, and the related shipping and handling costs are included in cost of revenue. Taxes Taxes imposed by governmental authorities on the Company’s revenue producing activities with customers, such as sales taxes and value added taxes, are excluded from revenue. Contract Costs As the Company incurs incremental costs of obtaining contracts, they are evaluated for recoverability using the expected consideration. The Company currently incurs significant losses on its offerings and as such incremental costs to obtain contracts are not recoverable and are expensed as incurred.
Stock-Based Compensation	Stock-Based Compensation The Company measures stock-based awards, including stock options and restricted stock units (“RSUs”) granted to employees and nonemployees based on the estimated fair value as of the grant date. Awards with only service vesting conditions The fair value of stock option awards with only service condition is estimated on the grant date using the Black-Scholes option-pricing model, which requires the input of assumptions, including the fair value of the underlying common stock, the expected term of the stock option, the expected volatility of the price of the Company’s common stock, risk-free interest rates, and the expected dividend yield of the Company’s common stock. These assumptions are subjective, generally require significant analysis and judgment to develop, and materially affect the fair value and ultimately how much stock-based compensation expense is recognized. The Company recognizes the fair value of each stock award on a straight-line basis over the requisite service period of the awards. Stock-based compensation expense is based on the value of the portion of stock-based awards that is ultimately expected to vest. As such, the Company’s stock-based compensation is reduced for the estimated forfeitures at the date of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. At Closing, as required by the Merger Agreement, the Company granted stock option awards to purchase 5,000,000 shares of the Company’s common stock to certain officers. See Note 10 for further information regarding these awards. Awards with service vesting and market conditions At Closing, as required by the Merger Agreement, the Company granted stock-based awards containing both service and market conditions, as follows: (i) a nonqualified stock option award to its CEO to purchase 25,000,000 shares of the Company common stock (“CEO Option Award”) and (ii) 12,500,000 RSUs to certain officers (“Officer RSUs”). The estimated fair value of the CEO Option Award and Officer RSUs is determined using the Monte Carlo simulation model and the effect of the market condition is reflected in the grant date fair value of the award. Monte Carlo simulations are a class of computational algorithms that rely on repeated random sampling to compute their results. This approach allows the
Sponsor Earn-Out Liability	Sponsor Earn-Out Liability At Closing, the Sponsor subjected 4,970,000 shares (“Sponsor Earn-Out Shares”) to vesting and potential forfeiture (and related transfer restrictions) based on a five year post-Closing earnout, with (a) 50% of the Sponsor Earn-Out Shares being released if the stock price of the Company exceeds $12.50 for 5 out of any 10 trading days, (b) 25% of the Sponsor Earn-Out Shares being released if the stock price of the Company exceeds $15.00 for 5 out of any 10 trading days and (c) 25% of the Sponsor Earn-Out Shares being released if the stock price of the Company exceeds $20.00 for 5 out of any 10 trading days, in each case, subject to early release for a sale, change of control or going private transaction or delisting after the Closing (collectively, the “Earn-Out Triggering Events”).
Public and Private Warrants	Public and Private Warrants Prior to the Merger, CF II issued 366,666 private placement warrants (“Private Warrants”) and 16,666,637 public warrants (“Public Warrants” and collectively “Warrants”). Each whole warrant entitles the holder to purchase one share of the Company’s common stock at a price of $11.50 per share, subject to adjustments. The Warrants become exercisable on August 26, 2021. The Public Warrants and Private Warrants will expire five years after the Closing and five years after August 26, 2020, respectively. The Private Warrants and the shares of common stock issuable upon the exercise of the Private Warrants are transferable, assignable or salable after the completion of the Merger, subject to certain limited exceptions. Additionally, the Private Warrants are exercisable for cash or on a cashless basis, at the holder’s option, and are non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrant. See Note 9 for further information. Upon consummation of the Merger, the Company concluded that (a) the Public Warrants meet the derivative scope exception for contracts in the Company’s own stock and are recorded in stockholders’ equity and (b) the Private Warrants do not meet the derivative scope exception and are accounted for as derivative liabilities. Specifically, the Private Warrants contain provisions that cause the settlement amounts dependent upon the characteristics of the holder of the warrant which is not an input into the pricing of a fixed-for-fixed option on equity shares. Therefore, the Private Warrants are not considered indexed to the Company’s stock and should be classified as a liability. Since the Private Warrants meet the definition of a derivative, the Company recorded the Private Warrants as liabilities on the condensed consolidated balance sheet at fair value upon the Closing, with subsequent changes in the fair value recognized in the condensed consolidated statements of comprehensive loss at each reporting date. The fair value of the Private Warrants was measured using the Black-Scholes option-pricing model at each measurement date.
Segment Reporting	Segment Reporting Operating segments are defined as components of an entity where discrete financial information is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company operates and manages its business as one reportable and operating segment. The Company’s chief executive officer, who is the chief operating decision maker, reviews financial information on a consolidated basis for purposes of allocating resources and assessing performance. All material long-lived assets are maintained in the United States. See “Concentration of Credit Risk and Other Risks and Uncertainties” for further information on revenue by customer and Note 4 for further information on revenue by geography and categorized by products and services.
Recent Accounting Pronouncements Adopted and Recent Accounting Pronouncements, Not Yet Adopted	Recent Accounting Pronouncements Adopted In December 2019, the Financial Accounting Standards Board ("FASB") issued ASU No. 2019-12, Income Taxes (Topic 740) , which simplifies the accounting for income taxes, primarily by eliminating certain exceptions to ASC 740. This standard is effective for fiscal periods beginning after December 15, 2020. The Company has adopted this standard as of the first quarter of 2021 and did not have a material impact on the condensed consolidated financial statements. Recent Accounting Pronouncements, Not Yet Adopted In February 2016, the FASB issued ASU No. 2016-2, Leases (Topic 842) , and has since issued several updates, amendments, and technical improvements to ASU 2016-2. The guidance requires recognition of lease right-of-use (“ROU”) assets and lease liabilities by lessees for those leases previously classified as operating. The standard also requires additional disclosures about leasing arrangements related to discount rates, lease terms, and the amount, timing, and uncertainty of cash flows arising from leases. Topic 842 was originally effective for financial statements issued for fiscal years beginning after December 15, 2021 as the Company has elected to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. As of June 30, 2021, the Company expects to lose its status as an emerging growth company by the end of the fiscal year and expects to adopt this guidance for the annual period beginning January 1, 2021 using the optional transition method. Under the optional transition method, the Company will adopt the standard in a period subsequent to that presented herein but will account for the standard from the beginning of the period presented upon adoption. The adoption of this guidance will result in recognition of ROU assets of approximately $23.7 million and lease liabilities of $28.8 million for our operating leases and ROU assets of $1.8 million and lease liabilities of $1.8 million for our finance leases at January 1, 2021. In June 2016, FASB issued an ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326) . The FASB also issued amendments and the initial ASU, and all updates are included herein as the Credit Losses standard or Topic 326.The new standard generally applies to financial assets and requires those assets to be reported at the amount expected to be realized. The ASU is effective for fiscal years beginning after December 15, 2022 and interim periods within those fiscal years. As of June 30, 2021, the Company expects to lose its status as an emerging growth company by the end of the fiscal year and expects to adopt this guidance for the annual period beginning January 1, 2021 using the optional transition method. Under the optional transition method, the Company will adopt the standard in a period subsequent to that presented herein but will account for the standard from the beginning of the period presented upon adoption. The adoption of this guidance will not have a material impact on the condensed consolidated financial statements. In August 2020, the FASB issued No. ASU 2020-6, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-6”) . This ASU simplifies accounting for convertible instruments by removing major separation models required under current U.S. GAAP. Consequently, more convertible debt instruments will be reported as a single liability instrument and more convertible preferred stock as a single equity instrument with no separate accounting for embedded conversion features. The ASU removes certain settlement conditions that are required for equity contracts to In May 2021, the FASB issued ASU No. 2021-04, Earnings Per Share (Topic 260), Debt — Modifications and Extinguishments (Subtopic 470-50), Compensation — Stock Compensation (Topic 718), and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options

Organization and Summary of S_3

Organization and Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Product Warranty Liability	June 30, December 31, 2020 Beginning balance $ 47,678 $ 53,296 Accruals for warranties issued 816 $ 1,304 Changes to estimates of volume and costs — $ (1,002) Settlements made (2,761) $ (5,920) Ending balance $ 45,733 $ 47,678 Warranty liability, current, beginning balance $ 8,864 $ 8,038 Warranty liability, noncurrent, beginning balance $ 38,814 $ 45,258 Warranty liability, current, ending balance $ 8,923 $ 8,864 Warranty liability, noncurrent, ending balance $ 36,810 $ 38,814
Schedule of Cash and Cash Equivalents	Cash, cash equivalents, and restricted cash reported within the accompanying condensed consolidated balance sheets that sum to the total of the same such amounts presented in the accompanying condensed consolidated statements of cash flows consisted of the following (in thousands): June 30, December 31, 2020 Cash $ 43,902 $ 24,657 Cash equivalents $ 407,457 $ 38,575 Cash and cash equivalents $ 451,359 $ 63,232 Restricted cash included in prepaid expenses and other current assets $ — $ 1,000 Restricted cash $ 8,468 $ 10,461 Total cash, cash equivalents, and restricted cash presented in the statements of cash flows $ 459,827 $ 74,693
Restrictions on Cash and Cash Equivalents	Cash, cash equivalents, and restricted cash reported within the accompanying condensed consolidated balance sheets that sum to the total of the same such amounts presented in the accompanying condensed consolidated statements of cash flows consisted of the following (in thousands): June 30, December 31, 2020 Cash $ 43,902 $ 24,657 Cash equivalents $ 407,457 $ 38,575 Cash and cash equivalents $ 451,359 $ 63,232 Restricted cash included in prepaid expenses and other current assets $ — $ 1,000 Restricted cash $ 8,468 $ 10,461 Total cash, cash equivalents, and restricted cash presented in the statements of cash flows $ 459,827 $ 74,693

Restatement of Previously Iss_2

Restatement of Previously Issued Financial Statements (Tables)	6 Months Ended
	Jun. 30, 2021
Accounting Changes and Error Corrections [Abstract]
Schedule of Error Corrections and Prior Period Adjustments	Condensed Consolidated Balance Sheet December 31, 2020 As Previously Reported Investigation Adjustments Other Adjustments As Restated Assets Current assets Cash and cash equivalents $ 63,232 $ — $ — $ 63,232 Accounts receivable, net of allowances 12,252 — — 12,252 Inventories 6,483 — — 6,483 Prepaid expenses and other current assets 6,881 — (668) (b), (e) 6,213 Total current assets 88,848 — (668) 88,180 Property and equipment, net 282,560 — — 282,560 Restricted cash 10,461 — — 10,461 Deposits with supplier 1,084 — — 1,084 Other assets 7,862 — — 7,862 Total assets $ 390,815 $ — $ (668) $ 390,147 Liabilities, Redeemable Convertible Preferred Stock, and Stockholders’ Equity (Deficit) Current liabilities Accounts payable $ 14,562 $ — $ — $ 14,562 Accrued expenses and other current liabilities 36,480 4,849 821 (d) 42,150 Accrued compensation 14,665 — (3,838) (b) 10,827 Deferred revenue 2,111 — 538 (c) 2,649 Debt, current 247,248 — — 247,248 Total current liabilities 315,066 4,849 (2,479) 317,436 Debt, non-current 15,430 — — 15,430 Redeemable convertible preferred stock warrant liability 12,323 — — 12,323 Other liabilities 36,731 20,113 — 56,844 Total liabilities 379,550 24,962 (2,479) 402,033 Redeemable convertible preferred stock 1,812,678 — — 1,812,678 Stockholders' equity (deficit): Additional paid-in-capital 89,789 — — 89,789 Accumulated deficit (1,891,202) (24,962) 1,811 (1,914,353) Total stockholders' equity (deficit) (1,801,413) (24,962) 1,811 (1,824,564) Total liabilities, redeemable convertible preferred stock, and stockholders’ equity (deficit) $ 390,815 $ — $ (668) $ 390,147 Condensed Consolidated Statements of Comprehensive Loss Three Months Ended June 30, 2020 As Previously Reported Investigation Adjustments Other Adjustments As Restated Revenue $ 6,664 $ — $ (1,017) (c), (e) 5,647 Costs and expenses: Cost of revenue 33,800 (1,063) 3,097 (a), (d), (e) 35,834 Research and development 13,536 — (175) (a), (e) 13,361 Selling, general, and administrative 19,201 — (2,605) (a), (b), (e) 16,596 Total costs and expenses 66,537 (1,063) 317 65,791 Loss from operations (59,873) 1,063 (1,334) (60,144) Interest and other income (expense), net Interest income 41 — — 41 Interest expense (6,146) — — (6,146) Other expense, net (80) — — (80) Gain (loss) on fair value change, net (3,068) — — (3,068) Interest and other income (expense), net (9,253) — — (9,253) Loss before benefit (provision) of income taxes (69,126) 1,063 (1,334) (69,397) Benefit (provision) for income taxes (98) — — (98) Net and comprehensive loss $ (69,224) $ 1,063 $ (1,334) $ (69,495) Net loss per share, basic and diluted $ (41.14) $ 0.63 $ (0.79) $ (41.30) Weighted-average shares used in calculation of net loss per share, basic and diluted 1,682,704 — — 1,682,704 Six Months Ended June 30, 2020 As Previously Reported Investigation Adjustments Other Adjustments As Restated Revenue $ 15,831 $ — $ (1,152) (c), (e) 14,679 Costs and expenses: Cost of revenue 69,372 (2,444) 5,369 (a), (d), (e) 72,297 Research and development 34,794 — 1,655 (a), (e) 36,449 Selling, general, and administrative 42,036 — (4,076) (a), (b), (e) 37,960 Total costs and expenses 146,202 (2,444) 2,948 146,706 Loss from operations (130,371) 2,444 (4,100) (132,027) Interest and other income (expense), net Interest income 486 — — 486 Interest expense (11,431) — — (11,431) Other expense, net (105) — — (105) Gain (loss) on fair value change, net 1,360 — — 1,360 Interest and other income (expense), net (9,690) — — (9,690) Loss before benefit (provision) of income taxes (140,061) 2,444 (4,100) (141,717) Benefit (provision) for income taxes (103) — — (103) Net and comprehensive loss $ (140,164) $ 2,444 $ (4,100) $ (141,820) Net loss per share, basic and diluted $ (83.94) $ 1.46 $ (2.46) $ (84.94) Weighted-average shares used in calculation of net loss per share, basic and diluted 1,669,739 — — 1,669,739 Condensed Consolidated Statement of Cash Flows Six Months Ended June 30, 2020 As Previously Reported Investigation Adjustments Other Adjustments As Restated Cash flows from operating activities: Net loss $ (140,164) $ 2,444 $ (4,100) (a), (b), (c), (d), (e) $ (141,820) Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization 12,040 — 860 (a) 12,900 Gain on fair value change, net (1,360) — — (1,360) Stock-based compensation 16,020 — — 16,020 Other 1,179 — — 1,179 Changes in operating assets and liabilities: Accounts receivable 5,504 — 1,091 (e) 6,595 Inventories 525 — — 525 Prepaid expenses and other current assets 23,294 — (654) (b), (e) 22,640 Other assets 26 — (315) (e) (289) Accounts payable (613) — — (613) Deferred revenue (822) — 387 (c) (435) Accrued compensation 1,313 — (523) (b) 790 Accrued expenses and other liabilities 499 (2,444) 3,254 (d), (e) 1,309 Net cash used in operating activities $ (82,559) $ — $ — $ (82,559) Non-cash investing and financing activities: Change in accounts payable balance and other liabilities related to purchase of property and equipment $ (2,742) $ — $ (1,039) (e) $ (3,781)

Reverse Recapitalization (Table

Reverse Recapitalization (Tables)	6 Months Ended
	Jun. 30, 2021
Reverse Recapitalization [Abstract]
Schedule Of Reverse Recapitalization	The number of shares of Class A common stock issued immediately following the consummation of the Merger at March 8, 2021 was: Number of Shares Common stock of CF II outstanding prior to the Merger (1) 62,500,000 Less redemption of CF II shares (12,587,893) CF II Sponsor Earnout Shares outstanding prior to the Merger 1,100,000 Common stock of CF II 51,012,107 Shares issued in PIPE financing 42,103,156 Shares issued for in kind banker fee payment 750,000 Merger and PIPE financing shares 42,853,156 Legacy View shares converted (2) 123,211,449 Total 217,076,712 1. Includes CF II Class A shareholders of 50,000,000 and CF II Class B shareholders of 12,500,000.

Revenue (Tables)

Revenue (Tables)	6 Months Ended
	Jun. 30, 2021
Revenue from Contract with Customer [Abstract]
Schedule of Companys Revenue	The following table summarizes the Company’s revenue by products and services (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Revenue: Products $ 16,814 $ 4,945 $ 26,525 $ 13,889 Services 112 702 170 790 Total $ 16,926 $ 5,647 $ 26,695 $ 14,679 The following table summarizes the Company’s revenue by major product offering (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Revenue: Smart Glass $ 11,580 $ 5,647 $ 19,795 $ 14,679 Smart Building Platform 5,136 — 5,136 — Smart Building Technologies $ 210 $ — $ 1,764 $ — Total $ 16,926 $ 5,647 $ 26,695 $ 14,679 The following table summarizes the Company’s revenue by geographic area, which is based on the shipping address of the customers (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Revenue: United States $ 12,053 $ 5,322 $ 21,718 $ 14,009 Canada 4,403 299 4,507 620 Other 470 26 470 50 Total $ 16,926 $ 5,647 $ 26,695 $ 14,679

Fair Value (Tables)

Fair Value (Tables)	6 Months Ended
	Jun. 30, 2021
Fair Value Disclosures [Abstract]
Schedule of Fair Value Measurements	The following table presents information about the Company’s financial assets and liabilities measured at fair value on a recurring basis (in thousands): June 30, 2021 Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 407,458 $ — $ — $ 407,458 Total cash equivalents 407,458 — — 407,458 Restricted cash: Certificates of deposit 8,468 — 8,468 Total assets measured at fair value $ 407,458 $ 8,468 $ — $ 415,926 Private warrants liability $ — $ — $ 639 $ 639 Sponsor earn-out liability — — 26,101 26,101 Total liabilities measured at fair value $ — $ — $ 26,740 $ 26,740 December 31, 2020 Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 38,574 $ — $ — $ 38,574 Total cash equivalents 38,574 — — 38,574 Restricted cash: Certificates of deposit — 11,461 — 11,461 Total assets measured at fair value $ 38,574 $ 11,461 $ — $ 50,035 Redeemable convertible preferred stock warrants $ — $ — $ 12,323 $ 12,323 Total liabilities measured at fair value $ — $ — $ 12,323 $ 12,323
Schedule of Level 3 Financial Liabilities Measured at Fair Value Using Significant Unobservable Inputs	The following table provides a reconciliation of the beginning and ending balances for the level 3 financial liabilities measured at fair value using significant unobservable inputs (in thousands): Private Sponsor Redeemable Balance as of December 31, 2020 $ — $ — $ 12,323 Additions during the period 589 26,443 — Change in fair value 50 (342) (5,056) Reclass to additional paid-in-capital upon Closing — — (7,267) Balance as of June 30, 2021 $ 639 $ 26,101 $ —
Schedule of Gain (Loss) in Fair Value	Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Private Warrants $ 53 $ — $ (50) $ — Sponsor Earn-out Liability (2,118) — 342 — Redeemable Convertible Preferred Stock Warrants — (3,068) 5,056 1,360 Gain (loss) on fair value change, net $ (2,065) $ (3,068) $ 5,348 $ 1,360
Schedule of Assumptions Used in Determination of Fair Value of Derivatives	The market-based assumptions used in the valuations include the following: March 8, 2021 (Closing Date) December 31, 2020 Expected volatility 52%-75% 70% Expected term (in years) 0.08-7.71 2.0 Expected dividends 0% 0% Risk-free rate 0.04%-1.28% 0.1% Discount for lack of marketability 5.0%-33.0% 11%-55% The estimated fair value of the Sponsor Earn-Out Shares was determined using a Monte Carlo simulation valuation model using the following assumptions: June 30, 2021 March 8, 2021 (Closing Date) Stock price $8.48 $9.19 Expected volatility 37.30% 29.20% Risk free rate 0.77% 0.86% Expected term (in years) 4.7 5.0 Expected dividends 0% 0% The estimated fair value of the Private Warrants was determined using the Black-Scholes option-pricing model using the following assumptions: June 30, 2021 March 8, 2021 (Closing Date) Stock price $8.48 $9.19 Expected volatility 37.30% 29.20% Risk free rate 0.67% 0.73% Expected term (in years) 4.2 4.5 Expected dividends 0% 0%

Commitments and Contingencies (

Commitments and Contingencies (Tables)	6 Months Ended
	Jun. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Schedule of Future Minimum Rental Payments	As of June 30, 2021, the future minimum rental payments under all operating leases are as follows (in thousands): Year Ending December 31, Operating Leases 2021 (remaining six months) $ 2,756 2022 5,618 2023 5,750 2024 5,887 2025 6,026 Thereafter 15,230 Total minimum lease payments $ 41,267
Schedule of Litigation Settlement Liability	The balance of the litigation settlement liability is reflected on our condensed consolidated balance sheets as follows (in thousands): June 30, December 31, 2020 Litigation settlement liability - current $ 3,000 $ 3,000 Litigation settlement liability - non-current 7,239 9,658 Total litigation settlement liability $ 10,239 $ 12,658

Debt (Tables)

Debt (Tables)	6 Months Ended
	Jun. 30, 2021
Debt Disclosure [Abstract]
Schedule of Debt	Debt outstanding consisted of the following (in thousands): Interest Rate June 30, December 31, 2020 Term loan, due June 30, 2032 0% $ 15,430 $ 15,430 Revolving debt facility, repaid on March 8, 2021 LIBOR+9.05% — 250,000 Debt discount — (2,752) Total debt 15,430 262,678 Debt, current 735 247,248 Debt, non-current $ 14,695 $ 15,430
Schedule of Estimated Principal Payments on all Debt Oustanding	Principal payments on all debt outstanding as of June 30, 2021 are estimated as follows (in thousands): Year Ending December 31, Total 2021 (remaining six months) $ — 2022 1,470 2023 1,470 2024 1,470 2025 1,470 Thereafter 9,550 Total $ 15,430

Equity (Tables)

Equity (Tables)	6 Months Ended
	Jun. 30, 2021
Equity [Abstract]
Temporary Equity	As of December 31, 2020, the redeemable convertible preferred stock consisted of the following (in thousands, except for share amounts): Shares Authorized December 31, 2020 Shares Outstanding December 31, 2020 Carry Value December 31, 2020 Liquidation Preference Common Stock Issuable Upon Conversion Series A 23,250 18,441 $ 166 $ 238 18,441 B 1,571,798 1,217,066 19,210 18,845 1,217,066 C 2,274,766 608,118 11,495 11,417 608,118 D 2,673,700 612,994 13,263 13,235 612,994 E 7,440,000 4,606,784 100,225 119,361 4,606,784 E-1 131,584 — — — — E-2 115,787 — — — — F 10,462,500 4,861,658 175,182 188,193 4,861,658 G 62,775,000 47,881,788 330,466 231,686 47,881,788 G-1 930,000 — — — — H 75,177,482 10,613,198 197,488 200,852 10,613,198 H-1 60,833,745 51,011,263 965,183 965,374 51,011,263 224,409,612 121,431,310 $ 1,812,678 $ 1,749,201 121,431,310

Stock Warrants (Tables)

Stock Warrants (Tables)	6 Months Ended
	Jun. 30, 2021
Equity [Abstract]
Schedule of Outstanding Common Stock Warrants	The following table summarizes the outstanding common stock warrants: Warrant issue date Types of shares Number of Warrants Number of Warrants December 31, 2020 (As converted) Exercise Expiry Date August 2010 - June 2011 Common stock (previously Series B redeemable convertible preferred stock) 46,498 46,498 $ 15.49 March 2023 August 2011 - January 2012 Common stock (previously Series C redeemable convertible preferred stock) 53,256 53,256 18.78 March 2023 August 2012 Common stock (previously Series D redeemable convertible preferred stock) 45,388 45,388 21.60 March 2023 December 2013 Common stock (previously Series E redeemable convertible preferred stock) 63,296 63,296 25.91 March 2023 April 2015 - April 2016 Common stock (previously Series F redeemable convertible preferred stock) 45,207 161,457 38.71 Through December 2022 April 2016 - November 2018 Common stock (previously Series H redeemable convertible preferred stock) 1,135,391 1,135,391 18.93 Through November 2028 March 2017 Common stock (previously Series H redeemable convertible preferred stock) 1,849,431 1,849,431 12.91 March 2027 March 2014 Common stock 2,324 2,324 9.47 August 2023 August 2015 Common stock 12,916 12,916 11.62 December 2022 December 2018 Common stock 24,910 24,910 9.04 December 2028 August 2020 Common stock (Private Warrants) 366,666 — 11.50 Through March 2026 August 2020 Common stock (Public Warrants) 16,666,637 — 11.50 Through March 2026 Total stock warrants 20,311,920 3,394,867

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	6 Months Ended
	Jun. 30, 2021
Share-based Payment Arrangement [Abstract]
Schedule of Stock Options Exercisable under CEO Incentive Plan	Tranche Option Shares (#) Average 60-day 1 2,500,000 20.00 2 2,500,000 30.00 3 2,500,000 40.00 4 2,500,000 50.00 5 2,500,000 60.00 6 2,500,000 70.00 7 2,500,000 80.00 8 2,500,000 90.00 9 2,500,000 100.00 10 2,500,000 110.00
Schedule of Share-based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable	The following table summarizes the activity under the 2021 Plan (in thousands, except per share data and contractual term) for time vested options: Options Outstanding Number of Weighted- Weighted-Average Aggregate Intrinsic Value 1 Outstanding as of December 31, 2020 1,071,605 $ 0.22 7.6 $ 20,564 Retroactive application of reverse recapitalization (1,046,690) Balance as of December 31, 2020, as converted 24,915 $ 9.32 7.6 $ 20,564 Options granted 5,000 $ 10.00 — — Exercised (190) $ 9.04 — — Canceled/forfeited (138) $ 9.29 — — Outstanding as of June 30, 2021 29,587 $ 9.44 7.6 $ 186 Options vested and expected to vest as of June 30, 2021 28,584 $ 9.46 7.6 $ 164 Exercisable as of June 30, 2021 16,281 $ 9.48 7.0 $ 55 ______________________ 1 The aggregate intrinsic value is calculated as the difference between the market value of the Company's common shares as of the relevant period end and the respective exercise prices of the options. The market value as of June 30, 2021 was $8.48 per share, which is the closing sale price of View's common shares on that day as reported by the Nasdaq Global Market. The market value as of December 31, 2020 was $9.89 per share, which is the fair value of View's common stock as historically determined in accordance with the guidelines outlined in the American Institute of Certified Public Accountants Practice Aid, Valuation of Privately-Held-Company Equity Securities Issued as Compensation.
Schedule of Outstanding Restricted Stock Units	The following table summarizes the activities for our outstanding RSUs under the Company’s 2021 Plan (in thousands, except per share data) during the six months ended June 30, 2021: Number of Weighted Outstanding as of December 31, 2020 — $ — Granted 12,758 $ 6.15 Vested (35) $ 7.23 Outstanding as of June 30, 2021 12,723 $ 6.15
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	The estimated grant date fair values of the Company’s time vested stock options granted to employees were calculated using the Black-Scholes option-pricing models based on the following assumptions: Six Months Ended June 30, 2021 2020 Expected volatility 53.0% 70% Expected terms (in years) 6.0 5.4-6.7 Expected dividends 0% 0% Risk-free rate 1.07% 0.4%-1.5% CEO Option Officer RSUs Officer Options Expected stock price $9.19 $9.19 $9.19 Expected volatility 54.0% 56.0% 53.0% Risk-free rate 1.59% 0.60% 1.07% Expected terms (in years) 10.0 4.0 6.0 Expected dividends 0% 0% 0% Discount for lack of marketability 20% n/a n/a
Schedule of Stock-based Compensation	The Company’s stock-based compensation included in its condensed consolidated statements of comprehensive loss was as follows (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Cost of revenue $ 1,297 $ 570 $ 2,175 $ 1,116 Research and development 2,628 559 3,543 3,467 Selling, general, and administrative 18,349 5,673 27,019 11,437 Total $ 22,274 $ 6,802 $ 32,737 $ 16,020

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	6 Months Ended
	Jun. 30, 2021
Earnings Per Share [Abstract]
Schedule of Basic and Diluted Net Loss Per Share	The following table sets forth the computation of basic and diluted net loss per share (in thousands, except share and per share data): Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Net loss $ (95,720) $ (69,495) $ (169,755) $ (141,820) Weighted-average shares outstanding, basic and diluted 212,116,112 1,682,704 134,240,831 1,669,739 Net loss per share, basic and diluted $ (0.45) $ (41.30) $ (1.26) $ (84.94)
Schedule of Antidilutive Securities Excluded From Computation of Earnings Per Share	June 30, 2021 2020 Stock options to purchase common stock 29,587,210 25,063,655 Unvested restricted stock units 257,625 — Warrants to purchase common stock 20,311,920 40,150 Redeemable convertible preferred stock (on an if-converted basis) — 121,431,310 Warrants to purchase redeemable convertible preferred stock (on an if-converted basis) — 3,354,717 Total 50,156,755 149,889,832

Organization and Summary of S_4

Organization and Summary of Significant Accounting Policies - Organization (Details) $ in Thousands	Mar. 08, 2021USD ($)	Jun. 30, 2021USD ($)	Jun. 30, 2020USD ($)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Charges associated with the mergers	$ 43,900
Repayments of other debt obligations		$ 0	$ 1,714
Common Class A
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Share exchange ratio	0.02325
Principal And Interest
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Repayments of other debt obligations	$ 276,800
Interest
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Repayments of other debt obligations	26,800
Reverse Recapitalization
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Net proceeds	771,300
Charges associated with the mergers	$ 43,900

Organization and Summary of S_5

Organization and Summary of Significant Accounting Policies - Liquidity and Going Concern (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended		12 Months Ended
	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020	Dec. 31, 2019
Product Information [Line Items]
Total stockholders’ deficit	$ (604,527)	$ (677,942)	$ 1,729,829	$ 1,667,183	$ (604,527)	$ 1,729,829	$ 1,824,564	$ 1,604,271
Loss from operations	95,720	74,035	69,495	72,325	169,755	141,820	141,800
Negative cash flow from operations					125,168	82,559	82,600
Cash and cash equivalents	451,359				451,359		63,232
Accumulated Deficit
Product Information [Line Items]
Total stockholders’ deficit	2,084,108	1,988,388	1,806,447	1,736,952	$ 2,084,108	$ 1,806,447	$ 1,914,353	$ 1,664,627
Loss from operations	$ 95,720	$ 74,035	$ 69,495	$ 72,325

Organization and Summary of S_6

Organization and Summary of Significant Accounting Policies - Concentration Risk (Details)	6 Months Ended		12 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Revenue Benchmark | Product Concentration Risk | Supplier One
Concentration Risk [Line Items]
Concentration risk percentage	34.50%	42.90%
Revenue Benchmark | Product Concentration Risk | Supplier Two
Concentration Risk [Line Items]
Concentration risk percentage		10.70%
Customer One | Revenue Benchmark | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk percentage	16.50%	17.30%
Customer One | Accounts Receivable | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk percentage	24.10%		23.60%
Customer Two | Revenue Benchmark | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk percentage	11.80%	16.70%
Customer Two | Accounts Receivable | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk percentage	15.50%
Customer Three | Revenue Benchmark | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk percentage	10.10%	11.60%
Customer Three | Accounts Receivable | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk percentage	14.10%
Three Customers | Accounts Receivable | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk percentage	53.70%

Organization and Summary of S_7

Organization and Summary of Significant Accounting Policies - Schedule of Cash, Cash Equivalents and Restricted Cash (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020	Jun. 30, 2020	Dec. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash	$ 43,902	$ 24,657
Cash equivalents	407,457	38,575
Cash and cash equivalents	451,359	63,232
Restricted cash included in prepaid expenses and other current assets	0	1,000
Restricted cash	8,468	10,461
Total cash, cash equivalents, and restricted cash presented in the statements of cash flows	$ 459,827	$ 74,693	$ 166,274	$ 148,674

Organization and Summary of S_8

Organization and Summary of Significant Accounting Policies - Contract Assets and Liabilities (Details) - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Retainage	$ 200,000	$ 0
Other contract assets	$ 3,200,000	$ 1,200,000

Organization and Summary of S_9

Organization and Summary of Significant Accounting Policies - Inventories (Details) $ in Millions	3 Months Ended
	Jun. 30, 2021USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Inventory write-down	$ 6.1

Organization and Summary of _10

Organization and Summary of Significant Accounting Policies - Impairment of Long-Lived Assets (Details) - USD ($)	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Asset impairment charges	$ 0	$ 0

Organization and Summary of _11

Organization and Summary of Significant Accounting Policies - Product Warranties (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Product Warranty Liability [Line Items]
Warranty liability	$ 45,733,000		$ 45,733,000		$ 47,678,000
Movement in Standard Product Warranty Accrual [Roll Forward]
Beginning balance			47,678,000	$ 53,296,000	53,296,000
Accruals for warranties issued			816,000		1,304,000
Changes to estimates of volume and costs			0		(1,002,000)
Settlements made			(2,761,000)		(5,920,000)
Ending balance	45,733,000		45,733,000		47,678,000
Warranty liability, current, beginning balance	8,923,000		8,923,000		8,864,000
Warranty liability, noncurrent, beginning balance			38,814,000	45,258,000	45,258,000
Warranty liability, current, ending balance			8,864,000	8,038,000	8,038,000
Warranty liability, noncurrent, ending balance	36,810,000		36,810,000		38,814,000
Product warranty expense	0	$ 1,700,000	5,100,000	2,700,000
Cost of revenue
Movement in Standard Product Warranty Accrual [Roll Forward]
Warranty liability adjustments charged to cost of revenues	400,000	$ 300,000	800,000	$ 600,000
Accrued expenses and other current liabilities
Product Warranty Liability [Line Items]
Warranty liability	40,400,000		40,400,000		42,100,000
Movement in Standard Product Warranty Accrual [Roll Forward]
Beginning balance			42,100,000
Ending balance	40,400,000		40,400,000		42,100,000
Other Liabilities
Product Warranty Liability [Line Items]
Warranty liability	4,400,000		4,400,000		800,000
Movement in Standard Product Warranty Accrual [Roll Forward]
Beginning balance			800,000
Ending balance	4,400,000		$ 4,400,000		800,000
IGU
Product Warranty Liability [Line Items]
Standard product warranty term			10 years
Warranty liability	5,300,000		$ 5,300,000		5,500,000
Movement in Standard Product Warranty Accrual [Roll Forward]
Beginning balance			5,500,000
Ending balance	$ 5,300,000		$ 5,300,000		$ 5,500,000
IGUS With Sloped Or Laminated Glass | Minimum
Product Warranty Liability [Line Items]
Standard product warranty term			5 years
IGUS With Sloped Or Laminated Glass | Maximum
Product Warranty Liability [Line Items]
Standard product warranty term			10 years
Control System Associated With The Sale Of IGUS
Product Warranty Liability [Line Items]
Standard product warranty term			5 years

Organization and Summary of _12

Organization and Summary of Significant Accounting Policies - Revenue Recognition (Details) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Initial contract loss	$ 14.3
Contract loss accrual	$ 11.5	$ 0

Organization and Summary of _13

Organization and Summary of Significant Accounting Policies - Stock-Based Compensation (Details) - shares	Mar. 08, 2021	Jun. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options granted (in shares)	5,000,000	5,000,000
CEO Option Award | Non Qualified Stock Option Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options granted (in shares)	25,000,000	25,000,000
Officer | Unvested restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation by share based payment arrangement equity instruments other than granted during the period (in shares)	12,500,000	12,500,000

Organization and Summary of _14

Organization and Summary of Significant Accounting Policies - Sponsor Earn-Out Liability (Details) - USD ($) $ / shares in Units, $ in Thousands	Mar. 08, 2021	Jun. 30, 2021	Jun. 30, 2021	Dec. 31, 2020
Product Information [Line Items]
Earn out shares subject to vesting and potential forfeiture	4,970,000	4,970,000	4,970,000
Earnout shares period of vesting	5 years
Share price (in dollars per share)		$ 8.48	$ 8.48
Sponsor earn-out liability, non-current	$ 26,400	$ 26,101	$ 26,101	$ 0
Loss of fair value, change in sponsor earnout liability		$ 2,100
Gain on fair value change in sponsor earnout liability			$ 300
Earnout Triggering Event One
Product Information [Line Items]
Percentage of the earnout shares relesable	50.00%
Share price (in dollars per share)	$ 12.50
Number of trading days	5 days
Number of consecutive trading days	10 days
Earnout Triggering Event Two
Product Information [Line Items]
Percentage of the earnout shares relesable	25.00%
Share price (in dollars per share)	$ 15
Number of trading days	5 days
Number of consecutive trading days	10 days
Earnout Triggering Event Three
Product Information [Line Items]
Percentage of the earnout shares relesable	25.00%
Share price (in dollars per share)	$ 20
Number of trading days	5 days
Number of consecutive trading days	10 days

Organization and Summary of _15

Organization and Summary of Significant Accounting Policies - Public and Private Warrants (Details) - USD ($) $ / shares in Units, $ in Millions	6 Months Ended
	Jun. 30, 2021	Mar. 08, 2021	Mar. 07, 2021
Class of Warrant or Right [Line Items]
Class of warrants or rights number of securities called by each warrant or right (in shares)			1
Exercise price per warrant (in dollars per share)			$ 11.50
Private Warrants
Class of Warrant or Right [Line Items]
Class of warrants or rights maturity (in shares)			366,666
Terminating initial public offering term	5 years
Warrants or rights outstanding		$ 0.6
Public Warrants
Class of Warrant or Right [Line Items]
Class of warrants or rights maturity (in shares)			16,666,637
Exercise price per warrant (in dollars per share)	$ 11.50
Terminating initial public offering term	5 years

Organization and Summary of _16

Organization and Summary of Significant Accounting Policies - Segment Reporting (Details)	6 Months Ended
	Jun. 30, 2021segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of reportable segments	1
Number of operating segments	1

Organization and Summary of _17

Organization and Summary of Significant Accounting Policies - Recent Accounting Pronouncements, Not Yet Adopted (Details) - Accounting Standards Update 2016-02 $ in Millions	Jan. 01, 2021USD ($)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating lease, right of use asset	$ 23.7
Operating lease liability	28.8
Finance lease right of use asset	1.8
Finance lease liability	$ 1.8

Restatement of Previously Iss_3

Restatement of Previously Issued Financial Statements - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended		12 Months Ended
	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020	Dec. 31, 2019
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total litigation settlement liability	$ 165,421				$ 165,421		$ 402,033
Cost of revenue	(49,610)		$ (35,834)		(85,789)	$ (72,297)
Net loss	$ (95,720)	$ (74,035)	(69,495)	$ (72,325)	$ (169,755)	(141,820)	(141,800)
Investigation Adjustments
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total litigation settlement liability							24,962
Cost of revenue			1,063			2,444		$ (25,000)
Net loss			1,063			2,444		(25,000)
Other Adjustments
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total litigation settlement liability							$ (2,479)
Cost of revenue			(3,097)			(5,369)
Net loss			$ (1,334)			$ (4,100)		$ 1,800

Restatement of Previously Iss_4

Restatement of Previously Issued Financial Statements - Condensed Consolidated Balance Sheets (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019
Current assets
Cash and cash equivalents	$ 451,359		$ 63,232
Accounts receivable, net of allowances	12,914		12,252
Inventories	8,295		6,483
Prepaid expenses and other current assets	8,633		6,213
Total current assets	481,201		88,180
Property and equipment, net	273,765		282,560
Restricted cash	8,468		10,461
Deposits with supplier	588		1,084
Other assets	5,926		7,862
Total assets	769,948		390,147
Current liabilities
Accounts payable	9,847		14,562
Accrued expenses and other current liabilities	40,743		42,150
Accrued compensation	11,473		10,827
Deferred revenue	5,137		2,649
Debt, current	735		247,248
Total current liabilities	67,935		317,436
Debt, non-current	14,695		15,430
Redeemable convertible preferred stock warrant liability	0		12,323
Other liabilities	56,690		56,844
Total liabilities	165,421		402,033
Redeemable convertible preferred stock		$ 0	1,812,678	$ 1,812,678	$ 1,812,678	$ 1,812,724
Stockholders' equity (deficit):
Additional paid-in capital	2,688,613		89,789
Accumulated deficit	(2,084,108)		(1,914,353)
Total stockholders’ equity (deficit)	604,527	$ 677,942	(1,824,564)	$ (1,729,829)	$ (1,667,183)	(1,604,271)
Total liabilities, redeemable convertible preferred stock, and stockholders’ equity (deficit)	$ 769,948		390,147
As Previously Reported
Current assets
Cash and cash equivalents			63,232
Accounts receivable, net of allowances			12,252
Inventories			6,483
Prepaid expenses and other current assets			6,881
Total current assets			88,848
Property and equipment, net			282,560
Restricted cash			10,461
Deposits with supplier			1,084
Other assets			7,862
Total assets			390,815
Current liabilities
Accounts payable			14,562
Accrued expenses and other current liabilities			36,480
Accrued compensation			14,665
Deferred revenue			2,111
Debt, current			247,248
Total current liabilities			315,066
Debt, non-current			15,430
Redeemable convertible preferred stock warrant liability			12,323
Other liabilities			36,731
Total liabilities			379,550
Redeemable convertible preferred stock			1,812,678			1,812,724
Stockholders' equity (deficit):
Additional paid-in capital			89,789
Accumulated deficit			(1,891,202)
Total stockholders’ equity (deficit)			(1,824,564)			$ (1,604,271)
Total liabilities, redeemable convertible preferred stock, and stockholders’ equity (deficit)			390,815
As Previously Reported
Stockholders' equity (deficit):
Total stockholders’ equity (deficit)			(1,801,413)
Investigation Adjustments
Current assets
Cash and cash equivalents			0
Accounts receivable, net of allowances			0
Inventories			0
Prepaid expenses and other current assets			0
Total current assets			0
Property and equipment, net			0
Restricted cash			0
Deposits with supplier			0
Other assets			0
Total assets			0
Current liabilities
Accounts payable			0
Accrued expenses and other current liabilities			4,849
Accrued compensation			0
Deferred revenue			0
Debt, current			0
Total current liabilities			4,849
Debt, non-current			0
Redeemable convertible preferred stock warrant liability			0
Other liabilities			20,113
Total liabilities			24,962
Redeemable convertible preferred stock			0
Stockholders' equity (deficit):
Additional paid-in capital			0
Accumulated deficit			(24,962)
Total stockholders’ equity (deficit)			(24,962)
Total liabilities, redeemable convertible preferred stock, and stockholders’ equity (deficit)			0
Other Adjustments
Current assets
Cash and cash equivalents			0
Accounts receivable, net of allowances			0
Inventories			0
Prepaid expenses and other current assets			(668)
Total current assets			(668)
Property and equipment, net			0
Restricted cash			0
Deposits with supplier			0
Other assets			0
Total assets			(668)
Current liabilities
Accounts payable			0
Accrued expenses and other current liabilities			821
Accrued compensation			(3,838)
Deferred revenue			538
Debt, current			0
Total current liabilities			(2,479)
Debt, non-current			0
Redeemable convertible preferred stock warrant liability			0
Other liabilities			0
Total liabilities			(2,479)
Redeemable convertible preferred stock			0
Stockholders' equity (deficit):
Additional paid-in capital			0
Accumulated deficit			1,811
Total stockholders’ equity (deficit)			1,811
Total liabilities, redeemable convertible preferred stock, and stockholders’ equity (deficit)			$ (668)

Restatement of Previously Iss_5

Restatement of Previously Issued Financial Statements - Condensed Consolidated Statements of Comprehensive Loss (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended				6 Months Ended		12 Months Ended
	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020	Dec. 31, 2019
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Revenue	$ 16,926		$ 5,647		$ 26,695	$ 14,679
Costs and expenses:
Cost of revenue	49,610		35,834		85,789	72,297
Research and development	21,040		13,361		37,610	36,449
Selling, general, and administrative	34,633		16,596		56,333	37,960
Total costs and expenses	105,283		65,791		179,732	146,706
Loss from operations	(88,357)		(60,144)		(153,037)	(132,027)
Interest and other income (expense), net
Interest income	15		41		20	486
Interest expense	(331)		(6,146)		(5,639)	(11,431)
Other expense, net			(80)			(105)
Gain (loss) on fair value change, net	(2,065)		(3,068)		5,348	1,360
Interest and other income (expense), net	(7,359)		(9,253)		(16,709)	(9,690)
Loss before benefit (provision) of income taxes	(95,716)		(69,397)		(169,746)	(141,717)
Benefit (provision) for income taxes	(4)		(98)		(9)	(103)
Net and comprehensive loss	(95,720)	$ (74,035)	(69,495)	$ (72,325)	(169,755)	(141,820)	$ (141,800)
Net and comprehensive loss	$ (95,720)		$ (69,495)		$ (169,755)	$ (141,820)
Net loss per share, basic (in shares)	$ (0.45)		$ (41.30)		$ (1.26)	$ (84.94)
Net loss per share, diluted (in shares)	$ (0.45)		$ (41.30)		$ (1.26)	$ (84.94)
Weighted-average shares used in calculation of net loss per share, basic (in shares)	212,116,112		1,682,704		134,240,831	1,669,739
Weighted-average shares used in calculation of net loss per share, diluted (in shares)	212,116,112		1,682,704		134,240,831	1,669,739
As Previously Reported
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Revenue			$ 6,664			$ 15,831
Costs and expenses:
Cost of revenue			33,800			69,372
Research and development			13,536			34,794
Selling, general, and administrative			19,201			42,036
Total costs and expenses			66,537			146,202
Loss from operations			(59,873)			(130,371)
Interest and other income (expense), net
Interest income			41			486
Interest expense			(6,146)			(11,431)
Other expense, net			(80)			(105)
Gain (loss) on fair value change, net			(3,068)			1,360
Interest and other income (expense), net			(9,253)			(9,690)
Loss before benefit (provision) of income taxes			(69,126)			(140,061)
Benefit (provision) for income taxes			(98)			(103)
Net and comprehensive loss			(69,224)			(140,164)
Net and comprehensive loss			$ (69,224)			$ (140,164)
Net loss per share, basic (in shares)			$ (41.14)			$ (83.94)
Net loss per share, diluted (in shares)			$ (41.14)			$ (83.94)
Weighted-average shares used in calculation of net loss per share, basic (in shares)			1,682,704			1,669,739
Weighted-average shares used in calculation of net loss per share, diluted (in shares)			1,682,704			1,669,739
Investigation Adjustments
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Revenue			$ 0			$ 0
Costs and expenses:
Cost of revenue			(1,063)			(2,444)		$ 25,000
Research and development			0			0
Selling, general, and administrative			0			0
Total costs and expenses			(1,063)			(2,444)
Loss from operations			1,063			2,444
Interest and other income (expense), net
Interest income			0			0
Interest expense			0			0
Other expense, net			0			0
Gain (loss) on fair value change, net			0			0
Interest and other income (expense), net			0			0
Loss before benefit (provision) of income taxes			1,063			2,444
Benefit (provision) for income taxes			0			0
Net and comprehensive loss			1,063			2,444		(25,000)
Net and comprehensive loss			$ 1,063			$ 2,444
Net loss per share, basic (in shares)			$ 0.63			$ 1.46
Net loss per share, diluted (in shares)			$ 0.63			$ 1.46
Weighted-average shares used in calculation of net loss per share, basic (in shares)			0			0
Weighted-average shares used in calculation of net loss per share, diluted (in shares)			0			0
Other Adjustments
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Revenue			$ (1,017)			$ (1,152)
Costs and expenses:
Cost of revenue			3,097			5,369
Research and development			(175)			1,655
Selling, general, and administrative			(2,605)			(4,076)
Total costs and expenses			317			2,948
Loss from operations			(1,334)			(4,100)
Interest and other income (expense), net
Interest income			0			0
Interest expense			0			0
Other expense, net			0			0
Gain (loss) on fair value change, net			0			0
Interest and other income (expense), net			0			0
Loss before benefit (provision) of income taxes			(1,334)			(4,100)
Benefit (provision) for income taxes			0			0
Net and comprehensive loss			(1,334)			(4,100)		$ 1,800
Net and comprehensive loss			$ (1,334)			$ (4,100)
Net loss per share, basic (in shares)			$ (0.79)			$ (2.46)
Net loss per share, diluted (in shares)			$ (0.79)			$ (2.46)
Weighted-average shares used in calculation of net loss per share, basic (in shares)			0			0
Weighted-average shares used in calculation of net loss per share, diluted (in shares)			0			0

Restatement of Previously Iss_6

Restatement of Previously Issued Financial Statements - Condensed Consolidated Statements of Cash Flows (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended		12 Months Ended
	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities:
Net loss	$ (95,720)	$ (74,035)	$ (69,495)	$ (72,325)	$ (169,755)	$ (141,820)	$ (141,800)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization					14,021	12,900
Gain on fair value change, net	$ 2,065		3,068		(5,348)	(1,360)
Stock-based compensation					32,737	16,020
Other					917	1,179
Changes in operating assets and liabilities:
Accounts receivable					(662)	6,595
Inventories					(1,812)	525
Prepaid expenses and other current assets					(3,421)	22,640
Other assets					(2,521)	(289)
Accounts payable					(3,378)	(613)
Deferred revenue					2,487	(435)
Accrued compensation					646	790
Accrued expenses and other liabilities					903	1,309
Net cash used in operating activities					(125,168)	(82,559)	$ (82,600)
Non-cash investing and financing activities:
Change in accounts payable balance and other liabilities related to purchase of property and equipment					$ (1,115)	(3,781)
As Previously Reported
Cash flows from operating activities:
Net loss			(69,224)			(140,164)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization						12,040
Gain on fair value change, net			3,068			(1,360)
Stock-based compensation						16,020
Other						1,179
Changes in operating assets and liabilities:
Accounts receivable						5,504
Inventories						525
Prepaid expenses and other current assets						23,294
Other assets						26
Accounts payable						(613)
Deferred revenue						(822)
Accrued compensation						1,313
Accrued expenses and other liabilities						499
Net cash used in operating activities						(82,559)
Non-cash investing and financing activities:
Change in accounts payable balance and other liabilities related to purchase of property and equipment						(2,742)
Investigation Adjustments
Cash flows from operating activities:
Net loss			1,063			2,444		$ (25,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization						0
Gain on fair value change, net			0			0
Stock-based compensation						0
Other						0
Changes in operating assets and liabilities:
Accounts receivable						0
Inventories						0
Prepaid expenses and other current assets						0
Other assets						0
Accounts payable						0
Deferred revenue						0
Accrued compensation						0
Accrued expenses and other liabilities						(2,444)
Net cash used in operating activities						0
Non-cash investing and financing activities:
Change in accounts payable balance and other liabilities related to purchase of property and equipment						0
Other Adjustments
Cash flows from operating activities:
Net loss			(1,334)			(4,100)		$ 1,800
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization						860
Gain on fair value change, net			$ 0			0
Stock-based compensation						0
Other						0
Changes in operating assets and liabilities:
Accounts receivable						1,091
Inventories						0
Prepaid expenses and other current assets						(654)
Other assets						(315)
Accounts payable						0
Deferred revenue						387
Accrued compensation						(523)
Accrued expenses and other liabilities						3,254
Net cash used in operating activities						0
Non-cash investing and financing activities:
Change in accounts payable balance and other liabilities related to purchase of property and equipment						$ (1,039)

Reverse Recapitalization (Detai

Reverse Recapitalization (Detail) - USD ($) $ / shares in Units, $ in Thousands	Mar. 08, 2021	Jun. 30, 2021	Jun. 30, 2020
Class of Stock [Line Items]
Proceeds from reverse recapitalization	$ 815,200	$ 815,184	$ 0
Recapitalization exchange, price per share (in dollars per share)	$ 10
Charges associated with the mergers	$ 43,900
Payment for merger related costs, expensed immediately	1,500
Additional Paid-In Capital
Class of Stock [Line Items]
Stock issuance costs recorded in APIC	42,400
Common Class A
Class of Stock [Line Items]
Proceeds from common stock issue net of redemption	374,100
Redemption of CFII common stock	125,900
Proceeds from private investment in public equity	$ 260,800
Price per share (in dollars per share)	$ 10
Proceeds from additional private investment in public equity	$ 180,300
Sale of additional stock issue price per share (in dollars per share)	$ 11.25

Reverse Recapitalization - Sche

Reverse Recapitalization - Schedule of Reverse Recapitalization (Details) - shares	Mar. 08, 2021	Jun. 30, 2021	Mar. 31, 2021	Mar. 07, 2021	Dec. 31, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019
Schedule of Reverse Recapitalization [Line Items]
Common stock, share outstanding (in shares)	217,076,712	217,115,573		76,565,107	1,708,476
CF II Sponsor Earnout Shares outstanding prior to the Merger (in shares)	1,100,000
Shares issued in PIPE financing (in shares)	42,103,156
Shares issued for in kind banker fee payment (in shares)	750,000
Merger and PIPE financing shares (in shares)	42,853,156
Legacy View shares converted (in shares)	123,211,449
Redeemable convertible preferred stock shares outstanding (in shares)		0	0	5,222,852,052	121,431,310	121,431,000	121,431,000	121,436,000
CF II
Schedule of Reverse Recapitalization [Line Items]
Common stock, share outstanding (in shares)	51,012,107			62,500,000
Less redemption of CF II shares (in shares)	(12,587,893)
CF II | Common Class A
Schedule of Reverse Recapitalization [Line Items]
Common stock, share outstanding (in shares)				50,000,000
CF II | Common Class B [Member]
Schedule of Reverse Recapitalization [Line Items]
Common stock, share outstanding (in shares)				12,500,000

Revenue - Schedule of Company's

Revenue - Schedule of Company's Revenue by Products and Services (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Disaggregation of Revenue [Line Items]
Revenue	$ 16,926	$ 5,647	$ 26,695	$ 14,679
Products
Disaggregation of Revenue [Line Items]
Revenue	16,814	4,945	26,525	13,889
Services
Disaggregation of Revenue [Line Items]
Revenue	112	702	170	790
Smart Glass
Disaggregation of Revenue [Line Items]
Revenue	11,580	5,647	19,795	14,679
Smart Building Platform
Disaggregation of Revenue [Line Items]
Revenue	5,136	0	5,136	0
Smart Building Technologies
Disaggregation of Revenue [Line Items]
Revenue	$ 210	$ 0	$ 1,764	$ 0

Revenue - Additional Informatio

Revenue - Additional Information (Detail) - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Disaggregation of Revenue [Line Items]
Current contract assets	$ 2,700,000	$ 1,200,000
Noncurrent contract assets	700,000	$ 0
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-01-01
Disaggregation of Revenue [Line Items]
Revenue recognize period
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-07-01
Disaggregation of Revenue [Line Items]
Transaction price allocated to remaining performance obligation	$ 4,900,000
Minimum | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-07-01
Disaggregation of Revenue [Line Items]
Revenue recognize period	12 months
Maximum | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-07-01
Disaggregation of Revenue [Line Items]
Revenue recognize period	24 months

Revenue - Schedule of Company_2

Revenue - Schedule of Company's Revenue by Geographic Area (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Disaggregation of Revenue [Line Items]
Revenue	$ 16,926	$ 5,647	$ 26,695	$ 14,679
United States
Disaggregation of Revenue [Line Items]
Revenue	12,053	5,322	21,718	14,009
Canada
Disaggregation of Revenue [Line Items]
Revenue	4,403	299	4,507	620
Other
Disaggregation of Revenue [Line Items]
Revenue	$ 470	$ 26	$ 470	$ 50

Fair Value - Schedule of Fair V

Fair Value - Schedule of Fair Value Measurements (Detail) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Cash equivalents:
Cash equivalents	$ 407,458	$ 38,574
Restricted cash:
Certificates of deposit	8,468	11,461
Total assets measured at fair value	415,926	50,035
Private warrants liability	639
Sponsor earn-out liability	26,101
Redeemable convertible preferred stock warrants		12,323
Total liabilities measured at fair value	26,740	12,323
Money market funds
Cash equivalents:
Cash equivalents	407,458	38,574
Level 1
Cash equivalents:
Cash equivalents	407,458	38,574
Restricted cash:
Certificates of deposit		0
Total assets measured at fair value	407,458	38,574
Private warrants liability	0
Sponsor earn-out liability	0
Redeemable convertible preferred stock warrants		0
Total liabilities measured at fair value	0	0
Level 1 | Money market funds
Cash equivalents:
Cash equivalents	407,458	38,574
Level 2
Cash equivalents:
Cash equivalents	0	0
Restricted cash:
Certificates of deposit	8,468	11,461
Total assets measured at fair value	8,468	11,461
Private warrants liability	0
Sponsor earn-out liability	0
Redeemable convertible preferred stock warrants		0
Total liabilities measured at fair value	0	0
Level 2 | Money market funds
Cash equivalents:
Cash equivalents	0	0
Level 3
Cash equivalents:
Cash equivalents	0	0
Restricted cash:
Certificates of deposit	0	0
Total assets measured at fair value	0	0
Private warrants liability	639
Sponsor earn-out liability	26,101
Redeemable convertible preferred stock warrants		12,323
Total liabilities measured at fair value	26,740	12,323
Level 3 | Money market funds
Cash equivalents:
Cash equivalents	$ 0	$ 0

Fair Value - Schedule of level

Fair Value - Schedule of level 3 financial liabilities measured at fair value using significant unobservable inputs (Detail) $ in Thousands	6 Months Ended
	Jun. 30, 2021USD ($)
Private Warrants
Summary of level 3 financial liabilities measured at fair value using significant unobservable inputs [Line Items]
Beginning balance	$ 0
Additions during the period	589
Change in fair value	50
Reclass to additional paid-in-capital upon Closing	0
Ending balance	639
Sponsor Earn-out Liability
Summary of level 3 financial liabilities measured at fair value using significant unobservable inputs [Line Items]
Beginning balance	0
Additions during the period	26,443
Change in fair value	(342)
Reclass to additional paid-in-capital upon Closing	0
Ending balance	26,101
Redeemable Convertible Preferred Stock Warrants
Summary of level 3 financial liabilities measured at fair value using significant unobservable inputs [Line Items]
Beginning balance	12,323
Additions during the period	0
Change in fair value	(5,056)
Reclass to additional paid-in-capital upon Closing	(7,267)
Ending balance	$ 0

Fair Value - Changes In Fair Va

Fair Value - Changes In Fair Value (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Line Items]
Gain (loss) on fair value change, net	$ (2,065)	$ (3,068)	$ 5,348	$ 1,360
Sponsor Earn-out Liability
Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Line Items]
Gain (loss) on fair value change, net	(2,118)	0	342	0
Private Warrants | Warrants to purchase common stock
Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Line Items]
Gain (loss) on fair value change, net	53	0	(50)	0
Redeemable Convertible Preferred Stock Warrants | Warrants to purchase common stock
Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Line Items]
Gain (loss) on fair value change, net	$ 0	$ (3,068)	$ 5,056	$ 1,360

Fair Value - Additional Informa

Fair Value - Additional Information (Detail) - Expected dividends	Jun. 30, 2021	Mar. 08, 2021	Dec. 31, 2020
Redeemable Convertible Preferred Stock Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input		0	0
Sponsor Earn-out Liability
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0	0

Fair Value - Schedule of Assump

Fair Value - Schedule of Assumptions Used in Determination of Fair Value of Derivatives (Detail)	Jun. 30, 2021yr	Mar. 08, 2021yr	Dec. 31, 2020yr
Redeemable Convertible Preferred Stock Warrants | Expected volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input			0.70
Redeemable Convertible Preferred Stock Warrants | Expected term (in years)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input			2
Redeemable Convertible Preferred Stock Warrants | Expected dividends
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input		0	0
Redeemable Convertible Preferred Stock Warrants | Risk free rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input			0.001
Sponsor Earn-out Liability | Expected volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.3730	0.2920
Sponsor Earn-out Liability | Expected term (in years)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	4.7	5
Sponsor Earn-out Liability | Expected dividends
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0	0
Sponsor Earn-out Liability | Risk free rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.0077	0.0086
Sponsor Earn-out Liability | Stock price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	8.48	9.19
Private Warrants | Expected volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.3730	0.2920
Private Warrants | Expected term (in years)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	4.2	4.5
Private Warrants | Expected dividends
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0	0
Private Warrants | Risk free rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.0067	0.0073
Private Warrants | Stock price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	8.48	9.19
Minimum | Redeemable Convertible Preferred Stock Warrants | Expected volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input		0.52
Minimum | Redeemable Convertible Preferred Stock Warrants | Expected term (in years)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input		0.08
Minimum | Redeemable Convertible Preferred Stock Warrants | Risk free rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input		0.0004
Minimum | Redeemable Convertible Preferred Stock Warrants | Discount for lack of marketability
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input		0.050	0.11
Maximum | Redeemable Convertible Preferred Stock Warrants | Expected volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input		0.75
Maximum | Redeemable Convertible Preferred Stock Warrants | Expected term (in years)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input		7.71
Maximum | Redeemable Convertible Preferred Stock Warrants | Risk free rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input		0.0128
Maximum | Redeemable Convertible Preferred Stock Warrants | Discount for lack of marketability
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input		0.330	0.55

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail)	1 Months Ended		6 Months Ended	12 Months Ended
	Jun. 30, 2021USD ($)ft²	Dec. 31, 2014USD ($)	Jun. 30, 2021USD ($)ft²	Dec. 31, 2020USD ($)	Apr. 30, 2021USD ($)	Jan. 31, 2019ft²	Mar. 31, 2018ft²	Sep. 30, 2015ft²	Jul. 31, 2010USD ($)ft²
Total minimum lease payments	$ 41,267,000		$ 41,267,000
Non-cancelable commitment to purchase certain license subscriptions	$ 10,000,000
Non-cancelable commitment to purchase certain license subscriptions, interest rate before maturity	0.00%		0.00%
Non-cancelable commitment to purchase certain license subscriptions, interest rate after maturity	3.50%		3.50%
Litigation settlement, payment made to third party		$ 32,000,000
Periodic payment term		10 years
Agreement One
Area of land | ft²	77,200		77,200
Agreement Three
Area of land | ft²									300,000
Agreement Four
Area of land | ft²								267,300
Agreement Five
Area of land | ft²							236,804
Agreement Six
Area of land | ft²						510,350
Letter of Credit | Agreement One
Total value of letters of credit issued by bank	$ 1,000,000		$ 1,000,000						$ 400,000
Letter of Credit | Agreement Six
Security deposit	0		0	$ 1,100,000
Total minimum lease payments					$ 19,500,000
Standby Letter of Credit
Total value of letters of credit issued by bank	$ 8,500,000		8,500,000	11,500,000
Amounts drawn under standby letters of credit			$ 0	$ 0

Commitments and Contingencies_2

Commitments and Contingencies - Schedule of future minimum payments (Detail) $ in Thousands	Jun. 30, 2021USD ($)
Leases, Operating [Abstract]
2021 (remaining six months)	$ 2,756
2022	5,618
2023	5,750
2024	5,887
2025	6,026
Thereafter	15,230
Total minimum lease payments	$ 41,267

Commitments and Contingencies_3

Commitments and Contingencies - Litigation Settlement Liability (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Litigation settlement liability - current	$ 3,000	$ 3,000
Litigation settlement liability - non-current	7,239	9,658
Total litigation settlement liability	$ 10,239	$ 12,658

Commitments and Contingencies_4

Commitments and Contingencies - Northern District of Mississippi Environmental Investigation (Details) - Northern District of Mississippi Environmental Matter - USD ($)	Apr. 13, 2022	Jun. 30, 2021
Long-term Purchase Commitment [Line Items]
Litigation settlement, penalties incurred		$ 5,000,000
Subsequent Event
Long-term Purchase Commitment [Line Items]
Agree to probation years	3 years
Subsequent Event | Environmental Management System Implementation
Long-term Purchase Commitment [Line Items]
Loss contingency, estimate of possible loss	$ 300,000
Subsequent Event | Wastewater Reduction Plan Implementation
Long-term Purchase Commitment [Line Items]
Loss contingency, estimate of possible loss	2,000,000
Federal Government | Subsequent Event
Long-term Purchase Commitment [Line Items]
Litigation settlement, amount due to third-party	$ 3,000,000
Litigation settlement, repayment period	3 years
Yearly installment amount	$ 1,000,000
Special assessment amount	125
Mississippi Commission On Environmental Quality | Subsequent Event
Long-term Purchase Commitment [Line Items]
Litigation settlement, amount due to third-party	1,500,000
Desoto County Regional Utility Authority | Subsequent Event
Long-term Purchase Commitment [Line Items]
Litigation settlement, amount due to third-party	$ 500,000

Debt - Schedule of Debt (Detail

Debt - Schedule of Debt (Detail) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2021	Dec. 31, 2020	Jan. 04, 2020
Debt Instrument [Line Items]
Long-term debt	$ 15,430
Debt discount	0	$ (2,752)
Total Debt	15,430	262,678
Debt, current	735	247,248
Debt, non-current	$ 14,695	15,430
London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Variable interest rate	9.05%
Term loan
Debt Instrument [Line Items]
Long-term debt	$ 15,430	15,430
Interest rate	0.00%
Line of Credit
Debt Instrument [Line Items]
Long-term debt	$ 0	$ 250,000	$ 250,000

Debt - Schedule of Estimated Pr

Debt - Schedule of Estimated Principal Payments on all Debt Outstanding (Detail) $ in Thousands	Jun. 30, 2021USD ($)
Long-term Debt, Fiscal Year Maturity [Abstract]
2021 (remaining nine months)	$ 0
2022	1,470
2023	1,470
2024	1,470
2025	1,470
Thereafter	9,550
Total	$ 15,430

Debt - Additional Information (

Debt - Additional Information (Detail)

Mar. 08, 2021USD ($)

Oct. 22, 2020USD ($)

May 31, 2020USD ($)

Oct. 31, 2019USD ($)

Dec. 31, 2020USD ($)notedraw

Jun. 30, 2021USD ($)day

Jun. 30, 2020USD ($)

Jun. 30, 2021USD ($)day

Jun. 30, 2020USD ($)

Jan. 04, 2020USD ($)

Jan. 03, 2020USD ($)

Nov. 22, 2010USD ($)day

Number of days audited financials are to be delivered to lender | day

210

210

Long-term debt

$ 15,430,000

$ 15,430,000

Repayment of long term line of credit

257,454,000

$ 75,000,000

Loss on extinguishment of debt

0

$ 0

$ 10,018,000

$ 0

London Interbank Offered Rate (LIBOR)

Variable interest rate

9.05%

Line of Credit

Long-term debt

$ 250,000,000

$ 0

$ 0

$ 250,000,000

Term loan | Mississippi

Debt Instrument face amount

$ 40,000,000

Number of semi-annual installments | day

24

Amended and restated term loan

Debt instrument semi annual payments

$ 700,000

Revolving debt facility

Line of credit facility maximum borrowing capacity

$ 200,000,000

Proceeds from line of credit

$ 100,000,000

$ 150,000,000

Repayment of long term line of credit

$ 276,800,000

Repayment of interest due on the notes

26,800,000

Loss on extinguishment of debt

$ 10,000,000

Amended revolving debt facility

Debt Instrument face amount

$ 37,500,000

Amended revolving debt facility | 13 Weekly Draw

Number of draws | draw

13

Proceeds from previous weekly draw

$ 2,900,000

Amended revolving debt facility | 4 Weekly Draw

Number of draws | note

4

Proceeds from previous weekly draw

$ 9,400,000

Minimum | Revolving debt facility

Maturity dates

8 days

Maximum | Revolving debt facility

Maturity dates

364 days

Stockholders' Equity (Detail)

Stockholders' Equity (Detail) - USD ($)	Jun. 30, 2021	Mar. 31, 2021	Mar. 08, 2021	Mar. 07, 2021	Dec. 31, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019
Temporary Equity [Line Items]
Redeemable convertible preferred stock authorized (in shares)	0				224,409,612
Redeemable convertible preferred stock shares outstanding (in shares)	0	0		5,222,852,052	121,431,310	121,431,000	121,431,000	121,436,000
Redeemable convertible preferred stock		$ 0			$ 1,812,678,000	$ 1,812,678,000	$ 1,812,678,000	$ 1,812,724,000
Redeemable convertible preferred stock liquidation preference	$ 0				$ 1,749,201,000
Common stock issuable upon conversion (in shares)					121,431,310
Common stock, shares authorized (in shares)	600,000,000		600,000,000		262,797,235
Common stock, par value (in dollars per share)	$ 0.0001		$ 0.0001		$ 0.0001
Common stock, shares issued (in shares)	217,115,573				1,708,476
Common stock, shares outstanding (in shares)	217,115,573		217,076,712	76,565,107	1,708,476
Preferred stock, shares authorized (in shares)	1,000,000				0
Preferred stock, par value (in dollars per share)	$ 0.0001				$ 0.0001
Preferred stock, shares issued (in shares)	0				0
Preferred stock, shares outstanding (in shares)	0				0
A
Temporary Equity [Line Items]
Redeemable convertible preferred stock authorized (in shares)					23,250
Redeemable convertible preferred stock shares outstanding (in shares)					18,441
Redeemable convertible preferred stock					$ 166,000
Redeemable convertible preferred stock liquidation preference					$ 238,000
Common stock issuable upon conversion (in shares)					18,441
B
Temporary Equity [Line Items]
Redeemable convertible preferred stock authorized (in shares)					1,571,798
Redeemable convertible preferred stock shares outstanding (in shares)					1,217,066
Redeemable convertible preferred stock					$ 19,210,000
Redeemable convertible preferred stock liquidation preference					$ 18,845,000
Common stock issuable upon conversion (in shares)					1,217,066
C
Temporary Equity [Line Items]
Redeemable convertible preferred stock authorized (in shares)					2,274,766
Redeemable convertible preferred stock shares outstanding (in shares)					608,118
Redeemable convertible preferred stock					$ 11,495,000
Redeemable convertible preferred stock liquidation preference					$ 11,417,000
Common stock issuable upon conversion (in shares)					608,118
D
Temporary Equity [Line Items]
Redeemable convertible preferred stock authorized (in shares)					2,673,700
Redeemable convertible preferred stock shares outstanding (in shares)					612,994
Redeemable convertible preferred stock					$ 13,263,000
Redeemable convertible preferred stock liquidation preference					$ 13,235,000
Common stock issuable upon conversion (in shares)					612,994
E
Temporary Equity [Line Items]
Redeemable convertible preferred stock authorized (in shares)					7,440,000
Redeemable convertible preferred stock shares outstanding (in shares)					4,606,784
Redeemable convertible preferred stock					$ 100,225,000
Redeemable convertible preferred stock liquidation preference					$ 119,361,000
Common stock issuable upon conversion (in shares)					4,606,784
E-1
Temporary Equity [Line Items]
Redeemable convertible preferred stock authorized (in shares)					131,584
Redeemable convertible preferred stock shares outstanding (in shares)					0
Redeemable convertible preferred stock					$ 0
Redeemable convertible preferred stock liquidation preference					$ 0
Common stock issuable upon conversion (in shares)					0
E-2
Temporary Equity [Line Items]
Redeemable convertible preferred stock authorized (in shares)					115,787
Redeemable convertible preferred stock shares outstanding (in shares)					0
Redeemable convertible preferred stock					$ 0
Redeemable convertible preferred stock liquidation preference					$ 0
Common stock issuable upon conversion (in shares)					0
F
Temporary Equity [Line Items]
Redeemable convertible preferred stock authorized (in shares)					10,462,500
Redeemable convertible preferred stock shares outstanding (in shares)					4,861,658
Redeemable convertible preferred stock					$ 175,182,000
Redeemable convertible preferred stock liquidation preference					$ 188,193,000
Common stock issuable upon conversion (in shares)					4,861,658
G
Temporary Equity [Line Items]
Redeemable convertible preferred stock authorized (in shares)					62,775,000
Redeemable convertible preferred stock shares outstanding (in shares)					47,881,788
Redeemable convertible preferred stock					$ 330,466,000
Redeemable convertible preferred stock liquidation preference					$ 231,686,000
Common stock issuable upon conversion (in shares)					47,881,788
G-1
Temporary Equity [Line Items]
Redeemable convertible preferred stock authorized (in shares)					930,000
Redeemable convertible preferred stock shares outstanding (in shares)					0
Redeemable convertible preferred stock					$ 0
Redeemable convertible preferred stock liquidation preference					$ 0
Common stock issuable upon conversion (in shares)					0
H
Temporary Equity [Line Items]
Redeemable convertible preferred stock authorized (in shares)					75,177,482
Redeemable convertible preferred stock shares outstanding (in shares)					10,613,198
Redeemable convertible preferred stock					$ 197,488,000
Redeemable convertible preferred stock liquidation preference					$ 200,852,000
Common stock issuable upon conversion (in shares)					10,613,198
H-1
Temporary Equity [Line Items]
Redeemable convertible preferred stock authorized (in shares)					60,833,745
Redeemable convertible preferred stock shares outstanding (in shares)					51,011,263
Redeemable convertible preferred stock					$ 965,183,000
Redeemable convertible preferred stock liquidation preference					$ 965,374,000
Common stock issuable upon conversion (in shares)					51,011,263

Stock Warrants - Additional Inf

Stock Warrants - Additional Information (Detail) - $ / shares	6 Months Ended
	Jun. 30, 2021	Mar. 07, 2021
Class of warrants or rights number of securities called by each warrant or right (in shares)		1
Class of warrants or rights exercise price of warrants or rights (in dollars per share)		$ 11.50
Length of trading period used to determine reference value	30 days
Class of warrant or right exercised (in shares)	0
Private Warrants
Class of warrants or rights maturity (in shares)		366,666
Terminating initial public offering term	5 years
Public Warrants
Class of warrants or rights maturity (in shares)		16,666,637
Class of warrants or rights exercise price of warrants or rights (in dollars per share)	$ 11.50
Terminating initial public offering term	5 years
Class of warrant or right period of redemption of outstanding warrants with prior written notice of redemption	30 days
Number of trading days within trading period	20 days
Redemption price (in dollars per share)	$ 0.01
Minimum share price for warrant redemption (in dollars per share)	$ 18
Public and Private Warrant
Class of warrants or rights exercise price of warrants or rights (in dollars per share)		$ 11.50

Stock Warrants - Schedule of Ou

Stock Warrants - Schedule of Outstanding Common Stock Warrants (Detail) - $ / shares	Jun. 30, 2021	Mar. 07, 2021	Dec. 31, 2020
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	20,311,920		3,394,867
Exercise price per warrant (in dollars per share)		$ 11.50
Private Warrants
Class of Warrant or Right [Line Items]
Class of warrants or rights maturity (in shares)		366,666
Public Warrants
Class of Warrant or Right [Line Items]
Exercise price per warrant (in dollars per share)	$ 11.50
Class of warrants or rights maturity (in shares)		16,666,637
August 2010 - June 2011 | Common stock (previously Series B redeemable convertible preferred stock)
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	46,498		46,498
Exercise price per warrant (in dollars per share)	$ 15.49
August 2011 - January 2012 | Common stock (previously Series C redeemable convertible preferred stock)
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	53,256		53,256
Exercise price per warrant (in dollars per share)	$ 18.78
August 2012 | Common stock (previously Series D redeemable convertible preferred stock)
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	45,388		45,388
Exercise price per warrant (in dollars per share)	$ 21.60
December 2013 | Common stock (previously Series E redeemable convertible preferred stock)
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	63,296		63,296
Exercise price per warrant (in dollars per share)	$ 25.91
April 2015 - April 2016 | Common stock (previously Series F redeemable convertible preferred stock)
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	45,207		161,457
Exercise price per warrant (in dollars per share)	$ 38.71
April 2016 - November 2018 | Common stock (previously Series H redeemable convertible preferred stock)
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	1,135,391		1,135,391
Exercise price per warrant (in dollars per share)	$ 18.93
March 2017 | Common stock (previously Series H redeemable convertible preferred stock)
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	1,849,431		1,849,431
Exercise price per warrant (in dollars per share)	$ 12.91
March 2014 | Common stock
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	2,324		2,324
Exercise price per warrant (in dollars per share)	$ 9.47
August 2015 | Common stock
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	12,916		12,916
Exercise price per warrant (in dollars per share)	$ 11.62
December 2018 | Common stock
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	24,910		24,910
Exercise price per warrant (in dollars per share)	$ 9.04
August 2020 | Common stock | Private Warrants
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	366,666		0
Exercise price per warrant (in dollars per share)	$ 11.50
August 2020 | Common stock | Public Warrants
Class of Warrant or Right [Line Items]
Number of warrants (in shares)	16,666,637		0
Exercise price per warrant (in dollars per share)	$ 11.50

Stock-Based Compensation - Addi

Stock-Based Compensation - Additional Information (Detail) - USD ($)	Mar. 08, 2021	Dec. 31, 2021	Jun. 30, 2021	Dec. 31, 2020
Options granted (in shares)	5,000,000		5,000,000
Share-based compensation arrangement by share-based payment award, options, outstanding, number (in shares)			29,587,000	24,915,000
Weighted-average exercise price (in dollars per share)			$ 9.44	$ 9.32
Share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value (in dollars per share)			$ 4.38
Share-based compensation arrangement by share-based payment award, options, vested in period, fair value			$ 12,800,000
Intrinsic value of options exercised			400,000
Unrecognized compensation cost related to unvested stock options			$ 52,000,000
Compensation cost related to unvested stock options expected to be recognised over a weighted average service period			2 years 4 months 24 days
Weighted-average remaining contractual term			7 years 7 months 6 days	7 years 7 months 6 days
Aggregate Intrinsic Value, Exercisable			$ 55,000
2018 Plan
Options granted (in shares)			0
Share-based compensation arrangement by share-based payment award, expiration period			10 years
2018 Plan | Vesting Option One
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage			20.00%
Share based compensation arrangement by share based payment award vesting period			1 year
2018 Plan | Vesting Option One | Subsequent Event
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage		1.67%
2018 Plan | Vesting Option One | Officer Options
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage	25.00%
2018 Plan | Vesting Option Two
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage			25.00%
Share based compensation arrangement by share based payment award vesting period			1 year
2018 Plan | Vesting Option Two | Subsequent Event
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage		2.08%
2021 Plan
Share-based compensation arrangement by share-based payment award, options, outstanding, number (in shares)	24,657,302
Share based payment arrangement number of options available to purchase (in shares)	58,631,907
Share-based compensation arrangement by share-based payment award, number of shares available for grant (in shares)			15,590,157
2021 Plan | Officer Restricted Stock Units
Share based compensation by share based payment arrangement equity instruments other than granted during the period (in shares)	12,500,000
2021 Plan | Officer Restricted Stock Units | Share Price Hurdle Achieved One
Share based compensation arrangement by share based payment award percentage of non option equity instruments granted	50.00%
Share based payment arrangement by share based payment award vested after share price hurdle achieved (in dollars per share)	$ 15
2021 Plan | Officer Restricted Stock Units | Share Price Hurdle Achieved Two
Share based compensation arrangement by share based payment award percentage of non option equity instruments granted	50.00%
Share based payment arrangement by share based payment award vested after share price hurdle achieved (in dollars per share)	$ 20
2021 Plan | Officer Options | Common Class A
Share based payment arrangement number of options available to purchase (in shares)	5,000,000
2021 Plan | Unvested restricted stock units
Share based compensation by share based payment arrangement equity instruments other than granted during the period (in shares)			12,758,000
2021 Plan | Vesting Option One | Officer Restricted Stock Units
Share based compensation arrangement by share based payment award vesting period	4 years
2021 Plan | Vesting Option One | Officer Options
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage	25.00%
Share based compensation arrangement by share based payment award vesting period	4 years
2021 Plan | Vesting Option Two | Officer Restricted Stock Units
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage	75.00%
Share based compensation arrangement by share based payment award vesting period	36 months
2021 Plan | Vesting Option Two | Officer Options
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage	75.00%
Share based compensation arrangement by share based payment award vesting period	36 months
CEO Incentive Plan
Options granted (in shares)			25,000,000
Weighted-average exercise price (in dollars per share)			$ 10
Share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value (in dollars per share)			$ 3.54
Unrecognized compensation cost related to unvested stock options			$ 82,500,000
Weighted-average remaining contractual term			9 years 8 months 12 days
Aggregate Intrinsic Value, Exercisable			$ 0
Share based compensation by share based payment award options shares issued in period				0
Compensation cost related to options expected to be recognised over a weighted average service period			4 years 10 months 24 days
CEO Incentive Plan | Common Stock
Share based compensation arrangement option granted to purchase stock at exercise price (in dollars per share)	$ 10
CEO Incentive Plan | Unvested restricted stock units
Grant date fair value of RSUs vested			$ 200,000
Unrecognised compensation cost related to Equity instruments other than options			$ 66,000,000
Compensation cost related to equity instruments other than options expected to be recognised over a weighted average service period			2 years

Stock-Based Compensation - Sche

Stock-Based Compensation - Schedule of Stock Options Exercisable under CEO Incentive Plan (Detail) - $ / shares	Mar. 08, 2021	Jun. 30, 2021
Option Shares	5,000,000	5,000,000
CEO Incentive Plan | Share-based Payment Arrangement, Tranche One
Option Shares		2,500,000
Share based payment arrangement by share based payment award vested after share price hurdle achieved (in dollars per share)		$ 20
CEO Incentive Plan | Share-based Payment Arrangement, Tranche Two
Option Shares		2,500,000
Share based payment arrangement by share based payment award vested after share price hurdle achieved (in dollars per share)		$ 30
CEO Incentive Plan | Share-based Payment Arrangement, Tranche Three
Option Shares		2,500,000
Share based payment arrangement by share based payment award vested after share price hurdle achieved (in dollars per share)		$ 40
CEO Incentive Plan | Share-based Payment Arrangement Tranche Four
Option Shares		2,500,000
Share based payment arrangement by share based payment award vested after share price hurdle achieved (in dollars per share)		$ 50
CEO Incentive Plan | Share-based Payment Arrangement Tranche Five
Option Shares		2,500,000
Share based payment arrangement by share based payment award vested after share price hurdle achieved (in dollars per share)		$ 60
CEO Incentive Plan | Share-based Payment Arrangement Tranche Six
Option Shares		2,500,000
Share based payment arrangement by share based payment award vested after share price hurdle achieved (in dollars per share)		$ 70
CEO Incentive Plan | Share-based Payment Arrangement Tranche Seven
Option Shares		2,500,000
Share based payment arrangement by share based payment award vested after share price hurdle achieved (in dollars per share)		$ 80
CEO Incentive Plan | Share-based Payment Arrangement Tranche Eight
Option Shares		2,500,000
Share based payment arrangement by share based payment award vested after share price hurdle achieved (in dollars per share)		$ 90
CEO Incentive Plan | Share-based Payment Arrangement Tranche Nine
Option Shares		2,500,000
Share based payment arrangement by share based payment award vested after share price hurdle achieved (in dollars per share)		$ 100
CEO Incentive Plan | Share-based Payment Arrangement Tranche Ten
Option Shares		2,500,000
Share based payment arrangement by share based payment award vested after share price hurdle achieved (in dollars per share)		$ 110

Stock-Based Compensation - Sc_2

Stock-Based Compensation - Schedule of Share-based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable (Detail) - USD ($) $ / shares in Units, $ in Thousands	Mar. 08, 2021	Jun. 30, 2021	Dec. 31, 2020
Number of Shares Subject to Stock Options Outstanding
Outstanding, beginning balance (in shares)		24,915,000
Options granted (in shares)	5,000,000	5,000,000
Exercised (in shares)		(190,000)
Canceled/forfeited (in shares)		(138,000)
Outstanding, ending balance (in shares)		29,587,000	24,915,000
Options vested and expected to vest as of June 30, 2021 (in shares)		28,584,000
Exercisable as of June 30, 2021 (in shares)		16,281,000
Weighted- Average Exercise Price
Weighted-Average Exercise Price, Outstanding, beginning balance (in dollars per share)		$ 9.32
Options granted (in dollars per share)		10
Exercised (in dollars per share)		9.04
Canceled/forfeited (in dollars per share)		9.29
Weighted-Average Exercise Price, Outstanding, ending balance (in dollars per share)		9.44	$ 9.32
Weighted-Average Exercise Price, Options vested and expected to vest (in dollars per share)		9.46
Weighted-Average Exercise Price, Exercisable (in dollars per share)		$ 9.48
Weighted-Average Remaining Contractual Term, Outstanding		7 years 7 months 6 days	7 years 7 months 6 days
Weighted-Average Remaining Contractual Term, Options vested and expected to vest		7 years 7 months 6 days
Weighted-Average Remaining Contractual Term, Exercisable		7 years
Aggregate Intrinsic Value, Outstanding, beginning balance		$ 20,564
Aggregate Intrinsic Value, Outstanding, ending balance		186	$ 20,564
Aggregate Intrinsic Value, Options vested and expected to vest		164
Aggregate Intrinsic Value, Exercisable		$ 55
Share price (in dollars per share)		$ 8.48
Pro Forma
Weighted- Average Exercise Price
Share price (in dollars per share)			$ 9.89
As Previously Reported
Number of Shares Subject to Stock Options Outstanding
Outstanding, beginning balance (in shares)		1,071,605,000
Outstanding, ending balance (in shares)			1,071,605,000
Weighted- Average Exercise Price
Weighted-Average Exercise Price, Outstanding, beginning balance (in dollars per share)		$ 0.22
Weighted-Average Exercise Price, Outstanding, ending balance (in dollars per share)			$ 0.22
Weighted-Average Remaining Contractual Term, Outstanding			7 years 7 months 6 days
Aggregate Intrinsic Value, Outstanding, beginning balance		$ 20,564
Aggregate Intrinsic Value, Outstanding, ending balance			$ 20,564
Retroactive application of reverse recapitalization
Number of Shares Subject to Stock Options Outstanding
Outstanding, beginning balance (in shares)		(1,046,690,000)
Outstanding, ending balance (in shares)			(1,046,690,000)

Stock Based Compensation - Sche

Stock Based Compensation - Schedule of Outstanding Restricted Stock Units (Detail) - 2021 Plan - Unvested restricted stock units shares in Thousands	6 Months Ended
	Jun. 30, 2021$ / sharesshares
Number of Shares
Outstanding as of December 31, 2020 (in shares) | shares	0
Granted (in shares) | shares	12,758
Vested (in shares) | shares	(35)
Outstanding as of June 30, 2021 (in shares) | shares	12,723
Weighted Average Grant Date Fair Value
Outstanding as of December 31, 2020 (in dollars per share) | $ / shares	$ 0
Granted (in dollars per share) | $ / shares	6.15
Vested (in dollars per share) | $ / shares	7.23
Outstanding as of June 30, 2021 (in dollars per share) | $ / shares	$ 6.15

Stock-Based Compensation - Sc_3

Stock-Based Compensation - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Detail) - $ / shares	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Expected stock price (in dollars per share)	$ 8.48
Share-based Payment Arrangement, Option | CEO Option Award
Expected volatility	54.00%
Expected terms (in years)	10 years
Expected dividends	0.00%
Risk-free rate	1.59%
Expected stock price (in dollars per share)	$ 9.19
Discount for lack of marketability	20.00%
Share-based Payment Arrangement, Option | Officer
Expected volatility	53.00%
Expected terms (in years)	6 years
Expected dividends	0.00%
Risk-free rate	1.07%
Expected stock price (in dollars per share)	$ 9.19
Unvested restricted stock units | Officer
Expected volatility	56.00%
Expected terms (in years)	4 years
Expected dividends	0.00%
Risk-free rate	0.60%
Expected stock price (in dollars per share)	$ 9.19
Share-based Payment Arrangement, Employee
Expected volatility	53.00%	70.00%
Expected terms (in years)	6 years
Expected dividends	0.00%	0.00%
Risk-free rate	1.07%
Share-based Payment Arrangement, Employee | Minimum
Expected terms (in years)		5 years 4 months 24 days
Risk-free rate		0.40%
Share-based Payment Arrangement, Employee | Maximum
Expected terms (in years)		6 years 8 months 12 days
Risk-free rate		1.50%

Stock-Based Compensation - Sc_4

Stock-Based Compensation - Schedule of Stock-based Compensation (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Share-based compensation expense	$ 22,274	$ 6,802	$ 32,737	$ 16,020
Cost of revenue
Share-based compensation expense	1,297	570	2,175	1,116
Research and development
Share-based compensation expense	2,628	559	3,543	3,467
Selling, general, and administrative
Share-based compensation expense	$ 18,349	$ 5,673	$ 27,019	$ 11,437

Income Taxes (Detail)

Income Taxes (Detail)	Jun. 30, 2021USD ($)
Income Tax Disclosure [Abstract]
Unrecognized tax benefits	$ 0

Net Loss Per Share - Schedule o

Net Loss Per Share - Schedule of Basic and Diluted Net Loss Per Share (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended				6 Months Ended		12 Months Ended
	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Earnings Per Share [Abstract]
Net loss	$ (95,720)	$ (74,035)	$ (69,495)	$ (72,325)	$ (169,755)	$ (141,820)	$ (141,800)
Weighted-average shares outstanding, basic (in shares)	212,116,112		1,682,704		134,240,831	1,669,739
Weighted-average shares outstanding, diluted (in shares)	212,116,112		1,682,704		134,240,831	1,669,739
Net loss per share, basic (in dollars per share)	$ (0.45)		$ (41.30)		$ (1.26)	$ (84.94)
Net loss per share, diluted (in dollars per share)	$ (0.45)		$ (41.30)		$ (1.26)	$ (84.94)

Net Loss Per Share - Schedule_2

Net Loss Per Share - Schedule of Antidilutive Securities Excluded From Computation of Earnings Per Share (Detail) - shares	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share	50,156,755	149,889,832
Stock options to purchase common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share	29,587,210	25,063,655
Unvested restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share	257,625	0
Warrants to purchase common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share	20,311,920	40,150
Redeemable convertible preferred stock (on an if-converted basis)
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share	0	121,431,310
Warrants to purchase redeemable convertible preferred stock (on an if-converted basis)
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share	0	3,354,717

Net Loss Per Share - Additional

Net Loss Per Share - Additional Information (Detail) - shares	Mar. 08, 2021	Jun. 30, 2021
Earn out shares subject to vesting and potential forfeiture	4,970,000	4,970,000
Options granted (in shares)	5,000,000	5,000,000
Non Qualified Stock Option Awards | CEO Option Award
Options granted (in shares)	25,000,000	25,000,000
Unvested restricted stock units | Officer
Share based compensation by share based payment arrangement equity instruments other than granted during the period (in shares)	12,500,000	12,500,000